# publications

authors: Lakshmi N Yatham
journal: ClinicalTrials.gov
publication_date: 2026-05-01
source_url: https://clinicaltrials.gov/study/NCT06943573
source_record_id: https://clinicaltrials.gov/study/NCT06943573
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:45
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06943573
text_rights_status: unverified_not_redistributed
title:
Psilocybin-Assisted Therapy for Treatment-Resistant Depression in Bipolar II Disorder: A Randomized Controlled Trial

topic_tags:
Depression,Wellbeing,Randomized Controlled Trial,Healthy Volunteers,Treatment-Resistant Depression,Safety

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06943573","source_url":"https://clinicaltrials.gov/study/NCT06943573","doi":"","pmid":"","publication_date":"2026-05-01","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin With Intracranial Neural Sensing
authors: Joshua Woolley, MD, PhD
journal: ClinicalTrials.gov
publication_date: 2025-06-06
source_url: https://clinicaltrials.gov/study/NCT06919640
source_record_id: https://clinicaltrials.gov/study/NCT06919640
substance_tags: psilocybin
topic_tags: Chronic Pain
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:43
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06919640
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06919640","source_url":"https://clinicaltrials.gov/study/NCT06919640","doi":"","pmid":"","publication_date":"2025-06-06","importer_version":"2.1.3","text_redistributed":false}


title: Safety for Home Administration of Microdose Psilocybin Use
authors: Johns Hopkins University
journal: ClinicalTrials.gov
publication_date: 2026-02-23
source_url: https://clinicaltrials.gov/study/NCT06450210
source_record_id: https://clinicaltrials.gov/study/NCT06450210
substance_tags: psilocybin
topic_tags: Microdosing,Healthy Volunteers,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:43
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06450210
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06450210","source_url":"https://clinicaltrials.gov/study/NCT06450210","doi":"","pmid":"","publication_date":"2026-02-23","importer_version":"2.1.3","text_redistributed":false}


title: Exploration of Synaptotrophic Effects of Psilocybin in Opioid Use Disorder (OUD)
authors: Yale University
journal: ClinicalTrials.gov
publication_date: 2026-07-07
source_url: https://clinicaltrials.gov/study/NCT06160284
source_record_id: https://clinicaltrials.gov/study/NCT06160284
substance_tags: psilocybin
topic_tags: Addiction,Brain Imaging,Aging,Toxicity
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:43
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06160284
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06160284","source_url":"https://clinicaltrials.gov/study/NCT06160284","doi":"","pmid":"","publication_date":"2026-07-07","importer_version":"2.1.3","text_redistributed":false}


authors: Johns Hopkins University
journal: ClinicalTrials.gov
publication_date: 2026-03-16
source_url: https://clinicaltrials.gov/study/NCT04123314
source_record_id: https://clinicaltrials.gov/study/NCT04123314
substance_tags: psilocybin
topic_tags: Depression,Receptor Pharmacology
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:45
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT04123314
text_rights_status: unverified_not_redistributed
title:
Pilot Study of Serotonin 2A Receptor (5-HT2A) Agonist Psilocybin for Depression in Patients With Mild Cognitive Impairment or Early Alzheimer's Disease

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT04123314","source_url":"https://clinicaltrials.gov/study/NCT04123314","doi":"","pmid":"","publication_date":"2026-03-16","importer_version":"2.1.3","text_redistributed":false}


authors: Milan Scheidegger
journal: ClinicalTrials.gov
publication_date: 2023-09-21
source_url: https://clinicaltrials.gov/study/NCT05780216
source_record_id: https://clinicaltrials.gov/study/NCT05780216
substance_tags: psilocybin
topic_tags: Brain Imaging,Receptor Pharmacology,Consciousness,Aging,Healthy Volunteers,Drug Interactions
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:44
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05780216
text_rights_status: unverified_not_redistributed
title:
Mindfulness and Psychedelics: A Combined Neurophenomenological and Pharmacological Approach to the Characterization of Mindfulness States in Experienced Meditators

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05780216","source_url":"https://clinicaltrials.gov/study/NCT05780216","doi":"","pmid":"","publication_date":"2023-09-21","importer_version":"2.1.3","text_redistributed":false}


authors: Alan Davis
journal: ClinicalTrials.gov
publication_date: 2026-05-14
source_url: https://clinicaltrials.gov/study/NCT07216404
source_record_id: https://clinicaltrials.gov/study/NCT07216404
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Clinical Trial,Observational Study,Cancer Patients,Safety,Adverse Events
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:44
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07216404
text_rights_status: unverified_not_redistributed
title:
Exploring the Safety, Acceptability, and Efficacy of Psilocybin Among Non-Small Cell Lung Cancer Patients With Major Depressive Disorder: A Proof-of-Concept Trial (DREAM LUNG STUDY)

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07216404","source_url":"https://clinicaltrials.gov/study/NCT07216404","doi":"","pmid":"","publication_date":"2026-05-14","importer_version":"2.1.3","text_redistributed":false}


title: Targeting Reward Circuits: Psilocybin as a Novel Therapy for Residual Anhedonia
authors: NYU Langone Health
journal: ClinicalTrials.gov
publication_date: 2026-05-27
source_url: https://clinicaltrials.gov/study/NCT07607938
source_record_id: https://clinicaltrials.gov/study/NCT07607938
substance_tags: psilocybin
topic_tags: Brain Imaging,Emotional Processing
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:45
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07607938
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07607938","source_url":"https://clinicaltrials.gov/study/NCT07607938","doi":"","pmid":"","publication_date":"2026-05-27","importer_version":"2.1.3","text_redistributed":false}


authors: Centre for Addiction and Mental Health
journal: ClinicalTrials.gov
publication_date: 2026-02-25
source_url: https://clinicaltrials.gov/study/NCT06041152
source_record_id: https://clinicaltrials.gov/study/NCT06041152
substance_tags: psilocybin
topic_tags: Neuroplasticity,Brain Imaging,Clinical Trial,Healthy Volunteers
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:45
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06041152
text_rights_status: unverified_not_redistributed
title:
Does Psilocybin Change Synaptic Density in the Brains of Patients With Amnestic Mild Cognitive Impairment

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06041152","source_url":"https://clinicaltrials.gov/study/NCT06041152","doi":"","pmid":"","publication_date":"2026-02-25","importer_version":"2.1.3","text_redistributed":false}


authors: Sheppard Pratt Health System
journal: ClinicalTrials.gov
publication_date: 2024-08-09
source_url: https://clinicaltrials.gov/study/NCT04433858
source_record_id: https://clinicaltrials.gov/study/NCT04433858
substance_tags: psilocybin
topic_tags: Depression,Treatment-Resistant Depression,Safety
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:45
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT04433858
text_rights_status: unverified_not_redistributed
title:
An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD)

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT04433858","source_url":"https://clinicaltrials.gov/study/NCT04433858","doi":"","pmid":"","publication_date":"2024-08-09","importer_version":"2.1.3","text_redistributed":false}


authors: University Health Network, Toronto
journal: ClinicalTrials.gov
publication_date: 2026-07-09
source_url: https://clinicaltrials.gov/study/NCT06341426
source_record_id: https://clinicaltrials.gov/study/NCT06341426
substance_tags: psilocybin
topic_tags: Depression,Clinical Trial,Observational Study,Treatment-Resistant Depression,Safety,Adverse Events
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:45
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06341426
text_rights_status: unverified_not_redistributed
title:
Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: A Randomized Phase II Clinical Trial Comparing One Versus Two Psychedelic Doses of Psilocybin (PSI-1V2)

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06341426","source_url":"https://clinicaltrials.gov/study/NCT06341426","doi":"","pmid":"","publication_date":"2026-07-09","importer_version":"2.1.3","text_redistributed":false}


authors: MycoMedica Life Sciences PBC
journal: ClinicalTrials.gov
publication_date: 2025-06-12
source_url: https://clinicaltrials.gov/study/NCT06643637
source_record_id: https://clinicaltrials.gov/study/NCT06643637
substance_tags: psilocybin
topic_tags: Pharmacology,Microdosing,Clinical Trial,Healthy Volunteers,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:43
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06643637
text_rights_status: unverified_not_redistributed
title:
A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of MLS101 (Psilocybin) in Healthy Participants

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06643637","source_url":"https://clinicaltrials.gov/study/NCT06643637","doi":"","pmid":"","publication_date":"2025-06-12","importer_version":"2.1.3","text_redistributed":false}


authors: Felix Mueller
journal: ClinicalTrials.gov
publication_date: 2025-04-14
source_url: https://clinicaltrials.gov/study/NCT05570708
source_record_id: https://clinicaltrials.gov/study/NCT05570708
substance_tags: psilocybin
topic_tags: Consciousness,Safety,Drug Interactions
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:44
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05570708
text_rights_status: unverified_not_redistributed
title:
The Role of Personal Experience for the Therapeutic Attitude in the Context of Substance-assisted Therapy Training

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05570708","source_url":"https://clinicaltrials.gov/study/NCT05570708","doi":"","pmid":"","publication_date":"2025-04-14","importer_version":"2.1.3","text_redistributed":false}


authors: University of North Carolina, Chapel Hill
journal: ClinicalTrials.gov
publication_date: 2026-05-06
source_url: https://clinicaltrials.gov/study/NCT06303739
source_record_id: https://clinicaltrials.gov/study/NCT06303739
substance_tags: psilocybin
topic_tags: Depression,Clinical Trial,Observational Study,Treatment-Resistant Depression
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:43
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06303739
text_rights_status: unverified_not_redistributed
title:
Induction Protocol for Psilocybin-Assisted Therapy in Treatment-Resistant Depression (TRD): A Pilot Study

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06303739","source_url":"https://clinicaltrials.gov/study/NCT06303739","doi":"","pmid":"","publication_date":"2026-05-06","importer_version":"2.1.3","text_redistributed":false}


title: Group Psilocybin-Assisted Therapy for Post-Traumatic Stress Disorder
authors: University of New Mexico
journal: ClinicalTrials.gov
publication_date: 2026-05-22
source_url: https://clinicaltrials.gov/study/NCT07506395
source_record_id: https://clinicaltrials.gov/study/NCT07506395
substance_tags: psilocybin
topic_tags: PTSD,Clinical Trial,Healthcare Workers,Safety,Adverse Events
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:44
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07506395
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07506395","source_url":"https://clinicaltrials.gov/study/NCT07506395","doi":"","pmid":"","publication_date":"2026-05-22","importer_version":"2.1.3","text_redistributed":false}


authors: Usona Institute
journal: ClinicalTrials.gov
publication_date: 2026-07-23
source_url: https://clinicaltrials.gov/study/NCT06308653
source_record_id: https://clinicaltrials.gov/study/NCT06308653
substance_tags: psilocybin
topic_tags: Depression,Safety,Adverse Events
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:45
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06308653
text_rights_status: unverified_not_redistributed
title:
A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Psilocybin in Adults With Major Depressive Disorder (MDD)

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06308653","source_url":"https://clinicaltrials.gov/study/NCT06308653","doi":"","pmid":"","publication_date":"2026-07-23","importer_version":"2.1.3","text_redistributed":false}


authors: Psyence Australia Pty Ltd
journal: ClinicalTrials.gov
publication_date: 2026-03-03
source_url: https://clinicaltrials.gov/study/NCT07072728
source_record_id: https://clinicaltrials.gov/study/NCT07072728
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Clinical Trial,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:44
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07072728
text_rights_status: unverified_not_redistributed
title:
A Phase 2b Double-blind, Randomized, Low-dose Comparator-controlled Clinical Trial to Assess the Efficacy and Safety of NPX-5 in Psilocybin-assisted Psychotherapy for the Treatment of Adjustment Disorder Associated With Cancer.

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07072728","source_url":"https://clinicaltrials.gov/study/NCT07072728","doi":"","pmid":"","publication_date":"2026-03-03","importer_version":"2.1.3","text_redistributed":false}


authors: University of California, San Francisco
journal: ClinicalTrials.gov
publication_date: 2025-06-10
source_url: https://clinicaltrials.gov/study/NCT05317689
source_record_id: https://clinicaltrials.gov/study/NCT05317689
substance_tags: psilocybin,psilocin
topic_tags: Healthcare Workers,Safety
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:44
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05317689
text_rights_status: unverified_not_redistributed
title:
Comparison of the Effects of PEX20 (Oral Psilocin), PEX30 (Sublingual Psilocin), and PEX10 (Oral Psilocybin) in Healthy Adults

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05317689","source_url":"https://clinicaltrials.gov/study/NCT05317689","doi":"","pmid":"","publication_date":"2025-06-10","importer_version":"2.1.3","text_redistributed":false}


authors: Usona Institute
journal: ClinicalTrials.gov
publication_date: 2023-08-15
source_url: https://clinicaltrials.gov/study/NCT05478278
source_record_id: https://clinicaltrials.gov/study/NCT05478278
substance_tags: psilocybin
topic_tags: Pharmacology,Clinical Trial,Healthy Volunteers
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:42
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05478278
text_rights_status: unverified_not_redistributed
title:
A Phase 1, Two-Part Study in Healthy Volunteers to Evaluate The Effect of Psilocybin on Cardiac Repolarization and The Effect of Food on Psilocybin Pharmacokinetics

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05478278","source_url":"https://clinicaltrials.gov/study/NCT05478278","doi":"","pmid":"","publication_date":"2023-08-15","importer_version":"2.1.3","text_redistributed":false}


title: Safety and Efficacy of Psilocybin for the Treatment of Headache Disorders: Sub-Study II
authors: Yale University
journal: ClinicalTrials.gov
publication_date: 2023-10-12
source_url: https://clinicaltrials.gov/study/NCT03806985
source_record_id: https://clinicaltrials.gov/study/NCT03806985
substance_tags: psilocybin
topic_tags: Headache / Migraine,Safety,Inflammation
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:45
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT03806985
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT03806985","source_url":"https://clinicaltrials.gov/study/NCT03806985","doi":"","pmid":"","publication_date":"2023-10-12","importer_version":"2.1.3","text_redistributed":false}


authors: Sunstone Medical
journal: ClinicalTrials.gov
publication_date: 2026-05-06
source_url: https://clinicaltrials.gov/study/NCT05947383
source_record_id: https://clinicaltrials.gov/study/NCT05947383
substance_tags: psilocybin
topic_tags: Depression,Clinical Trial,Observational Study,Cancer Patients,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:43
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05947383
text_rights_status: unverified_not_redistributed
title:
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of up to Two Doses of Psilocybin for the Treatment of Major Depressive Disorder in Adults With Cancer

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05947383","source_url":"https://clinicaltrials.gov/study/NCT05947383","doi":"","pmid":"","publication_date":"2026-05-06","importer_version":"2.1.3","text_redistributed":false}


authors: Unity Health Toronto
journal: ClinicalTrials.gov
publication_date: 2026-06-26
source_url: https://clinicaltrials.gov/study/NCT06386003
source_record_id: https://clinicaltrials.gov/study/NCT06386003
substance_tags: psilocybin
topic_tags: PTSD,Healthcare Workers,Safety
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:41
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06386003
text_rights_status: unverified_not_redistributed
title:
Psilocybin-Assisted Massed Cognitive Processing Therapy for Chronic Posttraumatic Stress Disorder: An Open-label Trial

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06386003","source_url":"https://clinicaltrials.gov/study/NCT06386003","doi":"","pmid":"","publication_date":"2026-06-26","importer_version":"2.1.3","text_redistributed":false}


authors: Centre Hospitalier Universitaire de Nīmes
journal: ClinicalTrials.gov
publication_date: 2025-08-21
source_url: https://clinicaltrials.gov/study/NCT06647056
source_record_id: https://clinicaltrials.gov/study/NCT06647056
substance_tags: psilocybin
topic_tags: Default Mode Network,Emotional Processing
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:41
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06647056
text_rights_status: unverified_not_redistributed
title:
Evaluation of the Effect of a Single Dose of Psilocybin on Neural Correlates of Cognitive Control in Patients With Psychogenic Nonepileptic Seizures

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06647056","source_url":"https://clinicaltrials.gov/study/NCT06647056","doi":"","pmid":"","publication_date":"2025-08-21","importer_version":"2.1.3","text_redistributed":false}


title: Safety and Tolerability of Psilocybin in Post-Traumatic Stress Disorder
authors: Johns Hopkins University
journal: ClinicalTrials.gov
publication_date: 2024-01-05
source_url: https://clinicaltrials.gov/study/NCT05562973
source_record_id: https://clinicaltrials.gov/study/NCT05562973
substance_tags: psilocybin
topic_tags: PTSD,Clinical Trial,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:45
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05562973
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05562973","source_url":"https://clinicaltrials.gov/study/NCT05562973","doi":"","pmid":"","publication_date":"2024-01-05","importer_version":"2.1.3","text_redistributed":false}


authors: Centre for Addiction and Mental Health
journal: ClinicalTrials.gov
publication_date: 2026-02-12
source_url: https://clinicaltrials.gov/study/NCT07405606
source_record_id: https://clinicaltrials.gov/study/NCT07405606
substance_tags: psilocybin
topic_tags: Depression,Addiction,Clinical Trial,Safety,Adverse Events
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:45
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07405606
text_rights_status: unverified_not_redistributed
title:
Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder: A Pilot Randomized Clinical Trial

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07405606","source_url":"https://clinicaltrials.gov/study/NCT07405606","doi":"","pmid":"","publication_date":"2026-02-12","importer_version":"2.1.3","text_redistributed":false}


authors: Imperial College London
journal: ClinicalTrials.gov
publication_date: 2025-12-05
source_url: https://clinicaltrials.gov/study/NCT06798636
source_record_id: https://clinicaltrials.gov/study/NCT06798636
substance_tags: psilocybin
topic_tags: Depression,Mechanism of Action,Emotional Processing,Safety
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:45
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06798636
text_rights_status: unverified_not_redistributed
title:
Investigating the Effects of a Psychedelic-augmented Mental Imagery-based Intervention for Young People With Self-harm Behaviour: an Experimental Medicine Study

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06798636","source_url":"https://clinicaltrials.gov/study/NCT06798636","doi":"","pmid":"","publication_date":"2025-12-05","importer_version":"2.1.3","text_redistributed":false}


title: The Therapeutic Potential of Psilocybin in Anorexia Nervosa in Young Adults
authors: Region Skane
journal: ClinicalTrials.gov
publication_date: 2026-03-06
source_url: https://clinicaltrials.gov/study/NCT07169747
source_record_id: https://clinicaltrials.gov/study/NCT07169747
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:45
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07169747
text_rights_status: unverified_not_redistributed
topic_tags:
Anxiety,Eating Disorders,Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Biomarkers,Aging,Personality Change,Emotional Processing,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Review Article,Animal Study,Adolescents,Healthcare Workers,Safety,Adverse Events,Toxicity,Drug Interactions

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07169747","source_url":"https://clinicaltrials.gov/study/NCT07169747","doi":"","pmid":"","publication_date":"2026-03-06","importer_version":"2.1.3","text_redistributed":false}


title: The Neurobiological Effect of 5-HT2AR Modulation
authors: Gitte Moos Knudsen
journal: ClinicalTrials.gov
publication_date: 2024-12-16
source_url: https://clinicaltrials.gov/study/NCT03289949
source_record_id: https://clinicaltrials.gov/study/NCT03289949
substance_tags: psilocybin
topic_tags: Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Healthy Volunteers
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:41
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT03289949
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT03289949","source_url":"https://clinicaltrials.gov/study/NCT03289949","doi":"","pmid":"","publication_date":"2024-12-16","importer_version":"2.1.3","text_redistributed":false}


title: Effects of Psilocybin and Spiritual Practice on Persisting Changes in Attitudes and Behavior
authors: Johns Hopkins University
journal: ClinicalTrials.gov
publication_date: 2016-02-24
source_url: https://clinicaltrials.gov/study/NCT00802282
source_record_id: https://clinicaltrials.gov/study/NCT00802282
substance_tags: psilocybin
topic_tags: Spirituality,Healthy Volunteers
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:42
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT00802282
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT00802282","source_url":"https://clinicaltrials.gov/study/NCT00802282","doi":"","pmid":"","publication_date":"2016-02-24","importer_version":"2.1.3","text_redistributed":false}


authors: Apex Labs Ltd.
journal: ClinicalTrials.gov
publication_date: 2023-11-29
source_url: https://clinicaltrials.gov/study/NCT06141876
source_record_id: https://clinicaltrials.gov/study/NCT06141876
substance_tags: psilocybin
topic_tags: Depression,Anxiety,PTSD,Addiction,OCD,Safety,Adverse Events
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:45
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06141876
text_rights_status: unverified_not_redistributed
title:
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of Psilocybin-Assisted Psychotherapy in Treating Severe Depression Among Adults With Post-Traumatic Stress Disorder (PTSD).

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06141876","source_url":"https://clinicaltrials.gov/study/NCT06141876","doi":"","pmid":"","publication_date":"2023-11-29","importer_version":"2.1.3","text_redistributed":false}


authors: King's College London
journal: ClinicalTrials.gov
publication_date: 2026-07-23
source_url: https://clinicaltrials.gov/study/NCT05723276
source_record_id: https://clinicaltrials.gov/study/NCT05723276
substance_tags: psilocybin
topic_tags: Brain Imaging,Default Mode Network,Aging
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:45
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05723276
text_rights_status: unverified_not_redistributed
title:
Probing the Functional Magnetic Resonance Imaging Response to Psilocybin in Functional Neurological Disorder (PsiFUND)

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05723276","source_url":"https://clinicaltrials.gov/study/NCT05723276","doi":"","pmid":"","publication_date":"2026-07-23","importer_version":"2.1.3","text_redistributed":false}


authors: University of Helsinki
journal: ClinicalTrials.gov
publication_date: 2017-12-21
source_url: https://clinicaltrials.gov/study/NCT03380442
source_record_id: https://clinicaltrials.gov/study/NCT03380442
substance_tags: psilocybin
topic_tags: Depression,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Emotional Processing
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:44
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT03380442
text_rights_status: unverified_not_redistributed
title:
Psilocybin and Depression - Assessing the Long-term Effects of a Single Administration of Psilocybin on the Psychiatric Symptoms and Brain Activity of Patients With Severe Depression

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT03380442","source_url":"https://clinicaltrials.gov/study/NCT03380442","doi":"","pmid":"","publication_date":"2017-12-21","importer_version":"2.1.3","text_redistributed":false}


authors: University of Calgary
journal: ClinicalTrials.gov
publication_date: 2024-05-07
source_url: https://clinicaltrials.gov/study/NCT05995769
source_record_id: https://clinicaltrials.gov/study/NCT05995769
substance_tags: psilocybin
topic_tags: Addiction,Brain Imaging,Mechanism of Action,Aging,Clinical Trial
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:45
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05995769
text_rights_status: unverified_not_redistributed
title:
Mechanisms Supporting Psilocybin-assisted Psychotherapy for Alcohol Use Disorder: A Randomized, Controlled Clinical Trial

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05995769","source_url":"https://clinicaltrials.gov/study/NCT05995769","doi":"","pmid":"","publication_date":"2024-05-07","importer_version":"2.1.3","text_redistributed":false}


authors: Emory University
journal: ClinicalTrials.gov
publication_date: 2025-07-23
source_url: https://clinicaltrials.gov/study/NCT05506982
source_record_id: https://clinicaltrials.gov/study/NCT05506982
substance_tags: psilocybin
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:45
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05506982
text_rights_status: unverified_not_redistributed
title:
The Safety, Feasibility, and Acceptability of Psilocybin Combined With Multidisciplinary Palliative Care in Demoralized Cancer Survivors With Chronic Pain (P-PC)

topic_tags:
Depression,Anxiety,End-of-Life Distress,Chronic Pain,Mystical Experience,Clinical Trial,Cancer Patients,Safety,Adverse Events

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05506982","source_url":"https://clinicaltrials.gov/study/NCT05506982","doi":"","pmid":"","publication_date":"2025-07-23","importer_version":"2.1.3","text_redistributed":false}


title: A Phase 1 Study Comparing the Pharmacokinetics and Safety of Intravenous and Oral Psilocybin
authors: University of Wisconsin, Madison
journal: ClinicalTrials.gov
publication_date: 2023-05-15
source_url: https://clinicaltrials.gov/study/NCT05467761
source_record_id: https://clinicaltrials.gov/study/NCT05467761
substance_tags: psilocybin,psilocin
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:45
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05467761
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Anxiety,Addiction,Pharmacology,Clinical Trial,Cancer Patients,Treatment-Resistant Depression,Safety,Adverse Events

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05467761","source_url":"https://clinicaltrials.gov/study/NCT05467761","doi":"","pmid":"","publication_date":"2023-05-15","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN
authors: Unity Health Toronto
journal: ClinicalTrials.gov
publication_date: 2025-03-30
source_url: https://clinicaltrials.gov/study/NCT06731335
source_record_id: https://clinicaltrials.gov/study/NCT06731335
substance_tags: psilocybin
topic_tags: Chronic Pain,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Safety
study_type: Randomized Controlled Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:42
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06731335
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06731335","source_url":"https://clinicaltrials.gov/study/NCT06731335","doi":"","pmid":"","publication_date":"2025-03-30","importer_version":"2.1.3","text_redistributed":false}


title: A Pilot Mechanistic Study of Psilocybin-Assisted Therapy as a Treatment for Depression
authors: Washington University School of Medicine
journal: ClinicalTrials.gov
publication_date: 2026-05-20
source_url: https://clinicaltrials.gov/study/NCT07582120
source_record_id: https://clinicaltrials.gov/study/NCT07582120
substance_tags: psilocybin
topic_tags: Depression,Biomarkers,Psychological Flexibility,Clinical Trial
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:44
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07582120
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07582120","source_url":"https://clinicaltrials.gov/study/NCT07582120","doi":"","pmid":"","publication_date":"2026-05-20","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin-Assisted Therapy for Prolonged Grief
authors: University of Virginia
journal: ClinicalTrials.gov
publication_date: 2026-06-23
source_url: https://clinicaltrials.gov/study/NCT06724289
source_record_id: https://clinicaltrials.gov/study/NCT06724289
substance_tags: psilocybin
topic_tags: Brain Imaging,Aging,Spirituality,Mystical Experience,Clinical Trial
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:45
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06724289
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06724289","source_url":"https://clinicaltrials.gov/study/NCT06724289","doi":"","pmid":"","publication_date":"2026-06-23","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin for Treatment of Alcohol Use Disorder: a Feasibility Study
authors: Anders Fink-Jensen, MD, DMSci
journal: ClinicalTrials.gov
publication_date: 2024-07-12
source_url: https://clinicaltrials.gov/study/NCT04718792
source_record_id: https://clinicaltrials.gov/study/NCT04718792
substance_tags: psilocybin,psilocin
topic_tags: Addiction,Pharmacology,Receptor Pharmacology,Safety,Adverse Events
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:45
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT04718792
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT04718792","source_url":"https://clinicaltrials.gov/study/NCT04718792","doi":"","pmid":"","publication_date":"2024-07-12","importer_version":"2.1.3","text_redistributed":false}


authors: NWTraumatherapies
journal: ClinicalTrials.gov
publication_date: 2022-11-16
source_url: https://clinicaltrials.gov/study/NCT05042466
source_record_id: https://clinicaltrials.gov/study/NCT05042466
substance_tags: psilocybin
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:41
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05042466
text_rights_status: unverified_not_redistributed
title:
NW Trauma Therapies, Chronic Illness of Chronic Depression, PTSD, MS, HIV, and SARS-CoV-2, Long Haulers Syndrome. Treatment of Unregulaaible Trauma by the Treatment of Enhanced Micro Dosing the Levels of 0.15, Thru 0.33, With a Maintenance Dose of 1 Gram Per Month for Neural Pathway Increase of Non Synthesized Psilocybin, Using the Actual Plant to Regulate the Highjacked Nervous System.

topic_tags:
Depression,PTSD,End-of-Life Distress,Mechanism of Action,Receptor Pharmacology,Microdosing,Immune Function

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05042466","source_url":"https://clinicaltrials.gov/study/NCT05042466","doi":"","pmid":"","publication_date":"2022-11-16","importer_version":"2.1.3","text_redistributed":false}


authors: University of Washington
journal: ClinicalTrials.gov
publication_date: 2025-10-14
source_url: https://clinicaltrials.gov/study/NCT06644170
source_record_id: https://clinicaltrials.gov/study/NCT06644170
substance_tags: psilocybin
topic_tags: Anxiety,Receptor Pharmacology,Wellbeing,Clinical Trial,Safety,Adverse Events
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:42
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06644170
text_rights_status: unverified_not_redistributed
title:
A Phase 1 Study of a Second Psilocybin Group Retreat for Partial Responders With Anxiety Associated With Metastatic Cancer

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06644170","source_url":"https://clinicaltrials.gov/study/NCT06644170","doi":"","pmid":"","publication_date":"2025-10-14","importer_version":"2.1.3","text_redistributed":false}


authors: Gustavo Vazquez
journal: ClinicalTrials.gov
publication_date: 2026-03-18
source_url: https://clinicaltrials.gov/study/NCT06818994
source_record_id: https://clinicaltrials.gov/study/NCT06818994
substance_tags: psilocybin
topic_tags: Depression,Anxiety,End-of-Life Distress,Aging,Clinical Trial,Cancer Patients,Safety,Adverse Events
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:41
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06818994
text_rights_status: unverified_not_redistributed
title:
Safety and Efficacy of Psilocybin-assisted Psychotherapy for Demoralization Syndrome in Patients Diagnosed With Advanced Stage Cancer: a Pilot Study

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06818994","source_url":"https://clinicaltrials.gov/study/NCT06818994","doi":"","pmid":"","publication_date":"2026-03-18","importer_version":"2.1.3","text_redistributed":false}


authors: Charles Raison
journal: ClinicalTrials.gov
publication_date: 2026-08-10
source_url: https://clinicaltrials.gov/study/NCT06512194
source_record_id: https://clinicaltrials.gov/study/NCT06512194
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Aging,Wellbeing,Adverse Events
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-13 01:25:57
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06512194
text_rights_status: unverified_not_redistributed
title:
An Investigation of Strategies to Understand and Optimize the Antidepressant Effects of Psilocybin (The OPTIMIZE Study)

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06512194","source_url":"https://clinicaltrials.gov/study/NCT06512194","doi":"","pmid":"","publication_date":"2026-08-10","importer_version":"2.1.3","text_redistributed":false}


title: Pilot Study of Psilocybin-assisted Treatment for Cannabis Use Disorder
authors: Johns Hopkins University
journal: ClinicalTrials.gov
publication_date: 2026-03-18
source_url: https://clinicaltrials.gov/study/NCT06660381
source_record_id: https://clinicaltrials.gov/study/NCT06660381
substance_tags: psilocybin
topic_tags: Biomarkers
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:42
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06660381
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06660381","source_url":"https://clinicaltrials.gov/study/NCT06660381","doi":"","pmid":"","publication_date":"2026-03-18","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative Mechanisms
authors: Imperial College London
journal: ClinicalTrials.gov
publication_date: 2024-10-24
source_url: https://clinicaltrials.gov/study/NCT03429075
source_record_id: https://clinicaltrials.gov/study/NCT03429075
substance_tags: psilocybin
topic_tags: Depression,Mechanism of Action,Receptor Pharmacology,Clinical Trial
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:44
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT03429075
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT03429075","source_url":"https://clinicaltrials.gov/study/NCT03429075","doi":"","pmid":"","publication_date":"2024-10-24","importer_version":"2.1.3","text_redistributed":false}


title: Behavioral and Neural Mechanisms Supporting Psilocybin-assisted Therapy for Phantom Limb Pain
authors: University of California, San Diego
journal: ClinicalTrials.gov
publication_date: 2026-01-09
source_url: https://clinicaltrials.gov/study/NCT05224336
source_record_id: https://clinicaltrials.gov/study/NCT05224336
substance_tags: psilocybin
topic_tags: Chronic Pain,Mechanism of Action
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:42
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05224336
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05224336","source_url":"https://clinicaltrials.gov/study/NCT05224336","doi":"","pmid":"","publication_date":"2026-01-09","importer_version":"2.1.3","text_redistributed":false}


authors: University Hospital, Basel, Switzerland
journal: ClinicalTrials.gov
publication_date: 2025-04-11
source_url: https://clinicaltrials.gov/study/NCT05695495
source_record_id: https://clinicaltrials.gov/study/NCT05695495
substance_tags: psilocybin
topic_tags: Consciousness,Spirituality
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:44
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05695495
text_rights_status: unverified_not_redistributed
title:
Acute Dose-dependent Effects of DMT-bolus Applications in Healthy Subjects: A Placebo-controlled Cross-over Study (DMT BDR-Study).

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05695495","source_url":"https://clinicaltrials.gov/study/NCT05695495","doi":"","pmid":"","publication_date":"2025-04-11","importer_version":"2.1.3","text_redistributed":false}


authors: Centre for Addiction and Mental Health
journal: ClinicalTrials.gov
publication_date: 2026-07-30
source_url: https://clinicaltrials.gov/study/NCT06512220
source_record_id: https://clinicaltrials.gov/study/NCT06512220
substance_tags: psilocybin
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:44
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06512220
text_rights_status: unverified_not_redistributed
title:
Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)

topic_tags:
Depression,Neuroplasticity,Brain Imaging,Receptor Pharmacology,Aging,Clinical Trial,Randomized Controlled Trial,Healthy Volunteers,Treatment-Resistant Depression

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06512220","source_url":"https://clinicaltrials.gov/study/NCT06512220","doi":"","pmid":"","publication_date":"2026-07-30","importer_version":"2.1.3","text_redistributed":false}


title: Mechanistic Studies of Psilocybin in Headache Disorders
authors: Yale University
journal: ClinicalTrials.gov
publication_date: 2026-07-13
source_url: https://clinicaltrials.gov/study/NCT06464367
source_record_id: https://clinicaltrials.gov/study/NCT06464367
substance_tags: psilocybin
topic_tags: Headache / Migraine,Neuroplasticity,Brain Imaging,Biomarkers,Clinical Trial,Inflammation
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:42
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06464367
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06464367","source_url":"https://clinicaltrials.gov/study/NCT06464367","doi":"","pmid":"","publication_date":"2026-07-13","importer_version":"2.1.3","text_redistributed":false}


title: Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety
authors: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
journal: ClinicalTrials.gov
publication_date: 2025-03-13
source_url: https://clinicaltrials.gov/study/NCT00302744
source_record_id: https://clinicaltrials.gov/study/NCT00302744
substance_tags: psilocybin
topic_tags: Depression,Anxiety,End-of-Life Distress,Chronic Pain,Consciousness,Spirituality,Cancer Patients
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:44
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT00302744
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT00302744","source_url":"https://clinicaltrials.gov/study/NCT00302744","doi":"","pmid":"","publication_date":"2025-03-13","importer_version":"2.1.3","text_redistributed":false}


authors: University Health Network, Toronto
journal: ClinicalTrials.gov
publication_date: 2026-06-23
source_url: https://clinicaltrials.gov/study/NCT07048743
source_record_id: https://clinicaltrials.gov/study/NCT07048743
substance_tags: psilocybin
topic_tags: Depression,Anxiety,End-of-Life Distress,Spirituality,Clinical Trial,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:42
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07048743
text_rights_status: unverified_not_redistributed
title:
Psilocybin-assisted Existential, Attachment and Relational (PEARL) Therapy for Caregivers of Patients With Advanced Cancer: A Phase II Open-Label Trial

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07048743","source_url":"https://clinicaltrials.gov/study/NCT07048743","doi":"","pmid":"","publication_date":"2026-06-23","importer_version":"2.1.3","text_redistributed":false}


title: Effects of Psilocybin in Obsessive Compulsive Disorder
authors: Johns Hopkins University
journal: ClinicalTrials.gov
publication_date: 2026-04-02
source_url: https://clinicaltrials.gov/study/NCT05546658
source_record_id: https://clinicaltrials.gov/study/NCT05546658
substance_tags: psilocybin
topic_tags: Depression,Anxiety,OCD,Mechanism of Action,Safety
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:44
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05546658
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05546658","source_url":"https://clinicaltrials.gov/study/NCT05546658","doi":"","pmid":"","publication_date":"2026-04-02","importer_version":"2.1.3","text_redistributed":false}


authors: University of Wisconsin, Madison
journal: ClinicalTrials.gov
publication_date: 2026-07-07
source_url: https://clinicaltrials.gov/study/NCT04161066
source_record_id: https://clinicaltrials.gov/study/NCT04161066
substance_tags: psilocybin
topic_tags: Addiction,Chronic Pain,Clinical Trial,Observational Study,Safety,Adverse Events
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:45
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT04161066
text_rights_status: unverified_not_redistributed
title:
Phase I Study of the Safety and Adjunctive Effects of Psilocybin in Adults With Opioid Use Disorder Maintained on a Buprenorphine/Naloxone Formulation

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT04161066","source_url":"https://clinicaltrials.gov/study/NCT04161066","doi":"","pmid":"","publication_date":"2026-07-07","importer_version":"2.1.3","text_redistributed":false}


authors: Wake Network, Inc.
journal: ClinicalTrials.gov
publication_date: 2022-06-30
source_url: https://clinicaltrials.gov/study/NCT04989972
source_record_id: https://clinicaltrials.gov/study/NCT04989972
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Wellbeing,Clinical Trial,Review Article,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:43
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT04989972
text_rights_status: unverified_not_redistributed
title:
Randomized Double Blind Placebo Controlled Assessing the Efficacy of Micro-dosed Psilocybin in Reducing Anxiety and or Depression Levels in Adults

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT04989972","source_url":"https://clinicaltrials.gov/study/NCT04989972","doi":"","pmid":"","publication_date":"2022-06-30","importer_version":"2.1.3","text_redistributed":false}


authors: Scottsdale Research Institute
journal: ClinicalTrials.gov
publication_date: 2026-07-29
source_url: https://clinicaltrials.gov/study/NCT07275970
source_record_id: https://clinicaltrials.gov/study/NCT07275970
substance_tags: psilocybin
topic_tags: PTSD,Pharmacology,Clinical Trial,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:45
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07275970
text_rights_status: unverified_not_redistributed
title:
An Open-Label, Phase 1 Study of the Safety Pharmacokinetic Profile, and Preliminary Efficacy, of Organic Whole Psilocybin-Containing Mushrooms in Patients Suffering From PTSD

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07275970","source_url":"https://clinicaltrials.gov/study/NCT07275970","doi":"","pmid":"","publication_date":"2026-07-29","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin-facilitated Smoking Cessation Treatment: A Pilot Study
authors: Johns Hopkins University
journal: ClinicalTrials.gov
publication_date: 2025-05-25
source_url: https://clinicaltrials.gov/study/NCT01943994
source_record_id: https://clinicaltrials.gov/study/NCT01943994
substance_tags: psilocybin
topic_tags: Addiction,Mechanism of Action,Spirituality,Randomized Controlled Trial
study_type: Randomized Controlled Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:42
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT01943994
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT01943994","source_url":"https://clinicaltrials.gov/study/NCT01943994","doi":"","pmid":"","publication_date":"2025-05-25","importer_version":"2.1.3","text_redistributed":false}


title: Safety Profile of 25 mg Psilocybin in Individuals With Cocaine Use Disorder
authors: University of California, Los Angeles
journal: ClinicalTrials.gov
publication_date: 2026-04-07
source_url: https://clinicaltrials.gov/study/NCT06102434
source_record_id: https://clinicaltrials.gov/study/NCT06102434
substance_tags: psilocybin
topic_tags: Addiction,Brain Imaging,Aging,Healthcare Workers,Safety
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:42
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06102434
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06102434","source_url":"https://clinicaltrials.gov/study/NCT06102434","doi":"","pmid":"","publication_date":"2026-04-07","importer_version":"2.1.3","text_redistributed":false}


title: Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies
authors: University of New Mexico
journal: ClinicalTrials.gov
publication_date: 2026-03-20
source_url: https://clinicaltrials.gov/study/NCT07484906
source_record_id: https://clinicaltrials.gov/study/NCT07484906
substance_tags: psilocybin
study_type: Observational Study
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:44
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07484906
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,PTSD,Neuroplasticity,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Emotional Processing,Observational Study,Veterans,Safety,Transcriptomics

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07484906","source_url":"https://clinicaltrials.gov/study/NCT07484906","doi":"","pmid":"","publication_date":"2026-03-20","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder
authors: Portland VA Research Foundation, Inc
journal: ClinicalTrials.gov
publication_date: 2026-04-22
source_url: https://clinicaltrials.gov/study/NCT04982796
source_record_id: https://clinicaltrials.gov/study/NCT04982796
substance_tags: psilocybin
topic_tags: Clinical Trial,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:44
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT04982796
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT04982796","source_url":"https://clinicaltrials.gov/study/NCT04982796","doi":"","pmid":"","publication_date":"2026-04-22","importer_version":"2.1.3","text_redistributed":false}


authors: University of Zurich
journal: ClinicalTrials.gov
publication_date: 2022-04-29
source_url: https://clinicaltrials.gov/study/NCT03715127
source_record_id: https://clinicaltrials.gov/study/NCT03715127
substance_tags: psilocybin
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:43
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT03715127
text_rights_status: unverified_not_redistributed
title:
Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group, Single Center Study of Psilocybin Efficacy in Major Depression

topic_tags:
Depression,Anxiety,Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Consciousness,Biomarkers,Aging,Resilience,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Review Article,Cancer Patients

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT03715127","source_url":"https://clinicaltrials.gov/study/NCT03715127","doi":"","pmid":"","publication_date":"2022-04-29","importer_version":"2.1.3","text_redistributed":false}


authors: Emory University
journal: ClinicalTrials.gov
publication_date: 2026-05-26
source_url: https://clinicaltrials.gov/study/NCT07332143
source_record_id: https://clinicaltrials.gov/study/NCT07332143
substance_tags: psilocybin
topic_tags: Depression,PTSD,Safety,Adverse Events
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:44
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07332143
text_rights_status: unverified_not_redistributed
title:
The Safety and Acceptability of Psilocybin With Support and With Massed Prolonged Exposure Therapy for PTSD

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07332143","source_url":"https://clinicaltrials.gov/study/NCT07332143","doi":"","pmid":"","publication_date":"2026-05-26","importer_version":"2.1.3","text_redistributed":false}


authors: University of Colorado, Denver
journal: ClinicalTrials.gov
publication_date: 2026-05-22
source_url: https://clinicaltrials.gov/study/NCT06230757
source_record_id: https://clinicaltrials.gov/study/NCT06230757
substance_tags: psilocybin
topic_tags: Depression,Randomized Controlled Trial,Treatment-Resistant Depression
study_type: Randomized Controlled Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:44
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06230757
text_rights_status: unverified_not_redistributed
title:
Effects of Psilocybin With Psychological Support on Anhedonia in Treatment-resistant Depression: a Randomized Controlled Pilot Trial

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06230757","source_url":"https://clinicaltrials.gov/study/NCT06230757","doi":"","pmid":"","publication_date":"2026-05-22","importer_version":"2.1.3","text_redistributed":false}


title: Efficacy in Relapse Prevention: Psilocybin in Alcohol Use Disorder With Depressive Symptoms
authors: Centre Hospitalier Universitaire de Nīmes
journal: ClinicalTrials.gov
publication_date: 2026-07-01
source_url: https://clinicaltrials.gov/study/NCT07638553
source_record_id: https://clinicaltrials.gov/study/NCT07638553
substance_tags: psilocybin
topic_tags: Depression,Addiction,Safety
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:45
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07638553
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07638553","source_url":"https://clinicaltrials.gov/study/NCT07638553","doi":"","pmid":"","publication_date":"2026-07-01","importer_version":"2.1.3","text_redistributed":false}


title: Engaging Mood Brain Circuits With Psilocybin: a Randomized Neuroimaging Trial in Depression
authors: Sunnybrook Health Sciences Centre
journal: ClinicalTrials.gov
publication_date: 2026-03-30
source_url: https://clinicaltrials.gov/study/NCT06072898
source_record_id: https://clinicaltrials.gov/study/NCT06072898
substance_tags: psilocybin
topic_tags: Depression,Brain Imaging,Aging,Clinical Trial
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:44
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06072898
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06072898","source_url":"https://clinicaltrials.gov/study/NCT06072898","doi":"","pmid":"","publication_date":"2026-03-30","importer_version":"2.1.3","text_redistributed":false}


authors: Yale University
journal: ClinicalTrials.gov
publication_date: 2026-06-04
source_url: https://clinicaltrials.gov/study/NCT05370911
source_record_id: https://clinicaltrials.gov/study/NCT05370911
substance_tags: psilocybin
topic_tags: OCD,Mechanism of Action
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:44
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05370911
text_rights_status: unverified_not_redistributed
title:
Effects of Repeated Dosing of Psilocybin on Obsessive-Compulsive Disorder: A Randomized, Waitlist-Controlled Study

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05370911","source_url":"https://clinicaltrials.gov/study/NCT05370911","doi":"","pmid":"","publication_date":"2026-06-04","importer_version":"2.1.3","text_redistributed":false}


authors: University of Zurich
journal: ClinicalTrials.gov
publication_date: 2025-11-19
source_url: https://clinicaltrials.gov/study/NCT06081179
source_record_id: https://clinicaltrials.gov/study/NCT06081179
substance_tags: psilocybin
topic_tags: Receptor Pharmacology,Healthy Volunteers
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:43
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06081179
text_rights_status: unverified_not_redistributed
title:
Does Serotonin System Stimulation Increase Pro-social Behavior? - A Comparative Pharmacological Neuroscientific Study in Healthy Humans

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06081179","source_url":"https://clinicaltrials.gov/study/NCT06081179","doi":"","pmid":"","publication_date":"2025-11-19","importer_version":"2.1.3","text_redistributed":false}


title: Acute Effects of 2C-B Compared With MDMA and Psilocybin in Healthy Subjects
authors: University Hospital, Basel, Switzerland
journal: ClinicalTrials.gov
publication_date: 2025-03-05
source_url: https://clinicaltrials.gov/study/NCT05523401
source_record_id: https://clinicaltrials.gov/study/NCT05523401
substance_tags: psilocybin,psilocin
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:45
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05523401
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,PTSD,Pharmacology,Receptor Pharmacology,Clinical Trial,In Vitro Study,Safety,Drug Interactions

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05523401","source_url":"https://clinicaltrials.gov/study/NCT05523401","doi":"","pmid":"","publication_date":"2025-03-05","importer_version":"2.1.3","text_redistributed":false}


title: Effects and Therapeutic Potential of Psilocybin in Alcohol Dependence
authors: University of New Mexico
journal: ClinicalTrials.gov
publication_date: 2023-09-26
source_url: https://clinicaltrials.gov/study/NCT01534494
source_record_id: https://clinicaltrials.gov/study/NCT01534494
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Spirituality,Safety
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:45
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT01534494
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT01534494","source_url":"https://clinicaltrials.gov/study/NCT01534494","doi":"","pmid":"","publication_date":"2023-09-26","importer_version":"2.1.3","text_redistributed":false}


authors: Kevin Murnane
journal: ClinicalTrials.gov
publication_date: 2025-10-07
source_url: https://clinicaltrials.gov/study/NCT06899594
source_record_id: https://clinicaltrials.gov/study/NCT06899594
substance_tags: psilocybin
topic_tags: Addiction,Emotional Processing,Review Article,Safety
study_type: Review Article
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:45
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06899594
text_rights_status: unverified_not_redistributed
title:
A Pilot Study in North Louisiana to Assess the Tolerability of Psilocybin as Well as Its Capacity to Promote Abstinence From Methamphetamine

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06899594","source_url":"https://clinicaltrials.gov/study/NCT06899594","doi":"","pmid":"","publication_date":"2025-10-07","importer_version":"2.1.3","text_redistributed":false}


authors: Imperial College London
journal: ClinicalTrials.gov
publication_date: 2024-11-06
source_url: https://clinicaltrials.gov/study/NCT06258031
source_record_id: https://clinicaltrials.gov/study/NCT06258031
substance_tags: psilocybin
study_type: Observational Study
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:44
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06258031
text_rights_status: unverified_not_redistributed
title:
PsilOCD: Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity (A Pharmacological-Challenge Feasibility Study)

topic_tags:
OCD,Neuroplasticity,Brain Imaging,Receptor Pharmacology,Biomarkers,Observational Study,Safety,Inflammation

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06258031","source_url":"https://clinicaltrials.gov/study/NCT06258031","doi":"","pmid":"","publication_date":"2024-11-06","importer_version":"2.1.3","text_redistributed":false}


authors: University Hospital, Basel, Switzerland
journal: ClinicalTrials.gov
publication_date: 2026-04-02
source_url: https://clinicaltrials.gov/study/NCT06180759
source_record_id: https://clinicaltrials.gov/study/NCT06180759
substance_tags: psilocybin
topic_tags: Chronic Pain,Headache / Migraine,Clinical Trial,Case Report,Healthy Volunteers
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:44
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06180759
text_rights_status: unverified_not_redistributed
title:
Acute Analgesic Effects of DMT on Experimentally Induced Acute Nociceptive Pain, Hyperalgesia and Allodynia in Healthy Participants

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06180759","source_url":"https://clinicaltrials.gov/study/NCT06180759","doi":"","pmid":"","publication_date":"2026-04-02","importer_version":"2.1.3","text_redistributed":false}


authors: National Council of Scientific and Technical Research, Argentina
journal: ClinicalTrials.gov
publication_date: 2021-12-16
source_url: https://clinicaltrials.gov/study/NCT05160220
source_record_id: https://clinicaltrials.gov/study/NCT05160220
substance_tags: psilocybin
topic_tags: Brain Imaging,Mechanism of Action,Microdosing,Wellbeing,Creativity
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:43
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05160220
text_rights_status: unverified_not_redistributed
title:
Double-blind Placebo-controlled Naturalistic Study of Microdosing With Psilocybin: Effects on Brain Activity, Behavior, Cognition, Creativity, and Mental Health

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05160220","source_url":"https://clinicaltrials.gov/study/NCT05160220","doi":"","pmid":"","publication_date":"2021-12-16","importer_version":"2.1.3","text_redistributed":false}


title: Low-Income Group Psilocybin Assisted Therapy for Depression: A Feasibility Study
authors: Matthew Hicks
journal: ClinicalTrials.gov
publication_date: 2025-06-05
source_url: https://clinicaltrials.gov/study/NCT06372197
source_record_id: https://clinicaltrials.gov/study/NCT06372197
substance_tags: psilocybin
topic_tags: Depression,Mechanism of Action,Consciousness,Clinical Trial,Observational Study,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:45
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06372197
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06372197","source_url":"https://clinicaltrials.gov/study/NCT06372197","doi":"","pmid":"","publication_date":"2025-06-05","importer_version":"2.1.3","text_redistributed":false}


authors: NYU Langone Health
journal: ClinicalTrials.gov
publication_date: 2026-01-23
source_url: https://clinicaltrials.gov/study/NCT06796062
source_record_id: https://clinicaltrials.gov/study/NCT06796062
substance_tags: psilocybin
topic_tags: Addiction,Clinical Trial,Randomized Controlled Trial,Safety
study_type: Randomized Controlled Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:42
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06796062
text_rights_status: unverified_not_redistributed
title:
A Phase 2 Trial of Psilocybin as an Adjunctive Treatment for OUD Patients Who Continue to Use Illicit Opioids Despite Adherence to Methadone Treatment

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06796062","source_url":"https://clinicaltrials.gov/study/NCT06796062","doi":"","pmid":"","publication_date":"2026-01-23","importer_version":"2.1.3","text_redistributed":false}


authors: M.D. Anderson Cancer Center
journal: ClinicalTrials.gov
publication_date: 2026-08-12
source_url: https://clinicaltrials.gov/study/NCT06801041
source_record_id: https://clinicaltrials.gov/study/NCT06801041
substance_tags: psilocybin
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-13 01:25:57
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06801041
text_rights_status: unverified_not_redistributed
title:
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors

topic_tags:
Depression,Anxiety,Chronic Pain,Neuroplasticity,Brain Imaging,Receptor Pharmacology,Biomarkers,Wellbeing,Mystical Experience,Healthcare Workers,Safety,Inflammation,Immune Function

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06801041","source_url":"https://clinicaltrials.gov/study/NCT06801041","doi":"","pmid":"","publication_date":"2026-08-12","importer_version":"2.1.3","text_redistributed":false}


authors: Johns Hopkins University
journal: ClinicalTrials.gov
publication_date: 2026-02-23
source_url: https://clinicaltrials.gov/study/NCT06005662
source_record_id: https://clinicaltrials.gov/study/NCT06005662
substance_tags: psilocybin
topic_tags: Addiction,Clinical Trial,Healthy Volunteers,Adverse Events
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:43
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06005662
text_rights_status: unverified_not_redistributed
title:
Inpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder: a Randomized Double-blind Trial

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06005662","source_url":"https://clinicaltrials.gov/study/NCT06005662","doi":"","pmid":"","publication_date":"2026-02-23","importer_version":"2.1.3","text_redistributed":false}


authors: National Institute of Mental Health, Czech Republic
journal: ClinicalTrials.gov
publication_date: 2022-05-20
source_url: https://clinicaltrials.gov/study/NCT05383313
source_record_id: https://clinicaltrials.gov/study/NCT05383313
substance_tags: psilocybin,psilocin
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:42
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05383313
text_rights_status: unverified_not_redistributed
title:
Psilocybin Versus Ketamine - Fast Acting Antidepressant Strategies in Treatment-resistant Depression

topic_tags:
Depression,Neuroplasticity,Brain Imaging,Biomarkers,Aging,Emotional Processing,Clinical Trial,Healthy Volunteers,Treatment-Resistant Depression,Safety

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05383313","source_url":"https://clinicaltrials.gov/study/NCT05383313","doi":"","pmid":"","publication_date":"2022-05-20","importer_version":"2.1.3","text_redistributed":false}


title: Retrospective Observational Study of Intensity Effects in Psychedelic-assisted Treatment
authors: University Hospital, Geneva
journal: ClinicalTrials.gov
publication_date: 2025-10-02
source_url: https://clinicaltrials.gov/study/NCT07164287
source_record_id: https://clinicaltrials.gov/study/NCT07164287
substance_tags: psilocybin
topic_tags: Depression,Anxiety,PTSD,Addiction,Observational Study,Treatment-Resistant Depression,Safety
study_type: Observational Study
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:42
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07164287
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07164287","source_url":"https://clinicaltrials.gov/study/NCT07164287","doi":"","pmid":"","publication_date":"2025-10-02","importer_version":"2.1.3","text_redistributed":false}


authors: University of Wisconsin, Madison
journal: ClinicalTrials.gov
publication_date: 2026-04-03
source_url: https://clinicaltrials.gov/study/NCT06692192
source_record_id: https://clinicaltrials.gov/study/NCT06692192
substance_tags: psilocybin
topic_tags: Neuroplasticity,Brain Imaging,Wellbeing,Emotional Processing,Clinical Trial
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:41
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06692192
text_rights_status: unverified_not_redistributed
title:
Role of Experience, Conscious Awareness, and Plasticity in Psilocybin's Behavioral Effects - Follow-Up Study (The RECAP 2 Study)

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06692192","source_url":"https://clinicaltrials.gov/study/NCT06692192","doi":"","pmid":"","publication_date":"2026-04-03","importer_version":"2.1.3","text_redistributed":false}


authors: Central Institute of Mental Health, Mannheim
journal: ClinicalTrials.gov
publication_date: 2025-01-20
source_url: https://clinicaltrials.gov/study/NCT04670081
source_record_id: https://clinicaltrials.gov/study/NCT04670081
substance_tags: psilocybin
topic_tags: Depression,Clinical Trial,Treatment-Resistant Depression,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:42
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT04670081
text_rights_status: unverified_not_redistributed
title:
A Phase II Randomized, Double-blind, Active Placebo-controlled Parallel Group Trial to Examine the Efficacy and Safety of Psilocybin in Treatment-resistant Major Depression

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT04670081","source_url":"https://clinicaltrials.gov/study/NCT04670081","doi":"","pmid":"","publication_date":"2025-01-20","importer_version":"2.1.3","text_redistributed":false}


authors: COMPASS Pathways
journal: ClinicalTrials.gov
publication_date: 2023-11-09
source_url: https://clinicaltrials.gov/study/NCT04739865
source_record_id: https://clinicaltrials.gov/study/NCT04739865
substance_tags: psilocybin
topic_tags: Depression,Treatment-Resistant Depression,Safety
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:42
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT04739865
text_rights_status: unverified_not_redistributed
title:
The Safety and Efficacy Of Psilocybin as an Adjunctive Therapy in Participants With Treatment Resistant Depression

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT04739865","source_url":"https://clinicaltrials.gov/study/NCT04739865","doi":"","pmid":"","publication_date":"2023-11-09","importer_version":"2.1.3","text_redistributed":false}


authors: University of Texas at Austin
journal: ClinicalTrials.gov
publication_date: 2025-11-26
source_url: https://clinicaltrials.gov/study/NCT06132178
source_record_id: https://clinicaltrials.gov/study/NCT06132178
substance_tags: psilocybin
topic_tags: Depression,Brain Imaging,Biomarkers,Aging,Clinical Trial,Safety,Inflammation
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:45
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06132178
text_rights_status: unverified_not_redistributed
title:
Assessing the Safety, Tolerability, and Efficacy of Psilocybin Therapy Followed by Accelerated Intermittent Theta Burst (aiTBS) Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment-Resistant Major Depressive Disorder

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06132178","source_url":"https://clinicaltrials.gov/study/NCT06132178","doi":"","pmid":"","publication_date":"2025-11-26","importer_version":"2.1.3","text_redistributed":false}


title: Visual Surround Suppression and Perceptual Expectation Under Psilocybin
authors: University of Minnesota
journal: ClinicalTrials.gov
publication_date: 2025-06-27
source_url: https://clinicaltrials.gov/study/NCT04424225
source_record_id: https://clinicaltrials.gov/study/NCT04424225
substance_tags: psilocybin
topic_tags: Mechanism of Action
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:45
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT04424225
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT04424225","source_url":"https://clinicaltrials.gov/study/NCT04424225","doi":"","pmid":"","publication_date":"2025-06-27","importer_version":"2.1.3","text_redistributed":false}


authors: University of Wisconsin, Madison
journal: ClinicalTrials.gov
publication_date: 2023-05-19
source_url: https://clinicaltrials.gov/study/NCT04842045
source_record_id: https://clinicaltrials.gov/study/NCT04842045
substance_tags: psilocybin
topic_tags: Depression,Addiction,Clinical Trial,Healthy Volunteers,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:44
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT04842045
text_rights_status: unverified_not_redistributed
title:
Recall of Experience and Conscious Awareness in Psilocybin Treatment of Depression (The RECAP Study): Pilot Phase in Healthy Adult Volunteers

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT04842045","source_url":"https://clinicaltrials.gov/study/NCT04842045","doi":"","pmid":"","publication_date":"2023-05-19","importer_version":"2.1.3","text_redistributed":false}


authors: M.D. Anderson Cancer Center
journal: ClinicalTrials.gov
publication_date: 2026-08-12
source_url: https://clinicaltrials.gov/study/NCT06200155
source_record_id: https://clinicaltrials.gov/study/NCT06200155
substance_tags: psilocybin
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-13 01:25:57
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06200155
text_rights_status: unverified_not_redistributed
title:
TRIP - TReatment to Improve Depression and/or Anxiety Using Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy

topic_tags:
Depression,Anxiety,Chronic Pain,Neuroplasticity,Brain Imaging,Receptor Pharmacology,Biomarkers,Wellbeing,Mystical Experience,Healthcare Workers,Safety,Inflammation,Immune Function

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06200155","source_url":"https://clinicaltrials.gov/study/NCT06200155","doi":"","pmid":"","publication_date":"2026-08-12","importer_version":"2.1.3","text_redistributed":false}


authors: Beckley Psytech Limited
journal: ClinicalTrials.gov
publication_date: 2022-10-12
source_url: https://clinicaltrials.gov/study/NCT04905121
source_record_id: https://clinicaltrials.gov/study/NCT04905121
substance_tags: psilocybin
topic_tags: Headache / Migraine,Clinical Trial,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:45
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT04905121
text_rights_status: unverified_not_redistributed
title:
An Exploratory Open-Label, Phase 1b, Ascending Dose Study to Evaluate the Effects of Oral 3-[2-(Dimethylamino)Ethyl]-1h-indol-4-yl Dihydrogen Phosphate (Psilocybin, BPL-PSILO) on Cognition in Patients With Chronic Short-Lasting Unilateral Neuralgiform Headache Attacks (SUNHA)

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT04905121","source_url":"https://clinicaltrials.gov/study/NCT04905121","doi":"","pmid":"","publication_date":"2022-10-12","importer_version":"2.1.3","text_redistributed":false}


authors: Johns Hopkins University
journal: ClinicalTrials.gov
publication_date: 2026-07-21
source_url: https://clinicaltrials.gov/study/NCT07610135
source_record_id: https://clinicaltrials.gov/study/NCT07610135
substance_tags: psilocybin
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:45
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07610135
text_rights_status: unverified_not_redistributed
title:
PRISMatic: A Phase 1b Randomized, Double-Armed, Parallel-Group, Placebo-Controlled Trial of Psilocybin Efficacy With or Without Pimavanserin Pretreatment

topic_tags:
Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Biomarkers,Wellbeing,Clinical Trial

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07610135","source_url":"https://clinicaltrials.gov/study/NCT07610135","doi":"","pmid":"","publication_date":"2026-07-21","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease: a Pilot Study
authors: Joshua Woolley, MD, PhD
journal: ClinicalTrials.gov
publication_date: 2025-01-01
source_url: https://clinicaltrials.gov/study/NCT04932434
source_record_id: https://clinicaltrials.gov/study/NCT04932434
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Safety,Adverse Events
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:43
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT04932434
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT04932434","source_url":"https://clinicaltrials.gov/study/NCT04932434","doi":"","pmid":"","publication_date":"2025-01-01","importer_version":"2.1.3","text_redistributed":false}


authors: University of California, Berkeley
journal: ClinicalTrials.gov
publication_date: 2025-10-21
source_url: https://clinicaltrials.gov/study/NCT06367738
source_record_id: https://clinicaltrials.gov/study/NCT06367738
substance_tags: psilocybin
study_type: Observational Study
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:45
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06367738
text_rights_status: unverified_not_redistributed
title:
Investigating the Persisting Effects of a Single Dose of Psilocybin on Structural Plasticity in Healthy Older Adults

topic_tags:
Neuroplasticity,Brain Imaging,Aging,Microdosing,Wellbeing,Emotional Processing,Observational Study,Older Adults

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06367738","source_url":"https://clinicaltrials.gov/study/NCT06367738","doi":"","pmid":"","publication_date":"2025-10-21","importer_version":"2.1.3","text_redistributed":false}


title: Efficacy and Safety of COMP360 Psilocybin Therapy in Anorexia Nervosa: a Proof-of-concept Study
authors: COMPASS Pathways
journal: ClinicalTrials.gov
publication_date: 2024-12-04
source_url: https://clinicaltrials.gov/study/NCT05481736
source_record_id: https://clinicaltrials.gov/study/NCT05481736
substance_tags: psilocybin
topic_tags: Eating Disorders,Safety
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:44
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05481736
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05481736","source_url":"https://clinicaltrials.gov/study/NCT05481736","doi":"","pmid":"","publication_date":"2024-12-04","importer_version":"2.1.3","text_redistributed":false}


title: Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy Volunteers
authors: Hadassah Medical Organization
journal: ClinicalTrials.gov
publication_date: 2026-02-05
source_url: https://clinicaltrials.gov/study/NCT07079930
source_record_id: https://clinicaltrials.gov/study/NCT07079930
substance_tags: psilocybin
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:44
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07079930
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Anxiety,Neuroplasticity,Brain Imaging,Receptor Pharmacology,Consciousness,Biomarkers,Clinical Trial,Observational Study,Animal Study,Healthy Volunteers,Safety,Toxicity,Inflammation

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07079930","source_url":"https://clinicaltrials.gov/study/NCT07079930","doi":"","pmid":"","publication_date":"2026-02-05","importer_version":"2.1.3","text_redistributed":false}


authors: Johns Hopkins University
journal: ClinicalTrials.gov
publication_date: 2026-07-17
source_url: https://clinicaltrials.gov/study/NCT06067737
source_record_id: https://clinicaltrials.gov/study/NCT06067737
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:42
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06067737
text_rights_status: unverified_not_redistributed
title:
Outpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder: a Randomized Double-blind Trial

topic_tags:
Addiction,Pharmacology,Clinical Trial,Randomized Controlled Trial,Healthy Volunteers,Healthcare Workers,Adverse Events

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06067737","source_url":"https://clinicaltrials.gov/study/NCT06067737","doi":"","pmid":"","publication_date":"2026-07-17","importer_version":"2.1.3","text_redistributed":false}


authors: University of British Columbia
journal: ClinicalTrials.gov
publication_date: 2025-12-04
source_url: https://clinicaltrials.gov/study/NCT05585229
source_record_id: https://clinicaltrials.gov/study/NCT05585229
substance_tags: psilocybin
topic_tags: Addiction,Chronic Pain,Mechanism of Action,Safety,Adverse Events,Contraindications
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:45
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05585229
text_rights_status: unverified_not_redistributed
title:
Standardized Natural Psilocybin-assisted Psychotherapy for Tapering of Opioid Medication in Patients With Chronic Pain: an Open-label Feasibility Study

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05585229","source_url":"https://clinicaltrials.gov/study/NCT05585229","doi":"","pmid":"","publication_date":"2025-12-04","importer_version":"2.1.3","text_redistributed":false}


title: Consciousness and Psilocybin Effects on Well-Being: The CoPEWell Study
authors: University of Wisconsin, Madison
journal: ClinicalTrials.gov
publication_date: 2026-07-02
source_url: https://clinicaltrials.gov/study/NCT07360301
source_record_id: https://clinicaltrials.gov/study/NCT07360301
substance_tags: psilocybin
topic_tags: Consciousness,Wellbeing,Psychological Flexibility
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:45
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07360301
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07360301","source_url":"https://clinicaltrials.gov/study/NCT07360301","doi":"","pmid":"","publication_date":"2026-07-02","importer_version":"2.1.3","text_redistributed":false}


authors: Icahn School of Medicine at Mount Sinai
journal: ClinicalTrials.gov
publication_date: 2025-05-14
source_url: https://clinicaltrials.gov/study/NCT06592833
source_record_id: https://clinicaltrials.gov/study/NCT06592833
substance_tags: psilocybin
topic_tags: Depression,Mechanism of Action,Receptor Pharmacology
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:45
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06592833
text_rights_status: unverified_not_redistributed
title:
Investigating the Role of Serotonin in the Mechanism of Action of Psilocybin in Patients With Major Depressive Disorder

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06592833","source_url":"https://clinicaltrials.gov/study/NCT06592833","doi":"","pmid":"","publication_date":"2025-05-14","importer_version":"2.1.3","text_redistributed":false}


title: SV2A Marker of Synaptogenesis in a Clinical Trial of Psilocybin for Depression
authors: Washington University School of Medicine
journal: ClinicalTrials.gov
publication_date: 2023-01-30
source_url: https://clinicaltrials.gov/study/NCT05601648
source_record_id: https://clinicaltrials.gov/study/NCT05601648
substance_tags: psilocybin
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:43
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05601648
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Neuroplasticity,Brain Imaging,Receptor Pharmacology,Biomarkers,Aging,Clinical Trial,Animal Study

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05601648","source_url":"https://clinicaltrials.gov/study/NCT05601648","doi":"","pmid":"","publication_date":"2023-01-30","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybe Cubensis Mushrooms With or Without Fluoxetine for Refractory Depression
authors: Federal University of Latin American Integration
journal: ClinicalTrials.gov
publication_date: 2026-03-27
source_url: https://clinicaltrials.gov/study/NCT06898606
source_record_id: https://clinicaltrials.gov/study/NCT06898606
substance_tags: psilocybin
topic_tags: Depression,Clinical Trial,Treatment-Resistant Depression,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:44
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06898606
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06898606","source_url":"https://clinicaltrials.gov/study/NCT06898606","doi":"","pmid":"","publication_date":"2026-03-27","importer_version":"2.1.3","text_redistributed":false}


title: A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer
authors: University of Utah
journal: ClinicalTrials.gov
publication_date: 2024-03-20
source_url: https://clinicaltrials.gov/study/NCT04522804
source_record_id: https://clinicaltrials.gov/study/NCT04522804
substance_tags: psilocybin
topic_tags: Safety
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:43
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT04522804
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT04522804","source_url":"https://clinicaltrials.gov/study/NCT04522804","doi":"","pmid":"","publication_date":"2024-03-20","importer_version":"2.1.3","text_redistributed":false}


authors: University College, London
journal: ClinicalTrials.gov
publication_date: 2025-11-26
source_url: https://clinicaltrials.gov/study/NCT06815653
source_record_id: https://clinicaltrials.gov/study/NCT06815653
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:43
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06815653
text_rights_status: unverified_not_redistributed
title:
Digital Intervention for Psychedelic Preparation (DIPP): A Randomised Controlled Feasibility Trial Comparing Meditation and Music-Based Programs in Healthy Volunteers.

topic_tags:
Mechanism of Action,Consciousness,Wellbeing,Emotional Processing,Randomized Controlled Trial,Healthy Volunteers

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06815653","source_url":"https://clinicaltrials.gov/study/NCT06815653","doi":"","pmid":"","publication_date":"2025-11-26","importer_version":"2.1.3","text_redistributed":false}


authors: King's College London
journal: ClinicalTrials.gov
publication_date: 2025-09-10
source_url: https://clinicaltrials.gov/study/NCT07164755
source_record_id: https://clinicaltrials.gov/study/NCT07164755
substance_tags: psilocybin
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:43
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07164755
text_rights_status: unverified_not_redistributed
title:
Measurement of Serum Cytokine Levels in Samples Collected as Part of a Clinical Trial of Psilocybin for Treatment-resistant Depression.

topic_tags:
Depression,Receptor Pharmacology,Biomarkers,Clinical Trial,Animal Study,In Vitro Study,Treatment-Resistant Depression,Safety,Inflammation,Immune Function

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07164755","source_url":"https://clinicaltrials.gov/study/NCT07164755","doi":"","pmid":"","publication_date":"2025-09-10","importer_version":"2.1.3","text_redistributed":false}


authors: Charles S. Grob, M.D.
journal: ClinicalTrials.gov
publication_date: 2025-11-25
source_url: https://clinicaltrials.gov/study/NCT05403086
source_record_id: https://clinicaltrials.gov/study/NCT05403086
substance_tags: psilocybin
topic_tags: Depression,Anxiety,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Safety
study_type: Randomized Controlled Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:43
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05403086
text_rights_status: unverified_not_redistributed
title:
Pragmatic Trial of Psilocybin Therapy in Palliative Care (PT2PC): A Multicenter Triple-blind Phase 2 Randomized Controlled Trial of Psilocybin Therapy for Demoralized Adults Near the End of Life

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05403086","source_url":"https://clinicaltrials.gov/study/NCT05403086","doi":"","pmid":"","publication_date":"2025-11-25","importer_version":"2.1.3","text_redistributed":false}


authors: Sheppard Pratt Health System
journal: ClinicalTrials.gov
publication_date: 2025-12-24
source_url: https://clinicaltrials.gov/study/NCT05220410
source_record_id: https://clinicaltrials.gov/study/NCT05220410
substance_tags: psilocybin
topic_tags: Depression,Treatment-Resistant Depression,Safety
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:42
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05220410
text_rights_status: unverified_not_redistributed
title:
The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal Ideation

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05220410","source_url":"https://clinicaltrials.gov/study/NCT05220410","doi":"","pmid":"","publication_date":"2025-12-24","importer_version":"2.1.3","text_redistributed":false}


authors: Robin Carhart-Harris, PhD, MA
journal: ClinicalTrials.gov
publication_date: 2026-06-05
source_url: https://clinicaltrials.gov/study/NCT05698511
source_record_id: https://clinicaltrials.gov/study/NCT05698511
substance_tags: psilocybin
topic_tags: Brain Imaging,Aging,Clinical Trial,Healthy Volunteers
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:42
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05698511
text_rights_status: unverified_not_redistributed
title:
Multivariate Neural and Physiological Correlates of Psychedelic Sub-states: a Within-subjects, Healthy Volunteer Study With Experience-sampling

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05698511","source_url":"https://clinicaltrials.gov/study/NCT05698511","doi":"","pmid":"","publication_date":"2026-06-05","importer_version":"2.1.3","text_redistributed":false}


authors: Baylor College of Medicine
journal: ClinicalTrials.gov
publication_date: 2026-01-22
source_url: https://clinicaltrials.gov/study/NCT06888128
source_record_id: https://clinicaltrials.gov/study/NCT06888128
substance_tags: psilocybin
topic_tags: PTSD,Veterans,Safety
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:44
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06888128
text_rights_status: unverified_not_redistributed
title:
The STARLIGHT Protocol: State-Funded Trial Assessing Recovery and Long-Term Impact of Guided Psilocybin for Healing Trauma

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06888128","source_url":"https://clinicaltrials.gov/study/NCT06888128","doi":"","pmid":"","publication_date":"2026-01-22","importer_version":"2.1.3","text_redistributed":false}


authors: Trent Emerick
journal: ClinicalTrials.gov
publication_date: 2026-08-06
source_url: https://clinicaltrials.gov/study/NCT07406828
source_record_id: https://clinicaltrials.gov/study/NCT07406828
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Addiction,Chronic Pain,Clinical Trial,Review Article,Observational Study,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-13 01:25:57
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07406828
text_rights_status: unverified_not_redistributed
title:
Single Dose Psilocybin for a Post-surgical Trauma Inpatient Population for Pain, Mood, and Opioid Use Disorder

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07406828","source_url":"https://clinicaltrials.gov/study/NCT07406828","doi":"","pmid":"","publication_date":"2026-08-06","importer_version":"2.1.3","text_redistributed":false}


title: Effects of Psilocybin Microdosing on Cognition, Mood and Quality of Life: A Pilot Study
authors: Yale University
journal: ClinicalTrials.gov
publication_date: 2026-06-23
source_url: https://clinicaltrials.gov/study/NCT07449351
source_record_id: https://clinicaltrials.gov/study/NCT07449351
substance_tags: psilocybin
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:43
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07449351
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Brain Imaging,Mechanism of Action,Aging,Longevity,Microdosing,Wellbeing,Treatment-Resistant Depression,Safety

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07449351","source_url":"https://clinicaltrials.gov/study/NCT07449351","doi":"","pmid":"","publication_date":"2026-06-23","importer_version":"2.1.3","text_redistributed":false}


authors: University Hospital, Basel, Switzerland
journal: ClinicalTrials.gov
publication_date: 2024-01-24
source_url: https://clinicaltrials.gov/study/NCT04227756
source_record_id: https://clinicaltrials.gov/study/NCT04227756
substance_tags: psilocybin
topic_tags: Brain Imaging,Receptor Pharmacology,Consciousness,Aging,Toxicity
study_type: Qualitative Study
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:45
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT04227756
text_rights_status: unverified_not_redistributed
title:
Comparative Acute Effects of LSD, Psilocybin and Mescaline in a Random-Order Placebo-Controlled Cross-Over Study in Healthy Subjects

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT04227756","source_url":"https://clinicaltrials.gov/study/NCT04227756","doi":"","pmid":"","publication_date":"2024-01-24","importer_version":"2.1.3","text_redistributed":false}


title: Effects of Psilocybin on Electrophysiology and the Dynamic Content of Thought
authors: Johns Hopkins University
journal: ClinicalTrials.gov
publication_date: 2026-07-23
source_url: https://clinicaltrials.gov/study/NCT05301608
source_record_id: https://clinicaltrials.gov/study/NCT05301608
substance_tags: psilocybin
topic_tags: Brain Imaging,Consciousness,Aging,Creativity,Healthy Volunteers
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:43
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT05301608
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05301608","source_url":"https://clinicaltrials.gov/study/NCT05301608","doi":"","pmid":"","publication_date":"2026-07-23","importer_version":"2.1.3","text_redistributed":false}


title: Role of the Serotonin 2A Receptor in Psilocybin-induced Altered States of Consciousness (PDR-Study)
authors: University Hospital, Basel, Switzerland
journal: ClinicalTrials.gov
publication_date: 2025-05-28
source_url: https://clinicaltrials.gov/study/NCT06796361
source_record_id: https://clinicaltrials.gov/study/NCT06796361
substance_tags: psilocybin,psilocin
study_type: Other
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:45
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT06796361
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Anxiety,Addiction,Receptor Pharmacology,Consciousness,Personality Change,Spirituality,Healthy Volunteers

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06796361","source_url":"https://clinicaltrials.gov/study/NCT06796361","doi":"","pmid":"","publication_date":"2025-05-28","importer_version":"2.1.3","text_redistributed":false}


title: PRoMiSS: Psilocybin and the Role of Music in Set and Setting
authors: Johns Hopkins University
journal: ClinicalTrials.gov
publication_date: 2025-09-18
source_url: https://clinicaltrials.gov/study/NCT07180108
source_record_id: https://clinicaltrials.gov/study/NCT07180108
substance_tags: psilocybin
topic_tags: Brain Imaging,Consciousness,Wellbeing,Emotional Processing,Clinical Trial
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:44
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07180108
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07180108","source_url":"https://clinicaltrials.gov/study/NCT07180108","doi":"","pmid":"","publication_date":"2025-09-18","importer_version":"2.1.3","text_redistributed":false}


authors: Francisco A Moreno
journal: ClinicalTrials.gov
publication_date: 2026-07-23
source_url: https://clinicaltrials.gov/study/NCT07347405
source_record_id: https://clinicaltrials.gov/study/NCT07347405
substance_tags: psilocybin
topic_tags: OCD,Safety
study_type: Clinical Trial
source_name: ClinicalTrials.gov
publication_status: clinical trial
date_added: 2026-07-01 11:04:28
last_checked: 2026-08-09 10:12:44
abstract_source: ClinicalTrials.gov
abstract_source_url: https://clinicaltrials.gov/study/NCT07347405
text_rights_status: unverified_not_redistributed
title:
A Randomized Double-masked Dose-controlled Trial to Assess the Tolerability, Safety, Subjective Experience, and Efficacy of Repeated Administration of Three Different Doses of Psilocybin Whole Mushroom for the Treatment of Obsessive-compulsive Disorder.

source_provenance_json:
{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07347405","source_url":"https://clinicaltrials.gov/study/NCT07347405","doi":"","pmid":"","publication_date":"2026-07-23","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelics and autobiographical memory - six open questions.
authors: Kangaslampi S, Lietz M
journal: Psychopharmacology
publication_date: 2025-10-01
doi: 10.1007/s00213-025-06771-5
pubmed_id: 40095090
source_url: https://pubmed.ncbi.nlm.nih.gov/40095090/
source_record_id: PMID:40095090
substance_tags: psilocybin
topic_tags: General
study_type: Other
source_name: PubMed
publication_status: published
date_added: 2026-07-01 11:08:40
last_checked: 2026-08-09 08:27:56
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/40095090/
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:40095090","source_url":"https://pubmed.ncbi.nlm.nih.gov/40095090/","doi":"10.1007/s00213-025-06771-5","pmid":"40095090","publication_date":"2025-10-01","importer_version":"2.1.3","text_redistributed":false}


journal: Pharmacology & therapeutics
publication_date: 2024-06-01
doi: 10.1016/j.pharmthera.2024.108641
pubmed_id: 38583670
source_url: https://pubmed.ncbi.nlm.nih.gov/38583670/
source_record_id: PMID:38583670
substance_tags: psilocybin
study_type: Clinical Trial
source_name: PubMed
publication_status: published
date_added: 2026-07-01 11:08:41
last_checked: 2026-08-09 08:28:08
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/38583670/
text_rights_status: unverified_not_redistributed
title:
Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases.

authors:
Haniff ZR, Bocharova M, Mantingh T, Rucker JJ, Velayudhan L, Taylor DM, Young AH, Aarsland D, Vernon AC, Thuret S

topic_tags:
Depression,Neuroplasticity,Neurogenesis,Mechanism of Action,Biomarkers,Review Article,Animal Study,Safety,Immune Function

source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:38583670","source_url":"https://pubmed.ncbi.nlm.nih.gov/38583670/","doi":"10.1016/j.pharmthera.2024.108641","pmid":"38583670","publication_date":"2024-06-01","importer_version":"2.1.3","text_redistributed":false}


authors: Zeller Matthias, Parent Stephan, Schultheiss Nate
journal: Acta Crystallographica Section E Crystallographic Communications
publication_date: 2024-06-01
doi: 10.1107/s2056989024004201
pubmed_id: 38845717
source_url: https://doi.org/10.1107/s2056989024004201
source_record_id: PMID:38845717
substance_tags: psilocybin,psilocin
topic_tags: General
study_type: Other
source_name: Crossref
publication_status: published
date_added: 2026-07-01 11:08:41
last_checked: 2026-08-09 08:28:49
abstract_source: Crossref
abstract_source_url: https://doi.org/10.1107/s2056989024004201
text_rights_status: unverified_not_redistributed
title:
Structural characterization and comparative analysis of polymorphic forms of psilocin (4-hydroxy-N,N-dimethyltryptamine)

source_provenance_json:
{"source_name":"Crossref","source_record_id":"PMID:38845717","source_url":"https://doi.org/10.1107/s2056989024004201","doi":"10.1107/s2056989024004201","pmid":"38845717","publication_date":"2024-06-01","importer_version":"2.1.3","text_redistributed":false}


title: [Psychedelic psychiatry].
authors: López E, Yngwe H, Beckman M, Tiger M, Hieronymus F, Lundberg J
journal: Lakartidningen
publication_date: 2024-04-04
pubmed_id: 38572715
source_url: https://pubmed.ncbi.nlm.nih.gov/38572715/
source_record_id: PMID:38572715
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Addiction,Receptor Pharmacology,Clinical Trial,Review Article,Adverse Events
study_type: Clinical Trial
source_name: PubMed
publication_status: published
date_added: 2026-07-01 11:08:41
last_checked: 2026-08-09 08:34:30
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/38572715/
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:38572715","source_url":"https://pubmed.ncbi.nlm.nih.gov/38572715/","doi":"","pmid":"38572715","publication_date":"2024-04-04","importer_version":"2.1.3","text_redistributed":false}


title: Neuroimaging in psychedelic drug development: past, present, and future.
authors: Wall MB, Harding R, Zafar R, Rabiner EA, Nutt DJ, Erritzoe D
journal: Molecular psychiatry
publication_date: 2023-09-01
doi: 10.1038/s41380-023-02271-0
pubmed_id: 37759038
source_url: https://pubmed.ncbi.nlm.nih.gov/37759038/
source_record_id: PMID:37759038
substance_tags: psilocybin
topic_tags: Depression,PTSD,Addiction,Neuroplasticity,Brain Imaging,Pharmacology,Receptor Pharmacology,Aging
study_type: Clinical Trial
source_name: PubMed
publication_status: published
date_added: 2026-07-01 11:08:42
last_checked: 2026-08-09 08:28:13
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/37759038/
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:37759038","source_url":"https://pubmed.ncbi.nlm.nih.gov/37759038/","doi":"10.1038/s41380-023-02271-0","pmid":"37759038","publication_date":"2023-09-01","importer_version":"2.1.3","text_redistributed":false}


title: Predictors of Psychedelic Experience: A Thematic Analysis.
authors: McCartney AM, McGovern HT, De Foe A
journal: Journal of psychoactive drugs
publication_date: 2023-01-01
doi: 10.1080/02791072.2022.2129885
pubmed_id: 36197103
source_url: https://pubmed.ncbi.nlm.nih.gov/36197103/
source_record_id: PMID:36197103
substance_tags: psilocybin
topic_tags: Mechanism of Action
study_type: Other
source_name: PubMed
publication_status: published
date_added: 2026-07-01 11:08:42
last_checked: 2026-08-09 08:28:13
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/36197103/
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:36197103","source_url":"https://pubmed.ncbi.nlm.nih.gov/36197103/","doi":"10.1080/02791072.2022.2129885","pmid":"36197103","publication_date":"2023-01-01","importer_version":"2.1.3","text_redistributed":false}


title: A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression.
journal: Psychedelic medicine (New Rochelle, N.Y.)
publication_date: 2023-03-01
doi: 10.1089/psymed.2022.0002
pubmed_id: 37337526
source_url: https://pubmed.ncbi.nlm.nih.gov/37337526/
source_record_id: PMID:37337526
substance_tags: psilocybin
topic_tags: Depression
study_type: Other
source_name: PubMed
publication_status: published
date_added: 2026-07-01 11:08:42
last_checked: 2026-08-09 08:28:17
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/37337526/
text_rights_status: unverified_not_redistributed
authors:
Nayak SM, Bari BA, Yaden DB, Spriggs MJ, Rosas FE, Peill JM, Giribaldi B, Erritzoe D, Nutt DJ, Carhart-Harris R

source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:37337526","source_url":"https://pubmed.ncbi.nlm.nih.gov/37337526/","doi":"10.1089/psymed.2022.0002","pmid":"37337526","publication_date":"2023-03-01","importer_version":"2.1.3","text_redistributed":false}


journal: Neuroscience and biobehavioral reviews
publication_date: 2022-07-01
doi: 10.1016/j.neubiorev.2022.104689
pubmed_id: 35588933
source_url: https://pubmed.ncbi.nlm.nih.gov/35588933/
source_record_id: PMID:35588933
substance_tags: psilocybin,psilocin
topic_tags: Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Review Article
study_type: Review Article
source_name: PubMed
publication_status: published
date_added: 2026-07-01 11:08:43
last_checked: 2026-08-09 08:28:19
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/35588933/
text_rights_status: unverified_not_redistributed
title:
Psychedelic resting-state neuroimaging: A review and perspective on balancing replication and novel analyses.

authors:
McCulloch DE, Knudsen GM, Barrett FS, Doss MK, Carhart-Harris RL, Rosas FE, Deco G, Kringelbach ML, Preller KH, Ramaekers JG, Mason NL, Müller F, Fisher PM

source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:35588933","source_url":"https://pubmed.ncbi.nlm.nih.gov/35588933/","doi":"10.1016/j.neubiorev.2022.104689","pmid":"35588933","publication_date":"2022-07-01","importer_version":"2.1.3","text_redistributed":false}


title: Microdosing psychedelics: personality, mental health, and creativity differences in microdosers.
authors: Anderson T, Petranker R, Rosenbaum D, Weissman CR, Dinh-Williams LA, Hui K, Hapke E, Farb NAS
journal: Psychopharmacology
publication_date: 2019-02-01
doi: 10.1007/s00213-018-5106-2
pubmed_id: 30604183
source_url: https://pubmed.ncbi.nlm.nih.gov/30604183/
source_record_id: PMID:30604183
substance_tags: psilocybin
study_type: Observational Study
source_name: PubMed
publication_status: published
date_added: 2026-07-01 11:08:44
last_checked: 2026-08-09 08:28:25
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/30604183/
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Anxiety,End-of-Life Distress,Microdosing,Wellbeing,Personality Change,Emotional Processing,Creativity,Observational Study,Safety

source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:30604183","source_url":"https://pubmed.ncbi.nlm.nih.gov/30604183/","doi":"10.1007/s00213-018-5106-2","pmid":"30604183","publication_date":"2019-02-01","importer_version":"2.1.3","text_redistributed":false}


authors: Casale JF
journal: Journal of Forensic Sciences
publication_date: 1985-01-01
doi: 10.1520/jfs10989j
source_url: https://doi.org/10.1520/jfs10989j
source_record_id: DOI:10.1520/jfs10989j
substance_tags: psilocin
topic_tags: General
study_type: Other
source_name: Crossref
publication_status: published
date_added: 2026-07-01 11:09:46
last_checked: 2026-08-09 08:28:51
abstract_source: Crossref
abstract_source_url: https://doi.org/10.1520/jfs10989j
text_rights_status: unverified_not_redistributed
title:
An Aqueous-Organic Extraction Method for the Isolation and Identification of Psilocin from Hallucinogenic Mushrooms

source_provenance_json:
{"source_name":"Crossref","source_record_id":"DOI:10.1520/jfs10989j","source_url":"https://doi.org/10.1520/jfs10989j","doi":"10.1520/jfs10989j","pmid":"","publication_date":"1985-01-01","importer_version":"2.1.3","text_redistributed":false}


authors: Thomson BM
journal: Journal of Forensic Sciences
publication_date: 1980-10-01
doi: 10.1520/jfs11292j
source_url: https://doi.org/10.1520/jfs11292j
source_record_id: DOI:10.1520/jfs11292j
substance_tags: psilocybin,psilocin
topic_tags: General
study_type: Clinical Trial
source_name: Crossref
publication_status: published
date_added: 2026-07-01 11:09:46
last_checked: 2026-08-09 08:28:51
abstract_source: Crossref
abstract_source_url: https://doi.org/10.1520/jfs11292j
text_rights_status: unverified_not_redistributed
title:
Analysis of Psilocybin and Psilocin in Mushroom Extracts by Reversed-Phase High Performance Liquid Chromatography

source_provenance_json:
{"source_name":"Crossref","source_record_id":"DOI:10.1520/jfs11292j","source_url":"https://doi.org/10.1520/jfs11292j","doi":"10.1520/jfs11292j","pmid":"","publication_date":"1980-10-01","importer_version":"2.1.3","text_redistributed":false}


title: Crystal structures of the Teonanácatl hallucinogens. Part II. Psilocin, C12 H15 N2 O
authors: Petcher Trevor J., Weber Hans Peter
journal: J. Chem. Soc., Perkin Trans. 2
publication_date: 1974-01-01
doi: 10.1039/p29740000946
source_url: https://doi.org/10.1039/p29740000946
source_record_id: DOI:10.1039/p29740000946
substance_tags: psilocin
topic_tags: General
study_type: Other
source_name: Crossref
publication_status: published
date_added: 2026-07-01 11:09:46
last_checked: 2026-08-09 08:28:51
abstract_source: Crossref
abstract_source_url: https://doi.org/10.1039/p29740000946
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Crossref","source_record_id":"DOI:10.1039/p29740000946","source_url":"https://doi.org/10.1039/p29740000946","doi":"10.1039/p29740000946","pmid":"","publication_date":"1974-01-01","importer_version":"2.1.3","text_redistributed":false}


title: Theoretical studies on the conformations of psilocin and mescaline.
authors: Kang S, Johnson CL, Green JP.
journal: Molecular pharmacology
publication_date: 1973-09-01
doi: 10.1016/s0026-895x(25)13989-8
source_url: https://doi.org/10.1016/s0026-895x(25)13989-8
source_record_id: DOI:10.1016/s0026-895x(25)13989-8
substance_tags: psilocybin,psilocin
topic_tags: General
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 11:09:46
last_checked: 2026-08-09 08:26:00
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"DOI:10.1016/s0026-895x(25)13989-8","source_url":"https://doi.org/10.1016/s0026-895x(25)13989-8","doi":"10.1016/s0026-895x(25)13989-8","pmid":"","publication_date":"1973-09-01","importer_version":"2.1.3","text_redistributed":false}


title: An open-label, dose-escalation trial of psilocybin-assisted therapy for bipolar 2 depression
authors: Szigeti B.
journal: PsyArXiv
publication_date: 2025-07-06
doi: 10.31234/osf.io/97cqx_v1
source_url: https://doi.org/10.31234/osf.io/97cqx_v1
source_record_id: DOI:10.31234/osf.io/97cqx_v1
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Headache / Migraine,Safety,Adverse Events
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:18
last_checked: 2026-07-01 11:22:00
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/97cqx_v1
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/97cqx_v1","source_url":"https://doi.org/10.31234/osf.io/97cqx_v1","doi":"10.31234/osf.io/97cqx_v1","pmid":"","publication_date":"2025-07-06","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin-Assisted Therapy Increases Self-Compassion in Patients with Alcohol Use Disorder
authors: Agin-Liebes G, Petridis P, Zeifman R, Link M, Cordova MJ, Bogenschutz M.
journal: PsyArXiv
publication_date: 2025-06-10
doi: 10.31234/osf.io/f27jm_v1
source_url: https://doi.org/10.31234/osf.io/f27jm_v1
source_record_id: DOI:10.31234/osf.io/f27jm_v1
substance_tags: psilocybin
topic_tags: Addiction,Safety
study_type: Clinical Trial
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:18
last_checked: 2026-08-09 08:14:55
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/f27jm_v1
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/f27jm_v1","source_url":"https://doi.org/10.31234/osf.io/f27jm_v1","doi":"10.31234/osf.io/f27jm_v1","pmid":"","publication_date":"2025-06-10","importer_version":"2.1.3","text_redistributed":false}


title: Age and cannabis co-use moderate experience and perceived benefits of psilocybin
authors: Hooper J, Williams S, Mueller R, Hutchison K.
journal: PsyArXiv
publication_date: 2025-05-22
doi: 10.31234/osf.io/dczw2_v1
source_url: https://doi.org/10.31234/osf.io/dczw2_v1
source_record_id: DOI:10.31234/osf.io/dczw2_v1
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Addiction,Mechanism of Action,Aging,Mystical Experience,Older Adults
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:18
last_checked: 2026-08-09 08:14:57
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/dczw2_v1
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/dczw2_v1","source_url":"https://doi.org/10.31234/osf.io/dczw2_v1","doi":"10.31234/osf.io/dczw2_v1","pmid":"","publication_date":"2025-05-22","importer_version":"2.1.3","text_redistributed":false}


authors: Hodge A, Forsyth A, Noorani T, Muthukumaraswamy S, Rolleston A, McHugh P.
journal: PsyArXiv
publication_date: 2025-02-28
doi: 10.31234/osf.io/93x5h_v3
source_url: https://doi.org/10.31234/osf.io/93x5h_v3
source_record_id: DOI:10.31234/osf.io/93x5h_v3
substance_tags: psilocybin
topic_tags: Addiction,Mechanism of Action,Spirituality,Safety
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:18
last_checked: 2026-08-09 08:15:00
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/93x5h_v3
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/93x5h_v3","source_url":"https://doi.org/10.31234/osf.io/93x5h_v3","doi":"10.31234/osf.io/93x5h_v3","pmid":"","publication_date":"2025-02-28","importer_version":"2.1.3","text_redistributed":false}


authors: Pincombe J, Williams M, Carruthers S, Rossell S.
journal: PsyArXiv
publication_date: 2024-10-07
doi: 10.31234/osf.io/ga9p2
source_url: https://doi.org/10.31234/osf.io/ga9p2
source_record_id: DOI:10.31234/osf.io/ga9p2
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Microdosing,Review Article
study_type: Review Article
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:18
last_checked: 2026-08-09 08:15:01
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/ga9p2
text_rights_status: unverified_not_redistributed
title:
Qualitative Research on Psilocybin-Assisted Psychotherapy for the Treatment of Mental Health Disorders: A Scoping Review Protocol

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/ga9p2","source_url":"https://doi.org/10.31234/osf.io/ga9p2","doi":"10.31234/osf.io/ga9p2","pmid":"","publication_date":"2024-10-07","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelic Therapy: A Primer for Primary Care Clinicians - Part IV. Psilocybin
authors: Tabaac BJ, Shinozuka K, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, Muir OS.
journal: PsyArXiv
publication_date: 2023-12-26
doi: 10.31234/osf.io/a8xwk
source_url: https://doi.org/10.31234/osf.io/a8xwk
source_record_id: DOI:10.31234/osf.io/a8xwk
substance_tags: psilocybin
study_type: Clinical Trial
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:18
last_checked: 2026-08-09 08:15:02
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/a8xwk
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Anxiety,Addiction,End-of-Life Distress,Pharmacology,Receptor Pharmacology,Consciousness,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/a8xwk","source_url":"https://doi.org/10.31234/osf.io/a8xwk","doi":"10.31234/osf.io/a8xwk","pmid":"","publication_date":"2023-12-26","importer_version":"2.1.3","text_redistributed":false}


title: Enhanced visual contrast suppression during peak psilocybin effects: A psychophysical study
authors: Swanson L, Jungers S, Varghese R, Cullen KR, Evans MD, Nielson J, Schallmo M.
journal: PsyArXiv
publication_date: 2024-01-11
doi: 10.31234/osf.io/5rm62
source_url: https://doi.org/10.31234/osf.io/5rm62
source_record_id: DOI:10.31234/osf.io/5rm62
substance_tags: psilocybin
topic_tags: Depression,Mechanism of Action
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:19
last_checked: 2026-08-09 08:15:03
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/5rm62
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/5rm62","source_url":"https://doi.org/10.31234/osf.io/5rm62","doi":"10.31234/osf.io/5rm62","pmid":"","publication_date":"2024-01-11","importer_version":"2.1.3","text_redistributed":false}


title: Methodological issues undermine evidence about adverse effects of psilocybin-assisted psychotherapy
authors: Marinis J, Clarke ST, Bedi G.
journal: PsyArXiv
publication_date: 2024-05-17
doi: 10.31234/osf.io/4bk2p
source_url: https://doi.org/10.31234/osf.io/4bk2p
source_record_id: DOI:10.31234/osf.io/4bk2p
substance_tags: psilocybin
topic_tags: General
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:19
last_checked: 2026-08-09 08:15:04
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/4bk2p
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/4bk2p","source_url":"https://doi.org/10.31234/osf.io/4bk2p","doi":"10.31234/osf.io/4bk2p","pmid":"","publication_date":"2024-05-17","importer_version":"2.1.3","text_redistributed":false}


authors: Tetem J, Fischmann T, Möller TJ.
journal: PsyArXiv
publication_date: 2023-07-06
doi: 10.31234/osf.io/ztyxh
source_url: https://doi.org/10.31234/osf.io/ztyxh
source_record_id: DOI:10.31234/osf.io/ztyxh
substance_tags: psilocybin
study_type: Systematic Review
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:19
last_checked: 2026-08-09 08:15:06
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/ztyxh
text_rights_status: unverified_not_redistributed
title:
Psychoactive substances in psychotherapy - A vision for the future? - A systematic review on Psilocybin

topic_tags:
Depression,Anxiety,Addiction,End-of-Life Distress,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Adverse Events

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/ztyxh","source_url":"https://doi.org/10.31234/osf.io/ztyxh","doi":"10.31234/osf.io/ztyxh","pmid":"","publication_date":"2023-07-06","importer_version":"2.1.3","text_redistributed":false}


title: Serotonergic antidepressant use is associated with weaker psilocybin effects
authors: Gukasyan N, Griffiths RR, Yaden DB, Antoine D, Nayak SM.
journal: PsyArXiv
publication_date: 2022-10-28
doi: 10.31234/osf.io/2zys9
source_url: https://doi.org/10.31234/osf.io/2zys9
source_record_id: DOI:10.31234/osf.io/2zys9
substance_tags: psilocybin
topic_tags: Depression,Observational Study
study_type: Observational Study
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:19
last_checked: 2026-08-09 08:15:07
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/2zys9
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/2zys9","source_url":"https://doi.org/10.31234/osf.io/2zys9","doi":"10.31234/osf.io/2zys9","pmid":"","publication_date":"2022-10-28","importer_version":"2.1.3","text_redistributed":false}


authors: Enriquez-Geppert S, Krc J, O'Higgins F, Lietz MP.
journal: PsyArXiv
publication_date: 2023-10-11
doi: 10.31234/osf.io/jqasf
source_url: https://doi.org/10.31234/osf.io/jqasf
source_record_id: DOI:10.31234/osf.io/jqasf
substance_tags: psilocybin
topic_tags: Neuroplasticity,Aging,Microdosing
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:19
last_checked: 2026-08-09 08:15:07
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/jqasf
text_rights_status: unverified_not_redistributed
title:
Psilocybin-assisted neurofeedback for the improvement of executive functions: a randomised semi-naturalistic-lab feasibility study

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/jqasf","source_url":"https://doi.org/10.31234/osf.io/jqasf","doi":"10.31234/osf.io/jqasf","pmid":"","publication_date":"2023-10-11","importer_version":"2.1.3","text_redistributed":false}


authors: Rebecchi K.
journal: PsyArXiv
publication_date: 2023-08-16
doi: 10.31234/osf.io/c9fpj
source_url: https://doi.org/10.31234/osf.io/c9fpj
source_record_id: DOI:10.31234/osf.io/c9fpj
substance_tags: psilocybin
topic_tags: Neuroplasticity,Wellbeing,Case Report
study_type: Case Report
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:19
last_checked: 2026-08-09 08:15:08
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/c9fpj
text_rights_status: unverified_not_redistributed
title:
“Diversity makes the richness of humanity”: the emergence of mental imagery after self-reported psilocybin mushrooms intake in an autistic woman with “blind imagination” (aphantasia): a 1-year retrospective case report

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/c9fpj","source_url":"https://doi.org/10.31234/osf.io/c9fpj","doi":"10.31234/osf.io/c9fpj","pmid":"","publication_date":"2023-08-16","importer_version":"2.1.3","text_redistributed":false}


authors: Basedow LA, Lottes L, Falkenberg I, Vogelbacher C, Yildiz C.
journal: PsyArXiv
publication_date: 2025-05-16
doi: 10.31234/osf.io/6hjkm_v1
source_url: https://doi.org/10.31234/osf.io/6hjkm_v1
source_record_id: DOI:10.31234/osf.io/6hjkm_v1
substance_tags: psilocybin
topic_tags: Depression,Aging,Observational Study,Healthcare Workers,Safety,Adverse Events
study_type: Observational Study
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:19
last_checked: 2026-08-09 08:15:08
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/6hjkm_v1
text_rights_status: unverified_not_redistributed
title:
Under Pressure: Stronger depressive symptoms are associated with more positive expectations towards experimental treatments

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/6hjkm_v1","source_url":"https://doi.org/10.31234/osf.io/6hjkm_v1","doi":"10.31234/osf.io/6hjkm_v1","pmid":"","publication_date":"2025-05-16","importer_version":"2.1.3","text_redistributed":false}


authors: Ching THW, Grazioplene R, Pittenger C, Kelmendi B.
journal: PsyArXiv
publication_date: 2023-03-17
doi: 10.31234/osf.io/ba42z
source_url: https://doi.org/10.31234/osf.io/ba42z
source_record_id: DOI:10.31234/osf.io/ba42z
substance_tags: psilocybin
topic_tags: OCD,Mechanism of Action,Safety
study_type: Clinical Trial
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:19
last_checked: 2026-08-09 08:15:08
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/ba42z
text_rights_status: unverified_not_redistributed
title:
Yale Program for Psychedelic Science (YPPS) Manual for Psilocybin Combined with Non-Directive Support in the Treatment of OCD

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/ba42z","source_url":"https://doi.org/10.31234/osf.io/ba42z","doi":"10.31234/osf.io/ba42z","pmid":"","publication_date":"2023-03-17","importer_version":"2.1.3","text_redistributed":false}


authors: Petrovitch D, Hosford S, Littlefield AK, Austin-Robillard H.
journal: PsyArXiv
publication_date: 2025-02-28
doi: 10.31234/osf.io/26tz7_v1
source_url: https://doi.org/10.31234/osf.io/26tz7_v1
source_record_id: DOI:10.31234/osf.io/26tz7_v1
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Clinical Trial
study_type: Clinical Trial
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:19
last_checked: 2026-08-09 08:15:10
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/26tz7_v1
text_rights_status: unverified_not_redistributed
title:
Sociodemographic and mental-health characteristics of psychedelic-assisted therapy participants: Latent class analysis of a cross-sectional, purposive online sample

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/26tz7_v1","source_url":"https://doi.org/10.31234/osf.io/26tz7_v1","doi":"10.31234/osf.io/26tz7_v1","pmid":"","publication_date":"2025-02-28","importer_version":"2.1.3","text_redistributed":false}


authors: Ching THW, Kichuk S, DePalmer G, Pittenger C, Kelmendi B.
journal: PsyArXiv
publication_date: 2022-10-05
doi: 10.31234/osf.io/85s9p
source_url: https://doi.org/10.31234/osf.io/85s9p
source_record_id: DOI:10.31234/osf.io/85s9p
substance_tags: psilocybin
topic_tags: OCD,Safety
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:19
last_checked: 2026-08-09 08:15:10
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/85s9p
text_rights_status: unverified_not_redistributed
title:
Yale Program for Psychedelic Science (YPPS) Manual for Psilocybin-OCD Session Monitors for Protocol HIC: 2000020355

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/85s9p","source_url":"https://doi.org/10.31234/osf.io/85s9p","doi":"10.31234/osf.io/85s9p","pmid":"","publication_date":"2022-10-05","importer_version":"2.1.3","text_redistributed":false}


authors: Molumby M, Gaynor K, Guerin S.
journal: PsyArXiv
publication_date: 2021-11-23
doi: 10.31234/osf.io/6f9qp
source_url: https://doi.org/10.31234/osf.io/6f9qp
source_record_id: DOI:10.31234/osf.io/6f9qp
substance_tags: psilocybin
topic_tags: Personality Change
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:19
last_checked: 2026-08-09 08:15:10
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/6f9qp
text_rights_status: unverified_not_redistributed
title:
Examining attitudes to psilocybin: Should candidates for medical psilocybin be required to pass a contextual suitability test

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/6f9qp","source_url":"https://doi.org/10.31234/osf.io/6f9qp","doi":"10.31234/osf.io/6f9qp","pmid":"","publication_date":"2021-11-23","importer_version":"2.1.3","text_redistributed":false}


authors: Turkia M.
journal: PsyArXiv
publication_date: 2023-03-10
doi: 10.31234/osf.io/t6k9b
source_url: https://doi.org/10.31234/osf.io/t6k9b
source_record_id: DOI:10.31234/osf.io/t6k9b
substance_tags: psilocybin
topic_tags: Depression,PTSD,Clinical Trial,Treatment-Resistant Depression
study_type: Clinical Trial
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:19
last_checked: 2026-08-09 08:15:10
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/t6k9b
text_rights_status: unverified_not_redistributed
title:
Underground small-group therapy of treatment-resistant depression and complex post-traumatic stress disorder (C-PTSD) with psilocybin-A retrospective case study

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/t6k9b","source_url":"https://doi.org/10.31234/osf.io/t6k9b","doi":"10.31234/osf.io/t6k9b","pmid":"","publication_date":"2023-03-10","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin for Depression: The ACE Model Manual
authors: Watts R.
journal: PsyArXiv
publication_date: 2021-07-05
doi: 10.31234/osf.io/5x2bu
source_url: https://doi.org/10.31234/osf.io/5x2bu
source_record_id: DOI:10.31234/osf.io/5x2bu
substance_tags: psilocybin
topic_tags: Depression
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:20
last_checked: 2026-08-09 08:15:11
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/5x2bu
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/5x2bu","source_url":"https://doi.org/10.31234/osf.io/5x2bu","doi":"10.31234/osf.io/5x2bu","pmid":"","publication_date":"2021-07-05","importer_version":"2.1.3","text_redistributed":false}


title: A critique of: Skepticism About Recent Evidence that Psilocybin Opens Depressed Minds
authors: Carhart-Harris R, Daws RE, Nutt D.
journal: PsyArXiv
publication_date: 2022-05-10
doi: 10.31234/osf.io/pdbf5
source_url: https://doi.org/10.31234/osf.io/pdbf5
source_record_id: DOI:10.31234/osf.io/pdbf5
substance_tags: psilocybin
topic_tags: General
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:20
last_checked: 2026-08-09 08:15:12
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/pdbf5
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/pdbf5","source_url":"https://doi.org/10.31234/osf.io/pdbf5","doi":"10.31234/osf.io/pdbf5","pmid":"","publication_date":"2022-05-10","importer_version":"2.1.3","text_redistributed":false}


authors: Turkia M.
journal: PsyArXiv
publication_date: 2023-06-09
doi: 10.31234/osf.io/qyce5
source_url: https://doi.org/10.31234/osf.io/qyce5
source_record_id: DOI:10.31234/osf.io/qyce5
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Emotional Processing
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:20
last_checked: 2026-08-09 08:15:13
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/qyce5
text_rights_status: unverified_not_redistributed
title:
Self-treatment of parental neglect-induced mixed anxiety and depressive disorder with psilocybin - A retrospective case study

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/qyce5","source_url":"https://doi.org/10.31234/osf.io/qyce5","doi":"10.31234/osf.io/qyce5","pmid":"","publication_date":"2023-06-09","importer_version":"2.1.3","text_redistributed":false}


authors: Turkia M.
journal: PsyArXiv
publication_date: 2023-03-10
doi: 10.31234/osf.io/wupvy
source_url: https://doi.org/10.31234/osf.io/wupvy
source_record_id: DOI:10.31234/osf.io/wupvy
substance_tags: psilocybin
topic_tags: Depression,Anxiety,PTSD,Treatment-Resistant Depression,Healthcare Workers,Safety,Drug Interactions
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:20
last_checked: 2026-08-09 08:15:13
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/wupvy
text_rights_status: unverified_not_redistributed
title:
Self-treatment of depression and complex post-traumatic stress disorder with psilocybin and LSD-A retrospective case study

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/wupvy","source_url":"https://doi.org/10.31234/osf.io/wupvy","doi":"10.31234/osf.io/wupvy","pmid":"","publication_date":"2023-03-10","importer_version":"2.1.3","text_redistributed":false}


journal: PsyArXiv
publication_date: 2021-12-14
doi: 10.31234/osf.io/xqzu2
source_url: https://doi.org/10.31234/osf.io/xqzu2
source_record_id: DOI:10.31234/osf.io/xqzu2
substance_tags: psilocybin
topic_tags: Mystical Experience,Healthy Volunteers
study_type: Qualitative Study
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:20
last_checked: 2026-08-09 08:15:13
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/xqzu2
text_rights_status: unverified_not_redistributed
title:
A Quantitative and Qualitative Report of Psilocybin Induced Mystical-Type Experiences and Their Relation to Lasting Positive Effects

authors:
McCulloch DE, Grzywacz MZ, Madsen MK, Jensen PS, Ozenne B, Armand S, Knudsen GM, Fisher PM, Stenbæk DS.

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/xqzu2","source_url":"https://doi.org/10.31234/osf.io/xqzu2","doi":"10.31234/osf.io/xqzu2","pmid":"","publication_date":"2021-12-14","importer_version":"2.1.3","text_redistributed":false}


title: Blunted psychedelic drug effects in older adults
authors: Aday JS, Carhart-Harris R, Boehnke KF.
journal: PsyArXiv
publication_date: 2025-09-04
doi: 10.31234/osf.io/yz4cd_v2
source_url: https://doi.org/10.31234/osf.io/yz4cd_v2
source_record_id: DOI:10.31234/osf.io/yz4cd_v2
substance_tags: psilocybin
topic_tags: Aging,Longevity,Older Adults,Safety
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:20
last_checked: 2026-08-09 08:15:14
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/yz4cd_v2
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/yz4cd_v2","source_url":"https://doi.org/10.31234/osf.io/yz4cd_v2","doi":"10.31234/osf.io/yz4cd_v2","pmid":"","publication_date":"2025-09-04","importer_version":"2.1.3","text_redistributed":false}


authors: Guss J, Krause R, Sloshower J.
journal: PsyArXiv
publication_date: 2020-08-13
doi: 10.31234/osf.io/u6v9y
source_url: https://doi.org/10.31234/osf.io/u6v9y
source_record_id: DOI:10.31234/osf.io/u6v9y
substance_tags: psilocybin
topic_tags: Depression
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:21
last_checked: 2026-08-09 08:15:18
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/u6v9y
text_rights_status: unverified_not_redistributed
title:
The Yale Manual for Psilocybin-Assisted Therapy of Depression (using Acceptance and Commitment Therapy as a Therapeutic Frame)

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/u6v9y","source_url":"https://doi.org/10.31234/osf.io/u6v9y","doi":"10.31234/osf.io/u6v9y","pmid":"","publication_date":"2020-08-13","importer_version":"2.1.3","text_redistributed":false}


authors: Tabaac BJ, Shinozuka K, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, Muir OS.
journal: PsyArXiv
publication_date: 2023-12-26
doi: 10.31234/osf.io/byms6
source_url: https://doi.org/10.31234/osf.io/byms6
source_record_id: DOI:10.31234/osf.io/byms6
substance_tags: psilocybin
topic_tags: Depression,Anxiety,PTSD,Receptor Pharmacology,Clinical Trial,Healthcare Workers
study_type: Clinical Trial
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:21
last_checked: 2026-08-09 08:15:20
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/byms6
text_rights_status: unverified_not_redistributed
title:
Psychedelic Therapy: A Primer for Primary Care Clinicians - Part I. Historical Perspective and Overview

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/byms6","source_url":"https://doi.org/10.31234/osf.io/byms6","doi":"10.31234/osf.io/byms6","pmid":"","publication_date":"2023-12-26","importer_version":"2.1.3","text_redistributed":false}


authors: McAlpine R, Krajnović K, Khan M, Morometescu L, Simonsson O, Sacchet M, Kamboj S.
journal: PsyArXiv
publication_date: 2023-11-22
doi: 10.31234/osf.io/9ev27
source_url: https://doi.org/10.31234/osf.io/9ev27
source_record_id: DOI:10.31234/osf.io/9ev27
substance_tags: psilocybin
topic_tags: Consciousness,Safety
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:21
last_checked: 2026-08-09 08:15:21
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/9ev27
text_rights_status: unverified_not_redistributed
title:
Development of a Digital Intervention for Psychedelic Preparation (DIPP): a theory- and person-centred approach

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/9ev27","source_url":"https://doi.org/10.31234/osf.io/9ev27","doi":"10.31234/osf.io/9ev27","pmid":"","publication_date":"2023-11-22","importer_version":"2.1.3","text_redistributed":false}


title: Understanding psychedelic 'mystical experience'-A case example
authors: Turkia M.
journal: PsyArXiv
publication_date: 2023-03-10
doi: 10.31234/osf.io/dh92g
source_url: https://doi.org/10.31234/osf.io/dh92g
source_record_id: DOI:10.31234/osf.io/dh92g
substance_tags: psilocybin
topic_tags: Mystical Experience,Clinical Trial,Healthcare Workers
study_type: Clinical Trial
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:21
last_checked: 2026-08-09 08:15:21
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/dh92g
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/dh92g","source_url":"https://doi.org/10.31234/osf.io/dh92g","doi":"10.31234/osf.io/dh92g","pmid":"","publication_date":"2023-03-10","importer_version":"2.1.3","text_redistributed":false}


authors: Turkia M.
journal: PsyArXiv
publication_date: 2025-03-27
doi: 10.31234/osf.io/mzkyv_v1
source_url: https://doi.org/10.31234/osf.io/mzkyv_v1
source_record_id: DOI:10.31234/osf.io/mzkyv_v1
substance_tags: psilocybin
topic_tags: Depression,Emotional Processing
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:21
last_checked: 2026-08-09 08:15:22
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/mzkyv_v1
text_rights_status: unverified_not_redistributed
title:
Ayahuasca in the treatment of the consequences of chronic childhood sexual abuse in a religious community

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/mzkyv_v1","source_url":"https://doi.org/10.31234/osf.io/mzkyv_v1","doi":"10.31234/osf.io/mzkyv_v1","pmid":"","publication_date":"2025-03-27","importer_version":"2.1.3","text_redistributed":false}


authors: Hooper J, Gyongyosi E, Hutchison K, Mueller R.
journal: PsyArXiv
publication_date: 2024-10-18
doi: 10.31234/osf.io/u9yeg_v1
source_url: https://doi.org/10.31234/osf.io/u9yeg_v1
source_record_id: DOI:10.31234/osf.io/u9yeg_v1
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Emotional Processing,Mystical Experience,Observational Study
study_type: Observational Study
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:22
last_checked: 2026-08-09 08:15:23
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/u9yeg_v1
text_rights_status: unverified_not_redistributed
title:
Aesthetic quality of psychedelic experience is linked to greater insight and improved psychological outcomes.

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/u9yeg_v1","source_url":"https://doi.org/10.31234/osf.io/u9yeg_v1","doi":"10.31234/osf.io/u9yeg_v1","pmid":"","publication_date":"2024-10-18","importer_version":"2.1.3","text_redistributed":false}


authors: Zeifman R, Spriggs MJ, Kettner H, Lyons T, Rosas F, Mediano P, Erritzoe D, Carhart-Harris R.
journal: PsyArXiv
publication_date: 2022-07-07
doi: 10.31234/osf.io/w8j6t
source_url: https://doi.org/10.31234/osf.io/w8j6t
source_record_id: DOI:10.31234/osf.io/w8j6t
substance_tags: psilocybin
topic_tags: Brain Imaging,Mechanism of Action,Wellbeing
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:22
last_checked: 2026-08-09 08:15:23
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/w8j6t
text_rights_status: unverified_not_redistributed
title:
From Relaxed Beliefs Under Psychedelics (REBUS) to Revised Beliefs After Psychedelics (REBAS): Preliminary Development of the RElaxed Beliefs Questionnaire (REB-Q)

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/w8j6t","source_url":"https://doi.org/10.31234/osf.io/w8j6t","doi":"10.31234/osf.io/w8j6t","pmid":"","publication_date":"2022-07-07","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelic Assisted Therapy for Major Depressive Disorder: A Review
authors: McCartney A, McGovern H, De Foe A.
journal: PsyArXiv
publication_date: 2021-06-27
doi: 10.31234/osf.io/9kuhs
source_url: https://doi.org/10.31234/osf.io/9kuhs
source_record_id: DOI:10.31234/osf.io/9kuhs
substance_tags: psilocybin
topic_tags: Depression,Clinical Trial,Review Article,Safety
study_type: Clinical Trial
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:22
last_checked: 2026-08-09 08:15:25
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/9kuhs
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/9kuhs","source_url":"https://doi.org/10.31234/osf.io/9kuhs","doi":"10.31234/osf.io/9kuhs","pmid":"","publication_date":"2021-06-27","importer_version":"2.1.3","text_redistributed":false}


authors: Turkia M.
journal: PsyArXiv
publication_date: 2024-06-07
doi: 10.31234/osf.io/bvk2f
source_url: https://doi.org/10.31234/osf.io/bvk2f
source_record_id: DOI:10.31234/osf.io/bvk2f
substance_tags: psilocybin
topic_tags: Emotional Processing
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:22
last_checked: 2026-08-09 08:15:25
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/bvk2f
text_rights_status: unverified_not_redistributed
title:
5-MeO-DMT in the complete resolution of the consequences of chronic, severe sexual abuse in early childhood-a retrospective case study

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/bvk2f","source_url":"https://doi.org/10.31234/osf.io/bvk2f","doi":"10.31234/osf.io/bvk2f","pmid":"","publication_date":"2024-06-07","importer_version":"2.1.3","text_redistributed":false}


authors: McGovern H, Wellman N, Hutchinson B, Oestreich LKL, Cooper SE, Fonzo G, Doss M.
journal: PsyArXiv
publication_date: 2024-05-26
doi: 10.31234/osf.io/y8sb7
source_url: https://doi.org/10.31234/osf.io/y8sb7
source_record_id: DOI:10.31234/osf.io/y8sb7
substance_tags: psilocybin
topic_tags: Anxiety,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Review Article
study_type: Review Article
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:22
last_checked: 2026-08-09 08:15:26
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/y8sb7
text_rights_status: unverified_not_redistributed
title:
Resetting the Hippocampal Buffer: A Neurocognitive Account of Psychedelic Therapy for Anxiety-Related Psychopathology

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/y8sb7","source_url":"https://doi.org/10.31234/osf.io/y8sb7","doi":"10.31234/osf.io/y8sb7","pmid":"","publication_date":"2024-05-26","importer_version":"2.1.3","text_redistributed":false}


authors: Gwyther M, Aspell JE.
journal: PsyArXiv
publication_date: 2023-06-30
doi: 10.31234/osf.io/8ncj6
source_url: https://doi.org/10.31234/osf.io/8ncj6
source_record_id: DOI:10.31234/osf.io/8ncj6
substance_tags: psilocybin
topic_tags: Consciousness,Mystical Experience
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:22
last_checked: 2026-08-09 08:15:26
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/8ncj6
text_rights_status: unverified_not_redistributed
title:
Alterations to self consciousness during mindfulness meditation and Flotation REST a comparative study

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/8ncj6","source_url":"https://doi.org/10.31234/osf.io/8ncj6","doi":"10.31234/osf.io/8ncj6","pmid":"","publication_date":"2023-06-30","importer_version":"2.1.3","text_redistributed":false}


title: Et psykoanalytisk og et postmoderne perspektiv på selv/egoopløsning i en psykedelisk kontekst
authors: Andersen S.
journal: PsyArXiv
publication_date: 2023-01-04
doi: 10.31234/osf.io/f26ce
source_url: https://doi.org/10.31234/osf.io/f26ce
source_record_id: DOI:10.31234/osf.io/f26ce
substance_tags: psilocybin
topic_tags: Systematic Review,Review Article
study_type: Systematic Review
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:22
last_checked: 2026-08-09 08:15:26
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/f26ce
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/f26ce","source_url":"https://doi.org/10.31234/osf.io/f26ce","doi":"10.31234/osf.io/f26ce","pmid":"","publication_date":"2023-01-04","importer_version":"2.1.3","text_redistributed":false}


authors: Petrovitch D, Mitchell SM, Van Allen J, Littlefield AK.
journal: PsyArXiv
publication_date: 2024-06-10
doi: 10.31234/osf.io/adnpg
source_url: https://doi.org/10.31234/osf.io/adnpg
source_record_id: DOI:10.31234/osf.io/adnpg
substance_tags: psilocybin
topic_tags: Addiction,Clinical Trial,Healthcare Workers,Safety
study_type: Clinical Trial
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:22
last_checked: 2026-08-09 08:15:27
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/adnpg
text_rights_status: unverified_not_redistributed
title:
Who believes psychedelic-assisted therapies work? Risky cannabis use and other factors are associated with positive treatment-outcome expectancies

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/adnpg","source_url":"https://doi.org/10.31234/osf.io/adnpg","doi":"10.31234/osf.io/adnpg","pmid":"","publication_date":"2024-06-10","importer_version":"2.1.3","text_redistributed":false}


title: Is Microdosing a Placebo?
authors: Polito V, Liknaitzky P.
journal: PsyArXiv
publication_date: 2023-06-04
doi: 10.31234/osf.io/3ykst_v1
source_url: https://doi.org/10.31234/osf.io/3ykst_v1
source_record_id: DOI:10.31234/osf.io/3ykst_v1
substance_tags: psilocybin
topic_tags: Microdosing
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:22
last_checked: 2026-08-09 08:15:27
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/3ykst_v1
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/3ykst_v1","source_url":"https://doi.org/10.31234/osf.io/3ykst_v1","doi":"10.31234/osf.io/3ykst_v1","pmid":"","publication_date":"2023-06-04","importer_version":"2.1.3","text_redistributed":false}


authors: Nayak SM, White S, Hilbert S, Lowe MX, Jackson H, Griffiths RR, Garcia-Romeu A, Yaden DB.
journal: PsyArXiv
publication_date: 2023-06-09
doi: 10.31234/osf.io/auycp
source_url: https://doi.org/10.31234/osf.io/auycp
source_record_id: DOI:10.31234/osf.io/auycp
substance_tags: psilocybin
topic_tags: General
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:22
last_checked: 2026-08-09 08:15:27
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/auycp
text_rights_status: unverified_not_redistributed
title:
Naturalistic Psilocybin Use Increases Mind Perception but not Atheist-Believer status: A Prospective Longitudinal Study

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/auycp","source_url":"https://doi.org/10.31234/osf.io/auycp","doi":"10.31234/osf.io/auycp","pmid":"","publication_date":"2023-06-09","importer_version":"2.1.3","text_redistributed":false}


title: Manuel de Yale pour la Thérapie de la Dépression Assistée par la Psilocybine
authors: Guss J, Krause R, Sloshower J.
journal: PsyArXiv
publication_date: 2022-11-15
doi: 10.31234/osf.io/r96tc
source_url: https://doi.org/10.31234/osf.io/r96tc
source_record_id: DOI:10.31234/osf.io/r96tc
substance_tags: psilocybin
topic_tags: Depression
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:22
last_checked: 2026-08-09 08:15:27
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/r96tc
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/r96tc","source_url":"https://doi.org/10.31234/osf.io/r96tc","doi":"10.31234/osf.io/r96tc","pmid":"","publication_date":"2022-11-15","importer_version":"2.1.3","text_redistributed":false}


authors: david J, Berkovich-Ohana A, Dor-Ziderman Y.
journal: PsyArXiv
publication_date: 2024-07-28
doi: 10.31234/osf.io/tmeb3
source_url: https://doi.org/10.31234/osf.io/tmeb3
source_record_id: DOI:10.31234/osf.io/tmeb3
substance_tags: psilocybin
topic_tags: Anxiety,Mechanism of Action,Aging,Personality Change,Veterans
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:22
last_checked: 2026-08-09 08:15:27
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/tmeb3
text_rights_status: unverified_not_redistributed
title:
Embracing Change: Impermanence Acceptance Mediates Differences in Death Processing Between Ayahuasca Users and Non-users

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/tmeb3","source_url":"https://doi.org/10.31234/osf.io/tmeb3","doi":"10.31234/osf.io/tmeb3","pmid":"","publication_date":"2024-07-28","importer_version":"2.1.3","text_redistributed":false}


title: Skepticism About Recent Evidence that Psilocybin Opens Depressed Minds
authors: Doss M, Barrett FS, Corlett PR.
journal: PsyArXiv
publication_date: 2022-04-28
doi: 10.31234/osf.io/a25wb
source_url: https://doi.org/10.31234/osf.io/a25wb
source_record_id: DOI:10.31234/osf.io/a25wb
substance_tags: psilocybin
topic_tags: General
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:22
last_checked: 2026-08-09 08:15:27
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/a25wb
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/a25wb","source_url":"https://doi.org/10.31234/osf.io/a25wb","doi":"10.31234/osf.io/a25wb","pmid":"","publication_date":"2022-04-28","importer_version":"2.1.3","text_redistributed":false}


authors: Schmidt TT, Costines C, Tagliazucchi E, Millière R, Garrido JM, Cuiule JI.
journal: PsyArXiv
publication_date: 2023-06-04
doi: 10.31234/osf.io/45z7w
source_url: https://doi.org/10.31234/osf.io/45z7w
source_record_id: DOI:10.31234/osf.io/45z7w
substance_tags: psilocybin
topic_tags: Consciousness,Aging
study_type: Qualitative Study
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:22
last_checked: 2026-08-09 08:15:28
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/45z7w
text_rights_status: unverified_not_redistributed
title:
The Altered Xperience Project (AXP): Quantitative and Qualitative Data from a Citizen Science Initiative on the Subjective Experience of Altered States of Consciousness

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/45z7w","source_url":"https://doi.org/10.31234/osf.io/45z7w","doi":"10.31234/osf.io/45z7w","pmid":"","publication_date":"2023-06-04","importer_version":"2.1.3","text_redistributed":false}


authors: Kratina S, Lo C, Schwartz R, Strike C, Jopling S, Nayfeh A, Rush B.
journal: PsyArXiv
publication_date: 2023-10-27
doi: 10.31234/osf.io/4gfyd
source_url: https://doi.org/10.31234/osf.io/4gfyd
source_record_id: DOI:10.31234/osf.io/4gfyd
substance_tags: psilocybin
topic_tags: Depression,Anxiety,End-of-Life Distress,Mechanism of Action,Systematic Review,Review Article,Safety
study_type: Systematic Review
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:22
last_checked: 2026-08-09 08:15:28
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/4gfyd
text_rights_status: unverified_not_redistributed
title:
A protocol for a scoping review of psychedelic interventions to alleviate psychological suffering in populations coping with end-of-life issues

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/4gfyd","source_url":"https://doi.org/10.31234/osf.io/4gfyd","doi":"10.31234/osf.io/4gfyd","pmid":"","publication_date":"2023-10-27","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelics and Health Behavior Change - Journal of Psychopharmacology (in press)
authors: Teixeira PJ, Johnson M, Timmermann C, Watts R, Erritzoe D, Douglass H, Kettner H, Carhart-Harris R.
journal: PsyArXiv
publication_date: 2021-03-24
doi: 10.31234/osf.io/8vks6
source_url: https://doi.org/10.31234/osf.io/8vks6
source_record_id: DOI:10.31234/osf.io/8vks6
substance_tags: psilocybin
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:23
last_checked: 2026-08-09 08:15:29
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/8vks6
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Anxiety,Addiction,Eating Disorders,Pharmacology,Mechanism of Action,Wellbeing,Safety,Toxicity

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/8vks6","source_url":"https://doi.org/10.31234/osf.io/8vks6","doi":"10.31234/osf.io/8vks6","pmid":"","publication_date":"2021-03-24","importer_version":"2.1.3","text_redistributed":false}


authors: Dworatzyk K, Jansen T, Schmidt TT.
journal: PsyArXiv
publication_date: 2021-04-02
doi: 10.31234/osf.io/kxmgq
source_url: https://doi.org/10.31234/osf.io/kxmgq
source_record_id: DOI:10.31234/osf.io/kxmgq
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Consciousness,Mystical Experience,Observational Study
study_type: Observational Study
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:23
last_checked: 2026-08-09 08:15:29
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/kxmgq
text_rights_status: unverified_not_redistributed
title:
Phenomenological assessment of psychedelic induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI)

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/kxmgq","source_url":"https://doi.org/10.31234/osf.io/kxmgq","doi":"10.31234/osf.io/kxmgq","pmid":"","publication_date":"2021-04-02","importer_version":"2.1.3","text_redistributed":false}


title: The treatment of abandonment anxiety with MDMA and LSD
authors: Turkia M.
journal: PsyArXiv
publication_date: 2023-06-09
doi: 10.31234/osf.io/pw2tf
source_url: https://doi.org/10.31234/osf.io/pw2tf
source_record_id: DOI:10.31234/osf.io/pw2tf
substance_tags: psilocybin
topic_tags: Anxiety,Emotional Processing
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:23
last_checked: 2026-08-09 08:15:31
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/pw2tf
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/pw2tf","source_url":"https://doi.org/10.31234/osf.io/pw2tf","doi":"10.31234/osf.io/pw2tf","pmid":"","publication_date":"2023-06-09","importer_version":"2.1.3","text_redistributed":false}


title: Naturalistic Entheogenics: Précis of Philosophy of Psychedelics
authors: Letheby C.
journal: PsyArXiv
publication_date: 2021-07-08
doi: 10.31234/osf.io/ztewb
source_url: https://doi.org/10.31234/osf.io/ztewb
source_record_id: DOI:10.31234/osf.io/ztewb
substance_tags: psilocybin
topic_tags: Consciousness,Spirituality
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:23
last_checked: 2026-08-09 08:15:31
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/ztewb
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/ztewb","source_url":"https://doi.org/10.31234/osf.io/ztewb","doi":"10.31234/osf.io/ztewb","pmid":"","publication_date":"2021-07-08","importer_version":"2.1.3","text_redistributed":false}


title: Global Drug Survey
authors: Petranker R, Anderson T, Maier L, Barratt MJ, Ferris J, Winstock A.
journal: PsyArXiv
publication_date: 2020-04-12
doi: 10.31234/osf.io/xb8ve
source_url: https://doi.org/10.31234/osf.io/xb8ve
source_record_id: DOI:10.31234/osf.io/xb8ve
substance_tags: psilocybin
topic_tags: Microdosing,Creativity,Observational Study
study_type: Observational Study
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:23
last_checked: 2026-08-09 08:15:31
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/xb8ve
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/xb8ve","source_url":"https://doi.org/10.31234/osf.io/xb8ve","doi":"10.31234/osf.io/xb8ve","pmid":"","publication_date":"2020-04-12","importer_version":"2.1.3","text_redistributed":false}


title: Blinding and Expectancy Confounds in Psychedelic Randomised Controlled Trials
authors: Muthukumaraswamy S, Forsyth A, Lumley T.
journal: PsyArXiv
publication_date: 2021-03-08
doi: 10.31234/osf.io/q2hzm
source_url: https://doi.org/10.31234/osf.io/q2hzm
source_record_id: DOI:10.31234/osf.io/q2hzm
substance_tags: psilocybin
topic_tags: Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article
study_type: Randomized Controlled Trial
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:23
last_checked: 2026-08-09 08:15:31
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/q2hzm
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/q2hzm","source_url":"https://doi.org/10.31234/osf.io/q2hzm","doi":"10.31234/osf.io/q2hzm","pmid":"","publication_date":"2021-03-08","importer_version":"2.1.3","text_redistributed":false}


authors: Forstmann M, Sagioglou C.
journal: PsyArXiv
publication_date: 2021-05-05
doi: 10.31234/osf.io/2489x
source_url: https://doi.org/10.31234/osf.io/2489x
source_record_id: DOI:10.31234/osf.io/2489x
substance_tags: psilocybin
study_type: Review Article
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:23
last_checked: 2026-08-09 08:15:31
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/2489x
text_rights_status: unverified_not_redistributed
title:
New insights into the clinical and nonclinical effects of psychedelic substances: an integrative review

topic_tags:
Depression,Anxiety,Addiction,Mechanism of Action,Wellbeing,Personality Change,Creativity,Review Article

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/2489x","source_url":"https://doi.org/10.31234/osf.io/2489x","doi":"10.31234/osf.io/2489x","pmid":"","publication_date":"2021-05-05","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelics and Mindfulness: A Systematic Review and Meta-Analysis
authors: Radakovic C, Radakovic R, Peryer G, Geere J.
journal: PsyArXiv
publication_date: 2021-10-11
doi: 10.31234/osf.io/yu7jf
source_url: https://doi.org/10.31234/osf.io/yu7jf
source_record_id: DOI:10.31234/osf.io/yu7jf
substance_tags: psilocybin
topic_tags: Meta-Analysis,Systematic Review,Review Article
study_type: Meta-Analysis
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:23
last_checked: 2026-08-09 08:15:31
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/yu7jf
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/yu7jf","source_url":"https://doi.org/10.31234/osf.io/yu7jf","doi":"10.31234/osf.io/yu7jf","pmid":"","publication_date":"2021-10-11","importer_version":"2.1.3","text_redistributed":false}


authors: Mitina O, Mirsaidov M, Molchanova N, Tutrin A.
journal: PsyArXiv
publication_date: 2020-08-07
doi: 10.31234/osf.io/b7mnz
source_url: https://doi.org/10.31234/osf.io/b7mnz
source_record_id: DOI:10.31234/osf.io/b7mnz
substance_tags: psilocybin
topic_tags: PTSD,Addiction,Chronic Pain,Creativity,Mystical Experience
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:23
last_checked: 2026-08-09 08:15:32
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/b7mnz
text_rights_status: unverified_not_redistributed
title:
Confirmatory factor analysis of Mystical Experience in Freediving as a recreative way to higher efficiency in sport performance and planet saving and money making

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/b7mnz","source_url":"https://doi.org/10.31234/osf.io/b7mnz","doi":"10.31234/osf.io/b7mnz","pmid":"","publication_date":"2020-08-07","importer_version":"2.1.3","text_redistributed":false}


authors: Corneille JS, Luke D.
journal: PsyArXiv
publication_date: 2021-05-31
doi: 10.31234/osf.io/8aeyf
source_url: https://doi.org/10.31234/osf.io/8aeyf
source_record_id: DOI:10.31234/osf.io/8aeyf
substance_tags: psilocybin
topic_tags: Consciousness,Wellbeing,Personality Change,Spirituality,Mystical Experience,Observational Study
study_type: Observational Study
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:23
last_checked: 2026-08-09 08:15:32
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/8aeyf
text_rights_status: unverified_not_redistributed
title:
Spontaneous Spiritual Awakenings: Phenomenology, Altered States, Individual Differences, and Wellbeing

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/8aeyf","source_url":"https://doi.org/10.31234/osf.io/8aeyf","doi":"10.31234/osf.io/8aeyf","pmid":"","publication_date":"2021-05-31","importer_version":"2.1.3","text_redistributed":false}


journal: PsyArXiv
publication_date: 2021-06-14
doi: 10.31234/osf.io/emcxw
source_url: https://doi.org/10.31234/osf.io/emcxw
source_record_id: DOI:10.31234/osf.io/emcxw
substance_tags: psilocybin
topic_tags: Receptor Pharmacology,Microdosing,Creativity
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 11:10:23
last_checked: 2026-08-09 08:15:33
abstract_source: PsyArXiv
abstract_source_url: https://doi.org/10.31234/osf.io/emcxw
text_rights_status: unverified_not_redistributed
title:
Microdosing psychedelics and its effect on creativity: Lessons learned from three double-blind placebo controlled longitudinal trials

authors:
Prochazkova L, van Elk M, Marschall JC, Rifkin BD, Fejer G, Schoen N, Fiacchino D, Kuchar M, Hommel B.

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/emcxw","source_url":"https://doi.org/10.31234/osf.io/emcxw","doi":"10.31234/osf.io/emcxw","pmid":"","publication_date":"2021-06-14","importer_version":"2.1.3","text_redistributed":false}


journal: Psychopharmacology
publication_date: 2026-07-01
doi: 10.1007/s00213-026-07110-y
pubmed_id: 42380668
source_url: https://pubmed.ncbi.nlm.nih.gov/42380668/
source_record_id: PMID:42380668
substance_tags: psilocybin
topic_tags: Depression,Anxiety,PTSD,Emotional Processing,Review Article
study_type: Review Article
source_name: PubMed
publication_status: published
date_added: 2026-07-01 13:00:05
last_checked: 2026-08-09 08:27:46
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/42380668/
text_rights_status: unverified_not_redistributed
title:
Investigating the impact of serotonergic psychedelic drugs, MDMA and ketamine on social cognition in psychiatric disorders: A scoping review.

authors:
Smith SA, Mohammad H, Lee LHN, Dennett L, Smith S, Burback L, Winkler O, Greenshaw A, Jetly R, Kennedy SH, Bhat V, Swainson J, Vermetten E, Cao B, Li XM, Zhang Y

source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:42380668","source_url":"https://pubmed.ncbi.nlm.nih.gov/42380668/","doi":"10.1007/s00213-026-07110-y","pmid":"42380668","publication_date":"2026-07-01","importer_version":"2.1.3","text_redistributed":false}


title: Past-Year Psilocybin and Alcohol Co-Use: Associations With Mental Health Symptoms
authors: Hummel Haley M., Obrochta Alexia N., Kerr David C. R., Cservenka Anita
journal: Journal of Drug Issues
publication_date: 2026-07-01
doi: 10.1177/00220426261466154
source_url: https://doi.org/10.1177/00220426261466154
source_record_id: DOI:10.1177/00220426261466154
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Observational Study
study_type: Observational Study
source_name: Crossref
publication_status: published
date_added: 2026-07-02 06:54:51
last_checked: 2026-08-09 08:28:46
abstract_source: Crossref
abstract_source_url: https://doi.org/10.1177/00220426261466154
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Crossref","source_record_id":"DOI:10.1177/00220426261466154","source_url":"https://doi.org/10.1177/00220426261466154","doi":"10.1177/00220426261466154","pmid":"","publication_date":"2026-07-01","importer_version":"2.1.3","text_redistributed":false}


authors: Askari M, Surapaneni V.
journal: EcoEvoRxiv
publication_date: 2026-07-01
doi: 10.32942/x2fd49
source_url: https://doi.org/10.32942/x2fd49
source_record_id: DOI:10.32942/x2fd49
substance_tags: psilocybin
topic_tags: Mechanism of Action,Receptor Pharmacology,Genomics
study_type: Other
source_name: Europe PMC
publication_status: preprint
date_added: 2026-07-02 20:31:02
last_checked: 2026-08-09 08:14:50
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.32942/x2fd49
text_rights_status: unverified_not_redistributed
title:
Convergent biosynthesis of psilocybin in an ectomycorrhizal lineage: is the psychoactive end-product the selected trait?

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"DOI:10.32942/x2fd49","source_url":"https://doi.org/10.32942/x2fd49","doi":"10.32942/x2fd49","pmid":"","publication_date":"2026-07-01","importer_version":"2.1.3","text_redistributed":false}


authors: Benjamin Dueck
journal: Journal of Posthuman Studies
publication_date: 2020-12-01
doi: 10.5325/jpoststud.4.2.0166
source_url: https://doi.org/10.5325/jpoststud.4.2.0166
source_record_id: DOI:10.5325/jpoststud.4.2.0166
substance_tags: psilocybin
topic_tags: Consciousness,Spirituality
study_type: Qualitative Study
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:47
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.5325/jpoststud.4.2.0166
text_rights_status: unverified_not_redistributed
title:
Describing the Unspeakable: Psychedelic Communication Technologies and the Development of a Posthuman Language

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.5325/jpoststud.4.2.0166","source_url":"https://doi.org/10.5325/jpoststud.4.2.0166","doi":"10.5325/jpoststud.4.2.0166","pmid":"","publication_date":"2020-12-01","importer_version":"2.1.3","text_redistributed":false}


journal: Neuropsychopharmacology
publication_date: 2020-11-19
doi: 10.1038/s41386-020-00906-2
pubmed_id: 33219313
source_url: https://doi.org/10.1038/s41386-020-00906-2
source_record_id: PMID:33219313
substance_tags: psilocybin
topic_tags: Brain Imaging,Pharmacology,Receptor Pharmacology,Default Mode Network,Aging,Healthy Volunteers
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-07-02 20:42:13
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1038/s41386-020-00906-2
text_rights_status: unverified_not_redistributed
title:
MDMA-induced changes in within-network connectivity contradict the specificity of these alterations for the effects of serotonergic hallucinogens

authors:
Felix Müller, Friederike Holze, Patrick C. Dolder, Laura Ley, Patrick Vizeli, Alain Soltermann, Matthias E. Liechti, Stefan Borgwardt

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"PMID:33219313","source_url":"https://doi.org/10.1038/s41386-020-00906-2","doi":"10.1038/s41386-020-00906-2","pmid":"33219313","publication_date":"2020-11-19","importer_version":"2.1.3","text_redistributed":false}


title: Advancing elite athlete mental health treatment with psychedelic-assisted psychotherapy
authors: Courtney C. Walton, Paul Liknaitzky
journal: Journal of Applied Sport Psychology
publication_date: 2020-11-10
doi: 10.1080/10413200.2020.1848941
source_url: https://doi.org/10.1080/10413200.2020.1848941
source_record_id: DOI:10.1080/10413200.2020.1848941
substance_tags: psilocybin
topic_tags: Mechanism of Action,Aging,Wellbeing,Healthcare Workers,Safety
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:47
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1080/10413200.2020.1848941
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1080/10413200.2020.1848941","source_url":"https://doi.org/10.1080/10413200.2020.1848941","doi":"10.1080/10413200.2020.1848941","pmid":"","publication_date":"2020-11-10","importer_version":"2.1.3","text_redistributed":false}


journal: European Neuropsychopharmacology
publication_date: 2020-11-01
doi: 10.1016/j.euroneuro.2020.09.589
source_url: https://doi.org/10.1016/j.euroneuro.2020.09.589
source_record_id: DOI:10.1016/j.euroneuro.2020.09.589
substance_tags: psilocybin
topic_tags: Neuroplasticity,Receptor Pharmacology
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:47
text_rights_status: not_applicable_no_text
title:
P.804A single dose of psilocybin increases synaptic density and decreases 5-HT2A receptor density in the pig brain

authors:
Nakul Ravi Raval, Annette Johansen, Lene Lundgaard Donovan, Nelson Ros, Brice Ozenne, Hanne D. Hansen, Gitte M. Knudsen

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.euroneuro.2020.09.589","source_url":"https://doi.org/10.1016/j.euroneuro.2020.09.589","doi":"10.1016/j.euroneuro.2020.09.589","pmid":"","publication_date":"2020-11-01","importer_version":"2.1.3","text_redistributed":false}


authors: Olivia Gosseries, Charlotte Martial
journal: Open Repository and Bibliography (University of Liège)
publication_date: 2020-10-12
doi: 10.34700/gv0w-y052
source_url: https://orbi.uliege.be/handle/2268/254726
source_record_id: DOI:10.34700/gv0w-y052
substance_tags: psilocybin
topic_tags: Consciousness,Clinical Trial,Healthy Volunteers
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-07-04 07:00:39
abstract_source: OpenAlex
abstract_source_url: https://orbi.uliege.be/handle/2268/254726
text_rights_status: unverified_not_redistributed
title:
The use of psychedelics in the treatment of disorders of consciousness. An interview with Olivia Gosseries by Charlotte Martial.

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.34700/gv0w-y052","source_url":"https://orbi.uliege.be/handle/2268/254726","doi":"10.34700/gv0w-y052","pmid":"","publication_date":"2020-10-12","importer_version":"2.1.3","text_redistributed":false}


title: Turn On, Tune In, Drop In: Psychedelics, Creativity and Entrepreneurship
authors: Lawrence Silver
journal: American Journal of Management
publication_date: 2020-10-02
doi: 10.33423/ajm.v20i3.3104
source_url: https://doi.org/10.33423/ajm.v20i3.3104
source_record_id: DOI:10.33423/ajm.v20i3.3104
substance_tags: psilocybin
topic_tags: Creativity,Review Article
study_type: Review Article
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:47
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.33423/ajm.v20i3.3104
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.33423/ajm.v20i3.3104","source_url":"https://doi.org/10.33423/ajm.v20i3.3104","doi":"10.33423/ajm.v20i3.3104","pmid":"","publication_date":"2020-10-02","importer_version":"2.1.3","text_redistributed":false}


title: The Role of Psychedelics and Counseling in Mental Health Treatment
journal: Journal of Mental Health Counseling
publication_date: 2020-10-01
doi: 10.17744/mehc.42.4.03
source_url: https://doi.org/10.17744/mehc.42.4.03
source_record_id: DOI:10.17744/mehc.42.4.03
substance_tags: psilocybin
topic_tags: Depression,Addiction,Receptor Pharmacology,Clinical Trial
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:47
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.17744/mehc.42.4.03
text_rights_status: unverified_not_redistributed
authors:
Russ Curtis, Lisen C. Roberts, Elizabeth Graves, Heather Thompson Rainey, D. D. Wynn, Daphne Krantz, Verena Wieloch

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.17744/mehc.42.4.03","source_url":"https://doi.org/10.17744/mehc.42.4.03","doi":"10.17744/mehc.42.4.03","pmid":"","publication_date":"2020-10-01","importer_version":"2.1.3","text_redistributed":false}


title: Wait for the Science Before Widespread Use of Psilocybin
authors: Nicole Harrington Cirino
journal: Psychiatric News
publication_date: 2020-09-29
doi: 10.1176/appi.pn.2020.10a32
source_url: https://doi.org/10.1176/appi.pn.2020.10a32
source_record_id: DOI:10.1176/appi.pn.2020.10a32
substance_tags: psilocybin
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:47
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1176/appi.pn.2020.10a32
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Anxiety,Addiction,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Safety,Drug Interactions

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1176/appi.pn.2020.10a32","source_url":"https://doi.org/10.1176/appi.pn.2020.10a32","doi":"10.1176/appi.pn.2020.10a32","pmid":"","publication_date":"2020-09-29","importer_version":"2.1.3","text_redistributed":false}


authors: Agata Tadeja
journal: Farmacja Polska
publication_date: 2020-09-28
doi: 10.32383/farmpol/127922
source_url: https://doi.org/10.32383/farmpol/127922
source_record_id: DOI:10.32383/farmpol/127922
substance_tags: psilocybin
topic_tags: Pharmacology,Receptor Pharmacology
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:47
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.32383/farmpol/127922
text_rights_status: unverified_not_redistributed
title:
Drugs in therapy. LSD, MDMA, marijuana, psilocybin, designer drugs and its potential in modern medicine.

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.32383/farmpol/127922","source_url":"https://doi.org/10.32383/farmpol/127922","doi":"10.32383/farmpol/127922","pmid":"","publication_date":"2020-09-28","importer_version":"2.1.3","text_redistributed":false}


authors: Shevaugn Johnson, Quentin Black
journal: International Journal of Mental Health and Addiction
publication_date: 2020-09-13
doi: 10.1007/s11469-020-00398-7
source_url: https://doi.org/10.1007/s11469-020-00398-7
source_record_id: DOI:10.1007/s11469-020-00398-7
substance_tags: psilocybin
topic_tags: Receptor Pharmacology,Case Report
study_type: Case Report
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-07-02 20:42:13
text_rights_status: not_applicable_no_text
title:
Classic Psychedelics as a Psychotherapeutic Aid in the Treatment of Stimulant Use Disorder: a Case Report

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1007/s11469-020-00398-7","source_url":"https://doi.org/10.1007/s11469-020-00398-7","doi":"10.1007/s11469-020-00398-7","pmid":"","publication_date":"2020-09-13","importer_version":"2.1.3","text_redistributed":false}


title: Case Report: Resolution of Rheumatoid Arthritis in a Patient Consuming Psilocybin Mushrooms
authors: Lin Denise S
journal: Journal of Healthcare
publication_date: 2020-08-19
doi: 10.36959/569/456
source_url: https://doi.org/10.36959/569/456
source_record_id: DOI:10.36959/569/456
substance_tags: psilocybin
topic_tags: Case Report,Observational Study
study_type: Case Report
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:48
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.36959/569/456
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.36959/569/456","source_url":"https://doi.org/10.36959/569/456","doi":"10.36959/569/456","pmid":"","publication_date":"2020-08-19","importer_version":"2.1.3","text_redistributed":false}


title: Oregon's Pioneering Effort to Enact State Law to Allow Access to Psilocybin
authors: James D. Tucker
journal: SSRN Electronic Journal
publication_date: 2020-08-13
source_url: https://papers.ssrn.com/sol3/Delivery.cfm/SSRN_ID3783484_code4550530.pdf?abstractid=3783484&mirid=1
source_record_id: https://papers.ssrn.com/sol3/Delivery.cfm/SSRN_ID3783484_code4550530.pdf?abstractid=3783484&mirid=1
substance_tags: psilocybin
topic_tags: Depression,Anxiety,End-of-Life Distress,Spirituality
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-07-04 07:00:39
abstract_source: OpenAlex
abstract_source_url: https://papers.ssrn.com/sol3/Delivery.cfm/SSRN_ID3783484_code4550530.pdf?abstractid=3783484&mirid=1
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"https://papers.ssrn.com/sol3/Delivery.cfm/SSRN_ID3783484_code4550530.pdf?abstractid=3783484&mirid=1","source_url":"https://papers.ssrn.com/sol3/Delivery.cfm/SSRN_ID3783484_code4550530.pdf?abstractid=3783484&mirid=1","doi":"","pmid":"","publication_date":"2020-08-13","importer_version":"2.1.3","text_redistributed":false}


authors: Callie Munson, Elyse Sunshine
journal: Pacific University CommonKnowledge
publication_date: 2020-08-08
source_url: https://commons.pacificu.edu/work/sc/b2be0580-b85b-405c-af50-8414cb3b2419
source_record_id: https://commons.pacificu.edu/work/sc/b2be0580-b85b-405c-af50-8414cb3b2419
substance_tags: psilocybin
topic_tags: End-of-Life Distress
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:57:51
text_rights_status: not_applicable_no_text
title:
Psilocybin as an Effective Treatment for Patients with Life-Threatening Cancer and Psychological Distress: A Critically Appraised Topic

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"https://commons.pacificu.edu/work/sc/b2be0580-b85b-405c-af50-8414cb3b2419","source_url":"https://commons.pacificu.edu/work/sc/b2be0580-b85b-405c-af50-8414cb3b2419","doi":"","pmid":"","publication_date":"2020-08-08","importer_version":"2.1.3","text_redistributed":false}


title: 4 Psychedelics: therapeutic mechanisms
authors: Robin Carhart-Harris
journal: Journal of Neurology Neurosurgery & Psychiatry
publication_date: 2020-07-20
doi: 10.1136/jnnp-2020-bnpa.4
source_url: https://doi.org/10.1136/jnnp-2020-bnpa.4
source_record_id: DOI:10.1136/jnnp-2020-bnpa.4
substance_tags: psilocybin
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:48
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1136/jnnp-2020-bnpa.4
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Treatment-Resistant Depression

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1136/jnnp-2020-bnpa.4","source_url":"https://doi.org/10.1136/jnnp-2020-bnpa.4","doi":"10.1136/jnnp-2020-bnpa.4","pmid":"","publication_date":"2020-07-20","importer_version":"2.1.3","text_redistributed":false}


title: Molecular docking and binding interaction between psychedelic drugs and human serum albumin
authors: Hossein Khastar, Kobra Foroughi, Seyed Shahrokh Aghayan, Maryam Yarmohammadi, Moslem Jafarisani
journal: Biotechnologia
publication_date: 2020-06-16
doi: 10.5114/bta.2020.94770
source_url: https://doi.org/10.5114/bta.2020.94770
source_record_id: DOI:10.5114/bta.2020.94770
substance_tags: psilocybin,psilocin
topic_tags: Pharmacology,Drug Interactions
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:48
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.5114/bta.2020.94770
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.5114/bta.2020.94770","source_url":"https://doi.org/10.5114/bta.2020.94770","doi":"10.5114/bta.2020.94770","pmid":"","publication_date":"2020-06-16","importer_version":"2.1.3","text_redistributed":false}


title: A potential role for psilocybin in the treatment of obsessive-compulsive disorder
authors: Edward Jacobs
journal: Journal of Psychedelic Studies
publication_date: 2020-06-01
doi: 10.1556/2054.2020.00128
source_url: https://doi.org/10.1556/2054.2020.00128
source_record_id: DOI:10.1556/2054.2020.00128
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:48
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1556/2054.2020.00128
text_rights_status: unverified_not_redistributed
topic_tags:
Addiction,OCD,Mechanism of Action,Receptor Pharmacology,Randomized Controlled Trial,Review Article,Animal Study,Safety

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1556/2054.2020.00128","source_url":"https://doi.org/10.1556/2054.2020.00128","doi":"10.1556/2054.2020.00128","pmid":"","publication_date":"2020-06-01","importer_version":"2.1.3","text_redistributed":false}


title: Hallucinogens/psychedelics resurrected as new tools in psychiatric therapy
authors: Rafael G. dos Santos, José Carlos Bouso, Jaime E. C. Hallak
journal: Brazilian Journal of Psychiatry
publication_date: 2020-05-31
doi: 10.1590/1516-4446-2020-1035
pubmed_id: 32491039
source_url: https://doi.org/10.1590/1516-4446-2020-1035
source_record_id: PMID:32491039
substance_tags: psilocybin
topic_tags: General
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-07-02 20:42:13
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"PMID:32491039","source_url":"https://doi.org/10.1590/1516-4446-2020-1035","doi":"10.1590/1516-4446-2020-1035","pmid":"32491039","publication_date":"2020-05-31","importer_version":"2.1.3","text_redistributed":false}


authors: Nick Zagorski
journal: Psychiatric News
publication_date: 2020-05-28
doi: 10.1176/appi.pn.2020.6a34
source_url: https://doi.org/10.1176/appi.pn.2020.6a34
source_record_id: DOI:10.1176/appi.pn.2020.6a34
substance_tags: psilocybin
study_type: Case Report
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:48
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1176/appi.pn.2020.6a34
text_rights_status: unverified_not_redistributed
title:
Journal Digest: Home Environment; Postpartum Mental Illness; Placebo in Psychedelic Study; Single Gene Mutation; Topiramate

topic_tags:
Depression,Anxiety,Addiction,Eating Disorders,Brain Imaging,Pharmacology,Consciousness,Aging,Creativity,Case Report,Observational Study,Healthcare Workers,Safety,Adverse Events

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1176/appi.pn.2020.6a34","source_url":"https://doi.org/10.1176/appi.pn.2020.6a34","doi":"10.1176/appi.pn.2020.6a34","pmid":"","publication_date":"2020-05-28","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelics, Safety and Clinical Trial Design
authors: Ron Shore
journal: QSpace (Queen's University Library)
publication_date: 2020-05-19
source_url: http://hdl.handle.net/1974/27835
source_record_id: http://hdl.handle.net/1974/27835
substance_tags: psilocybin
topic_tags: Headache / Migraine,Clinical Trial,Review Article,Safety,Toxicity
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-07-04 07:00:39
abstract_source: OpenAlex
abstract_source_url: http://hdl.handle.net/1974/27835
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"http://hdl.handle.net/1974/27835","source_url":"http://hdl.handle.net/1974/27835","doi":"","pmid":"","publication_date":"2020-05-19","importer_version":"2.1.3","text_redistributed":false}


title: Scoping Review Protocol: Mapping Psilocybin Therapy Research
authors: Ron Shore, Paul Ioudovski, Sandra McKeown, Éric C. Dumont, Craig Goldie
journal: Queen's University QSpace
publication_date: 2020-05-20
source_url: https://qspace.library.queensu.ca/jspui/handle/1974/27833
source_record_id: https://qspace.library.queensu.ca/jspui/handle/1974/27833
substance_tags: psilocybin
topic_tags: Review Article
study_type: Review Article
source_name: OpenAlex
publication_status: protocol
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 09:00:16
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"https://qspace.library.queensu.ca/jspui/handle/1974/27833","source_url":"https://qspace.library.queensu.ca/jspui/handle/1974/27833","doi":"","pmid":"","publication_date":"2020-05-20","importer_version":"2.1.3","text_redistributed":false}


title: Scoping Review Protocol: Mapping Psilocybin Animal Research
authors: Ron Shore, Nigel Barnim, Katrina Dobson, Sandra McKeown, Éric C. Dumont, Craig Goldie
journal: Queen's University QSpace
publication_date: 2020-05-20
source_url: https://qspace.library.queensu.ca/handle/1974/27834
source_record_id: https://qspace.library.queensu.ca/handle/1974/27834
substance_tags: psilocybin
topic_tags: Review Article
study_type: Review Article
source_name: OpenAlex
publication_status: protocol
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 09:00:16
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"https://qspace.library.queensu.ca/handle/1974/27834","source_url":"https://qspace.library.queensu.ca/handle/1974/27834","doi":"","pmid":"","publication_date":"2020-05-20","importer_version":"2.1.3","text_redistributed":false}


title: Binding Interactions of Psilocin and Serotonin in the 5-HT2A Receptor
authors: Katie R. Barnes, Stephanie N. Lewis
journal: VTechWorks (Virginia Tech)
publication_date: 2020-05-05
source_url: http://hdl.handle.net/10919/99299
source_record_id: http://hdl.handle.net/10919/99299
substance_tags: psilocybin,psilocin
topic_tags: Depression,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Drug Interactions
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:48
abstract_source: OpenAlex
abstract_source_url: http://hdl.handle.net/10919/99299
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"http://hdl.handle.net/10919/99299","source_url":"http://hdl.handle.net/10919/99299","doi":"","pmid":"","publication_date":"2020-05-05","importer_version":"2.1.3","text_redistributed":false}


title: Klassiske psykedeliske stoffer - inkl. psilocybin og LSD
authors: Morten Hesse
journal: Patienthåndbogen
publication_date: 2020-04-21
source_url: https://pure.au.dk/portal/en/publications/45be7e79-66e2-4f51-af03-6c20860526cd
source_record_id: https://pure.au.dk/portal/en/publications/45be7e79-66e2-4f51-af03-6c20860526cd
substance_tags: psilocybin
topic_tags: Receptor Pharmacology
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:57:51
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"https://pure.au.dk/portal/en/publications/45be7e79-66e2-4f51-af03-6c20860526cd","source_url":"https://pure.au.dk/portal/en/publications/45be7e79-66e2-4f51-af03-6c20860526cd","doi":"","pmid":"","publication_date":"2020-04-21","importer_version":"2.1.3","text_redistributed":false}


title: Isness: Using Multi-Person VR to Design Peak Mystical Type Experiences Comparable to Psychedelics
journal: Proceedings of the 2020 CHI Conference on Human Factors in Computing Systems
publication_date: 2020-04-20
doi: 10.1145/3313831.3376649
source_url: https://doi.org/10.1145/3313831.3376649
source_record_id: DOI:10.1145/3313831.3376649
substance_tags: psilocybin
topic_tags: Mystical Experience
study_type: Qualitative Study
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:37:32
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1145/3313831.3376649
text_rights_status: unverified_not_redistributed
authors:
David R. Glowacki, Mark D. Wonnacott, Rachel Freire, Becca R. Glowacki, Ella M. Gale, James E. Pike, Tiu de Haan, Mike Chatziapostolou, Oussama Metatla

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1145/3313831.3376649","source_url":"https://doi.org/10.1145/3313831.3376649","doi":"10.1145/3313831.3376649","pmid":"","publication_date":"2020-04-20","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelics for Psychiatric Disorders: More Research Needed
authors: Nick Zagorski
journal: Psychiatric News
publication_date: 2020-04-13
doi: 10.1176/appi.pn.2020.4a14
source_url: https://doi.org/10.1176/appi.pn.2020.4a14
source_record_id: DOI:10.1176/appi.pn.2020.4a14
substance_tags: psilocybin
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:48
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1176/appi.pn.2020.4a14
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Anxiety,PTSD,Addiction,Pharmacology,Receptor Pharmacology,Biomarkers,Clinical Trial,Review Article,Cancer Patients

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1176/appi.pn.2020.4a14","source_url":"https://doi.org/10.1176/appi.pn.2020.4a14","doi":"10.1176/appi.pn.2020.4a14","pmid":"","publication_date":"2020-04-13","importer_version":"2.1.3","text_redistributed":false}


authors: Meghan Hibicke, Charles D. Nichols
journal: The FASEB Journal
publication_date: 2020-03-31
doi: 10.1096/fasebj.2020.34.s1.02912
source_url: https://doi.org/10.1096/fasebj.2020.34.s1.02912
source_record_id: DOI:10.1096/fasebj.2020.34.s1.02912
substance_tags: psilocybin
topic_tags: Depression,Mechanism of Action,Receptor Pharmacology,Adolescents
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-07-04 07:00:39
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1096/fasebj.2020.34.s1.02912
text_rights_status: unverified_not_redistributed
title:
One Dose of Psilocybin in Late Adolescence Mitigates Deleterious Effects of Developmental Stress on Cognition and Behavioral Despair in Adult Female Rats

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1096/fasebj.2020.34.s1.02912","source_url":"https://doi.org/10.1096/fasebj.2020.34.s1.02912","doi":"10.1096/fasebj.2020.34.s1.02912","pmid":"","publication_date":"2020-03-31","importer_version":"2.1.3","text_redistributed":false}


title: Long-Term Analysis of Psilocybin in Cancer Patients With Distress
authors: Richard Simoneaux
journal: Oncology Times
publication_date: 2020-03-26
doi: 10.1097/01.cot.0000660232.19098.7f
source_url: https://doi.org/10.1097/01.cot.0000660232.19098.7f
source_record_id: DOI:10.1097/01.cot.0000660232.19098.7f
substance_tags: psilocybin
topic_tags: Depression,Anxiety,End-of-Life Distress,Wellbeing,Spirituality,Mystical Experience,Cancer Patients
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:48
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1097/01.cot.0000660232.19098.7f
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1097/01.cot.0000660232.19098.7f","source_url":"https://doi.org/10.1097/01.cot.0000660232.19098.7f","doi":"10.1097/01.cot.0000660232.19098.7f","pmid":"","publication_date":"2020-03-26","importer_version":"2.1.3","text_redistributed":false}


title: Can Psychedelics Radically Change SUD Treatment?
authors: Katie O’Connor
journal: Psychiatric News
publication_date: 2020-03-20
doi: 10.1176/appi.pn.2020.2a12
source_url: https://doi.org/10.1176/appi.pn.2020.2a12
source_record_id: DOI:10.1176/appi.pn.2020.2a12
substance_tags: psilocybin
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:48
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1176/appi.pn.2020.2a12
text_rights_status: unverified_not_redistributed
topic_tags:
Anxiety,PTSD,Addiction,Chronic Pain,Pharmacology,Consciousness,Clinical Trial,Observational Study,Healthcare Workers,Safety

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1176/appi.pn.2020.2a12","source_url":"https://doi.org/10.1176/appi.pn.2020.2a12","doi":"10.1176/appi.pn.2020.2a12","pmid":"","publication_date":"2020-03-20","importer_version":"2.1.3","text_redistributed":false}


title: Trip: Psychedelics, Alienation, and Change
authors: Brent Schnipke
journal: American Journal of Psychiatry Residents Journal
publication_date: 2020-03-05
doi: 10.1176/appi.ajp-rj.2020.150310
source_url: https://doi.org/10.1176/appi.ajp-rj.2020.150310
source_record_id: DOI:10.1176/appi.ajp-rj.2020.150310
substance_tags: psilocybin
topic_tags: General
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-07-02 20:42:13
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1176/appi.ajp-rj.2020.150310","source_url":"https://doi.org/10.1176/appi.ajp-rj.2020.150310","doi":"10.1176/appi.ajp-rj.2020.150310","pmid":"","publication_date":"2020-03-05","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelic Birth: Bodies, Boundaries and the Perception of Pain in the 1970s
authors: Wendy Kline
journal: Gender & History
publication_date: 2020-03-01
doi: 10.1111/1468-0424.12471
source_url: https://doi.org/10.1111/1468-0424.12471
source_record_id: DOI:10.1111/1468-0424.12471
substance_tags: psilocybin
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:48
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1111/1468-0424.12471
text_rights_status: unverified_not_redistributed
topic_tags:
PTSD,Chronic Pain,Mechanism of Action,Consciousness,Personality Change,Emotional Processing,Creativity,Spirituality,Safety

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1111/1468-0424.12471","source_url":"https://doi.org/10.1111/1468-0424.12471","doi":"10.1111/1468-0424.12471","pmid":"","publication_date":"2020-03-01","importer_version":"2.1.3","text_redistributed":false}


title: Prophylactic Effects of Psilocybin on Chronic Cluster Headache
authors: Case Medical Research
journal: Case Medical Research
publication_date: 2020-02-21
doi: 10.31525/ct1-nct04280055
source_url: https://doi.org/10.31525/ct1-nct04280055
source_record_id: DOI:10.31525/ct1-nct04280055
substance_tags: psilocybin
topic_tags: Chronic Pain,Headache / Migraine,Pharmacology
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:48
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.31525/ct1-nct04280055","source_url":"https://doi.org/10.31525/ct1-nct04280055","doi":"10.31525/ct1-nct04280055","pmid":"","publication_date":"2020-02-21","importer_version":"2.1.3","text_redistributed":false}


authors: Rebecca Wallersteiner
journal: BMJ
publication_date: 2020-01-31
doi: 10.1136/bmj.m407
source_url: https://doi.org/10.1136/bmj.m407
source_record_id: DOI:10.1136/bmj.m407
substance_tags: psilocybin
topic_tags: Consciousness,Spirituality,Adolescents
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:48
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1136/bmj.m407
text_rights_status: unverified_not_redistributed
title:
Richard Alpert (Ram Dass): Harvard psychologist who experimented with psychedelic drugs and became one of America’s most prominent and respected spiritual leaders

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1136/bmj.m407","source_url":"https://doi.org/10.1136/bmj.m407","doi":"10.1136/bmj.m407","pmid":"","publication_date":"2020-01-31","importer_version":"2.1.3","text_redistributed":false}


journal: European Neuropsychopharmacology
publication_date: 2020-01-28
doi: 10.1016/j.euroneuro.2019.12.087
source_url: https://doi.org/10.1016/j.euroneuro.2019.12.087
source_record_id: DOI:10.1016/j.euroneuro.2019.12.087
substance_tags: psilocybin
topic_tags: General
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:48
text_rights_status: not_applicable_no_text
title:
P.324 Acute effects of psilocybin on glutamate concentration levels, functional connectivity and subjective state

authors:
Natasha L. Mason, Kim P. C. Kuypers, Johannes T. Reckweg, Desmond H. Y. Tse, Felix Müller, Stefan W. Toennes, Amanda Feilding, Johannes G. Ramaekers

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.euroneuro.2019.12.087","source_url":"https://doi.org/10.1016/j.euroneuro.2019.12.087","doi":"10.1016/j.euroneuro.2019.12.087","pmid":"","publication_date":"2020-01-28","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelic therapy: Fresh promise for mental health
authors: Heidi Bush
journal: Mental Health Weekly
publication_date: 2020-01-24
doi: 10.1002/mhw.32207
source_url: https://doi.org/10.1002/mhw.32207
source_record_id: DOI:10.1002/mhw.32207
substance_tags: psilocybin
topic_tags: Depression,PTSD,Pharmacology,Receptor Pharmacology
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:48
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1002/mhw.32207
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1002/mhw.32207","source_url":"https://doi.org/10.1002/mhw.32207","doi":"10.1002/mhw.32207","pmid":"","publication_date":"2020-01-24","importer_version":"2.1.3","text_redistributed":false}


title: Comparative Acute Effects of LSD, Psilocybin and Mescaline
authors: Case Medical Research
journal: Case Medical Research
publication_date: 2020-01-14
doi: 10.31525/ct1-nct04227756
source_url: https://doi.org/10.31525/ct1-nct04227756
source_record_id: DOI:10.31525/ct1-nct04227756
substance_tags: psilocybin
topic_tags: Pharmacology,Receptor Pharmacology
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:49
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.31525/ct1-nct04227756","source_url":"https://doi.org/10.31525/ct1-nct04227756","doi":"10.31525/ct1-nct04227756","pmid":"","publication_date":"2020-01-14","importer_version":"2.1.3","text_redistributed":false}


title: Matthew Oram, The Trials of Psychedelic Therapy: LSD Psychotherapy in America
authors: Michael Draper
journal: Journal of the History of Medicine and Allied Sciences
publication_date: 2020-01-13
doi: 10.1093/jhmas/jraa002
source_url: https://doi.org/10.1093/jhmas/jraa002
source_record_id: DOI:10.1093/jhmas/jraa002
substance_tags: psilocybin
topic_tags: Receptor Pharmacology,Spirituality
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:49
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1093/jhmas/jraa002
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1093/jhmas/jraa002","source_url":"https://doi.org/10.1093/jhmas/jraa002","doi":"10.1093/jhmas/jraa002","pmid":"","publication_date":"2020-01-13","importer_version":"2.1.3","text_redistributed":false}


title: An Improved, Practical, and Scalable Five-Step Synthesis of Psilocybin
authors: Robert B. Kargbo, Alexander M. Sherwood, Poncho Meisenheimer, Gary Tarpley
journal: Synthesis
publication_date: 2020-01-08
doi: 10.1055/s-0039-1691565
source_url: https://doi.org/10.1055/s-0039-1691565
source_record_id: DOI:10.1055/s-0039-1691565
substance_tags: psilocybin
topic_tags: Pharmacology
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:49
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1055/s-0039-1691565
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1055/s-0039-1691565","source_url":"https://doi.org/10.1055/s-0039-1691565","doi":"10.1055/s-0039-1691565","pmid":"","publication_date":"2020-01-08","importer_version":"2.1.3","text_redistributed":false}


title: Social Work and Psychedelic-Assisted Therapies: Practice Considerations for Breakthrough Treatments
authors: Courtney Hutchison, Sara Bressi
journal: Clinical Social Work Journal
publication_date: 2020-01-06
doi: 10.1007/s10615-019-00743-x
source_url: https://doi.org/10.1007/s10615-019-00743-x
source_record_id: DOI:10.1007/s10615-019-00743-x
substance_tags: psilocybin
topic_tags: Anxiety,Receptor Pharmacology
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-07-02 20:42:13
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1007/s10615-019-00743-x","source_url":"https://doi.org/10.1007/s10615-019-00743-x","doi":"10.1007/s10615-019-00743-x","pmid":"","publication_date":"2020-01-06","importer_version":"2.1.3","text_redistributed":false}


title: Repeat Dosing of Psilocybin in Migraine Headache
authors: Case Medical Research
journal: Case Medical Research
publication_date: 2020-01-06
doi: 10.31525/ct1-nct04218539
source_url: https://doi.org/10.31525/ct1-nct04218539
source_record_id: DOI:10.31525/ct1-nct04218539
substance_tags: psilocybin
topic_tags: Headache / Migraine,Pharmacology,Receptor Pharmacology
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:49
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.31525/ct1-nct04218539","source_url":"https://doi.org/10.31525/ct1-nct04218539","doi":"10.31525/ct1-nct04218539","pmid":"","publication_date":"2020-01-06","importer_version":"2.1.3","text_redistributed":false}


authors: Natasha L. Mason, Patrick C. Dolder, Kim P. C. Kuypers
journal: Drug Science Policy and Law
publication_date: 2020-01-01
doi: 10.1177/2050324519900068
source_url: https://doi.org/10.1177/2050324519900068
source_record_id: DOI:10.1177/2050324519900068
substance_tags: psilocybin
topic_tags: Receptor Pharmacology,Wellbeing,Personality Change,Emotional Processing,Adverse Events
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:49
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1177/2050324519900068
text_rights_status: unverified_not_redistributed
title:
Reported effects of psychedelic use on those with low well-being given various emotional states and social contexts

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1177/2050324519900068","source_url":"https://doi.org/10.1177/2050324519900068","doi":"10.1177/2050324519900068","pmid":"","publication_date":"2020-01-01","importer_version":"2.1.3","text_redistributed":false}


authors: JEC Anthony, Adam Winstock, JA Ferris, DJ Nutt
journal: Drug Science Policy and Law
publication_date: 2020-01-01
doi: 10.1177/2050324520942345
source_url: https://doi.org/10.1177/2050324520942345
source_record_id: DOI:10.1177/2050324520942345
substance_tags: psilocybin
topic_tags: Receptor Pharmacology,Observational Study
study_type: Observational Study
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:49
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1177/2050324520942345
text_rights_status: unverified_not_redistributed
title:
Improved colour blindness symptoms associated with recreational psychedelic use: Results from the Global Drug Survey 2017

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1177/2050324520942345","source_url":"https://doi.org/10.1177/2050324520942345","doi":"10.1177/2050324520942345","pmid":"","publication_date":"2020-01-01","importer_version":"2.1.3","text_redistributed":false}


title: Medicinal use of psilocybin: Reducing restrictions on research and treatment.
authors: James Rucker, Jessie Schnall, Daniel D’Hotman, David King, Timmy Davis, Joanna C. Neill
journal: Conservative Drug Policy Reform Group
publication_date: 2020-01-01
source_url: https://www.drugsandalcohol.ie/32599/
source_record_id: https://www.drugsandalcohol.ie/32599/
substance_tags: psilocybin
topic_tags: Pharmacology,Safety
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:57:51
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"https://www.drugsandalcohol.ie/32599/","source_url":"https://www.drugsandalcohol.ie/32599/","doi":"","pmid":"","publication_date":"2020-01-01","importer_version":"2.1.3","text_redistributed":false}


title: Development of an improved psilocybin synthesis
authors: Reham Shaba
journal: Uppsala University Publications (Uppsala University)
publication_date: 2019-12-31
source_url: http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-420295
source_record_id: http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-420295
substance_tags: psilocybin,psilocin
topic_tags: Depression,Anxiety,Addiction,Clinical Trial,Observational Study
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-07-04 07:00:39
abstract_source: OpenAlex
abstract_source_url: http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-420295
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-420295","source_url":"http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-420295","doi":"","pmid":"","publication_date":"2019-12-31","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin may help cancer patients with depression and anxiety for years
authors: Laura Sanders
journal: Access Science
publication_date: 2020-01-01
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Cancer Patients
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:49
text_rights_status: not_applicable_no_text
source_url:
https://www.accessscience.com/content/psilocybin-may-help-cancer-patients-with-depression-and-anxiety-for-years/SN2002031

source_record_id:
https://www.accessscience.com/content/psilocybin-may-help-cancer-patients-with-depression-and-anxiety-for-years/SN2002031

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"https://www.accessscience.com/content/psilocybin-may-help-cancer-patients-with-depression-and-anxiety-for-years/SN2002031","source_url":"https://www.accessscience.com/content/psilocybin-may-help-cancer-patients-with-depression-and-anxiety-for-years/SN2002031","doi":"","pmid":"","publication_date":"2020-01-01","importer_version":"2.1.3","text_redistributed":false}


authors: Ammar Jawad
journal: VCU Scholars Compass (Virginia Commonwealth University)
publication_date: 2020-01-01
source_url: https://scholarscompass.vcu.edu/uresposters/356
source_record_id: https://scholarscompass.vcu.edu/uresposters/356
substance_tags: psilocybin
topic_tags: Pharmacology,Mechanism of Action,Receptor Pharmacology,Creativity
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:49
abstract_source: OpenAlex
abstract_source_url: https://scholarscompass.vcu.edu/uresposters/356
text_rights_status: unverified_not_redistributed
title:
Drugs and the Music Industry: How the Neurological and Visual Effects of LSD and Psilocybin Impact Creativity and Songwriting Abilities

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"https://scholarscompass.vcu.edu/uresposters/356","source_url":"https://scholarscompass.vcu.edu/uresposters/356","doi":"","pmid":"","publication_date":"2020-01-01","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin's effects on the brain and implications for depression treatment
authors: Katariina Sarajärvi
journal: Epubl LTU
publication_date: 2019-12-31
source_url: http://urn.kb.se/resolve?urn=urn:nbn:se:ltu:diva-79481
source_record_id: http://urn.kb.se/resolve?urn=urn:nbn:se:ltu:diva-79481
substance_tags: psilocybin
topic_tags: Depression,Receptor Pharmacology,Consciousness,Wellbeing,Adverse Events
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-07-04 07:00:39
abstract_source: OpenAlex
abstract_source_url: http://urn.kb.se/resolve?urn=urn:nbn:se:ltu:diva-79481
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"http://urn.kb.se/resolve?urn=urn:nbn:se:ltu:diva-79481","source_url":"http://urn.kb.se/resolve?urn=urn:nbn:se:ltu:diva-79481","doi":"","pmid":"","publication_date":"2019-12-31","importer_version":"2.1.3","text_redistributed":false}


title: Predicting the Efficacy of Psilocybin in Treating Mental Health and Addiction
authors: Courtney Ledford
journal: PDXScholar (Portland State University)
publication_date: 2020-01-01
source_url: https://pdxscholar.library.pdx.edu/altreu_projects/5
source_record_id: https://pdxscholar.library.pdx.edu/altreu_projects/5
substance_tags: psilocybin,psilocin
study_type: Meta-Analysis
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:49
abstract_source: OpenAlex
abstract_source_url: https://pdxscholar.library.pdx.edu/altreu_projects/5
text_rights_status: unverified_not_redistributed
topic_tags:
Anxiety,Addiction,OCD,Receptor Pharmacology,Consciousness,Meta-Analysis,Observational Study,Healthy Volunteers

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"https://pdxscholar.library.pdx.edu/altreu_projects/5","source_url":"https://pdxscholar.library.pdx.edu/altreu_projects/5","doi":"","pmid":"","publication_date":"2020-01-01","importer_version":"2.1.3","text_redistributed":false}


authors: Sofia Gyllvik
journal: Diva portal (Dalarna University Library)
publication_date: 2019-12-31
source_url: http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18729
source_record_id: http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18729
substance_tags: psilocybin
topic_tags: Depression,Anxiety,PTSD,Mechanism of Action,Clinical Trial,Review Article,Safety
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-07-04 07:00:39
abstract_source: OpenAlex
abstract_source_url: http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18729
text_rights_status: unverified_not_redistributed
title:
The Therapeutic Potential of Psilocybin and 3,4-Methylenedioxymethamphetamine in the Treatment of Depression and Post-Traumatic Stress Disorder

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18729","source_url":"http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18729","doi":"","pmid":"","publication_date":"2019-12-31","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin and LSD in the Treatment of Depression and Anxiety
authors: Marcus Allgulin
journal: Diva portal (Dalarna University Library)
publication_date: 2019-12-31
source_url: http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18843
source_record_id: http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18843
substance_tags: psilocybin
study_type: Review Article
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-07-04 07:00:39
abstract_source: OpenAlex
abstract_source_url: http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18843
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Anxiety,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Mystical Experience,Review Article

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18843","source_url":"http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18843","doi":"","pmid":"","publication_date":"2019-12-31","importer_version":"2.1.3","text_redistributed":false}


title: Analysis of Newspaper Coverage of Psilocybin from January 1, 1989 to December 31, 2019
authors: Dax Oliver
journal: CUNY Academic Works (City University of New York)
publication_date: 2019-12-31
source_url: https://academicworks.cuny.edu/gc_etds/4074
source_record_id: https://academicworks.cuny.edu/gc_etds/4074
substance_tags: psilocybin
topic_tags: Safety
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-07-04 07:00:39
abstract_source: OpenAlex
abstract_source_url: https://academicworks.cuny.edu/gc_etds/4074
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"https://academicworks.cuny.edu/gc_etds/4074","source_url":"https://academicworks.cuny.edu/gc_etds/4074","doi":"","pmid":"","publication_date":"2019-12-31","importer_version":"2.1.3","text_redistributed":false}


authors: Brooke Reichenbach
journal: Digital Commons - PCOM (Philadelphia College of Osteopathic Medicine)
publication_date: 2020-01-01
source_url: https://digitalcommons.pcom.edu/pa_systematic_reviews/531
source_record_id: https://digitalcommons.pcom.edu/pa_systematic_reviews/531
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Systematic Review,Review Article,Cancer Patients
study_type: Systematic Review
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:49
abstract_source: OpenAlex
abstract_source_url: https://digitalcommons.pcom.edu/pa_systematic_reviews/531
text_rights_status: unverified_not_redistributed
title:
Is Psilocybin an Effective Treatment to Reduce Depression and Anxiety in Cancer Patients with a Diagnosis of an Anxiety Disorder, Mood Disorder, And/Or Stress Disorder?

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"https://digitalcommons.pcom.edu/pa_systematic_reviews/531","source_url":"https://digitalcommons.pcom.edu/pa_systematic_reviews/531","doi":"","pmid":"","publication_date":"2020-01-01","importer_version":"2.1.3","text_redistributed":false}


authors: Krishna Kumar Varshney
journal: SSRN Electronic Journal
publication_date: 2019-12-29
source_url: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3528349
source_record_id: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3528349
substance_tags: psilocybin
topic_tags: Depression,Pharmacology,Receptor Pharmacology,Toxicity,Drug Interactions
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-07-04 07:00:39
abstract_source: OpenAlex
abstract_source_url: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3528349
text_rights_status: unverified_not_redistributed
title:
Structure Based Drug Design towards Exploring Potential Anti-Psychotic and Anti-Depressant Activity of Possible Stiff Base of Psilocybin

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3528349","source_url":"https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3528349","doi":"","pmid":"","publication_date":"2019-12-29","importer_version":"2.1.3","text_redistributed":false}


title: The use of the psychological flexibility model to support psychedelic assisted therapy
authors: Rosalind Watts, Jason B. Luoma
journal: Journal of Contextual Behavioral Science
publication_date: 2019-12-13
doi: 10.1016/j.jcbs.2019.12.004
source_url: https://doi.org/10.1016/j.jcbs.2019.12.004
source_record_id: DOI:10.1016/j.jcbs.2019.12.004
substance_tags: psilocybin
topic_tags: Anxiety,Receptor Pharmacology,Psychological Flexibility
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-07-02 20:42:13
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.jcbs.2019.12.004","source_url":"https://doi.org/10.1016/j.jcbs.2019.12.004","doi":"10.1016/j.jcbs.2019.12.004","pmid":"","publication_date":"2019-12-13","importer_version":"2.1.3","text_redistributed":false}


journal: European Neuropsychopharmacology
publication_date: 2019-12-01
doi: 10.1016/j.euroneuro.2019.09.702
source_url: https://doi.org/10.1016/j.euroneuro.2019.09.702
source_record_id: DOI:10.1016/j.euroneuro.2019.09.702
substance_tags: psilocybin
topic_tags: Pharmacology,Receptor Pharmacology
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:49
text_rights_status: not_applicable_no_text
title:
P.839 Modelling the acute temporal dynamics of psilocybin psychoactive effects; relation to brain serotonin 2a receptor levels

authors:
Dea Siggaard Stenbæk, M.K. Madsen, Brice Ozenne, Søren Kristiansen, Daniel Burmester, David Erritzøe, Gitte M. Knudsen, Patrick M. Fisher

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.euroneuro.2019.09.702","source_url":"https://doi.org/10.1016/j.euroneuro.2019.09.702","doi":"10.1016/j.euroneuro.2019.09.702","pmid":"","publication_date":"2019-12-01","importer_version":"2.1.3","text_redistributed":false}


authors: Laura Mertens, M.B. Wall, L. Roseman, L. Demetriou, D.J. Nutt, R.L. Carhart-Harris
journal: European Neuropsychopharmacology
publication_date: 2019-12-01
doi: 10.1016/j.euroneuro.2019.09.593
source_url: https://doi.org/10.1016/j.euroneuro.2019.09.593
source_record_id: DOI:10.1016/j.euroneuro.2019.09.593
substance_tags: psilocybin
topic_tags: Depression,Mechanism of Action,Emotional Processing,Clinical Trial,Treatment-Resistant Depression
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:49
text_rights_status: not_applicable_no_text
title:
P.609 Therapeutic mechanisms of psychedelic drugs: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.euroneuro.2019.09.593","source_url":"https://doi.org/10.1016/j.euroneuro.2019.09.593","doi":"10.1016/j.euroneuro.2019.09.593","pmid":"","publication_date":"2019-12-01","importer_version":"2.1.3","text_redistributed":false}


title: P.188 Long-term effects of psilocybin on cerebral serotonin 2A receptor levels and personality
journal: European Neuropsychopharmacology
publication_date: 2019-12-01
doi: 10.1016/j.euroneuro.2019.09.232
source_url: https://doi.org/10.1016/j.euroneuro.2019.09.232
source_record_id: DOI:10.1016/j.euroneuro.2019.09.232
substance_tags: psilocybin
topic_tags: Receptor Pharmacology,Personality Change
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:49
text_rights_status: not_applicable_no_text
authors:
Mie Madsen, P.M. Fisher, D.S. Stenbæk, S. Kristiansen, D. Burmester, S. Lehel, Tomáš Páleníček, Claus Svarer, B. Ozenne, Gitte M. Knudsen

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.euroneuro.2019.09.232","source_url":"https://doi.org/10.1016/j.euroneuro.2019.09.232","doi":"10.1016/j.euroneuro.2019.09.232","pmid":"","publication_date":"2019-12-01","importer_version":"2.1.3","text_redistributed":false}


journal: European Neuropsychopharmacology
publication_date: 2019-12-01
doi: 10.1016/j.euroneuro.2019.09.271
source_url: https://doi.org/10.1016/j.euroneuro.2019.09.271
source_record_id: DOI:10.1016/j.euroneuro.2019.09.271
substance_tags: psilocybin
topic_tags: Pharmacology,Oxidative Stress
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:49
text_rights_status: not_applicable_no_text
title:
P.228 The polypharmacological profile of psilocybin and potential behavioural effects of very low doses

authors:
K. Kiilerich, Nikolaj Speth, J. Lorenz, Agata Casado-Sainz, Vladimir Shalgunov, Denise Lange, Mengfei Xiong, Matthias M. Herth, Agnete Overgaard, Hanne D. Hansen, Mikael Palner

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.euroneuro.2019.09.271","source_url":"https://doi.org/10.1016/j.euroneuro.2019.09.271","doi":"10.1016/j.euroneuro.2019.09.271","pmid":"","publication_date":"2019-12-01","importer_version":"2.1.3","text_redistributed":false}


title: Injury-Triggered Blueing Reactions of Psilocybe “Magic” Mushrooms
journal: Angewandte Chemie
publication_date: 2019-11-14
doi: 10.1002/ange.201910175
source_url: https://doi.org/10.1002/ange.201910175
source_record_id: DOI:10.1002/ange.201910175
substance_tags: psilocybin,psilocin
topic_tags: General
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:49
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1002/ange.201910175
text_rights_status: unverified_not_redistributed
authors:
Claudius Lenz, Jonas Wick, Daniel Braga, María García-Altares, Gerald Lackner, Christian Hertweck, Markus Gressler, Dirk Hoffmeister

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1002/ange.201910175","source_url":"https://doi.org/10.1002/ange.201910175","doi":"10.1002/ange.201910175","pmid":"","publication_date":"2019-11-14","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin-assisted Psychotherapy for Opioid Use Disorder
authors: Case Medical Research
journal: Case Medical Research
publication_date: 2019-11-13
doi: 10.31525/ct1-nct04161066
source_url: https://doi.org/10.31525/ct1-nct04161066
source_record_id: DOI:10.31525/ct1-nct04161066
substance_tags: psilocybin
topic_tags: Addiction,Receptor Pharmacology
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:49
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.31525/ct1-nct04161066
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.31525/ct1-nct04161066","source_url":"https://doi.org/10.31525/ct1-nct04161066","doi":"10.31525/ct1-nct04161066","pmid":"","publication_date":"2019-11-13","importer_version":"2.1.3","text_redistributed":false}


journal: Journal of Contextual Behavioral Science
publication_date: 2019-11-05
doi: 10.1016/j.jcbs.2019.11.002
source_url: https://doi.org/10.1016/j.jcbs.2019.11.002
source_record_id: DOI:10.1016/j.jcbs.2019.11.002
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Receptor Pharmacology
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:49
text_rights_status: not_applicable_no_text
title:
Psilocybin-assisted therapy of major depressive disorder using Acceptance and Commitment Therapy as a therapeutic frame

authors:
Jordan Sloshower, Jeffrey Guss, Robert Krause, Ryan Wallace, Monnica T. Williams, Sara Reed, Matthew D. Skinta

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.jcbs.2019.11.002","source_url":"https://doi.org/10.1016/j.jcbs.2019.11.002","doi":"10.1016/j.jcbs.2019.11.002","pmid":"","publication_date":"2019-11-05","importer_version":"2.1.3","text_redistributed":false}


title: The Varieties of Psychedelic Epistemology
authors: Chris Letheby
journal: UWA Profiles and Research Repository (University of Western Australia)
publication_date: 2019-10-31
source_url: https://admin.research-repository.uwa.edu.au/en/publications/12436068-2f0c-4c50-8bb8-de189a427289
source_record_id: https://admin.research-repository.uwa.edu.au/en/publications/12436068-2f0c-4c50-8bb8-de189a427289
substance_tags: psilocybin
topic_tags: Receptor Pharmacology,Consciousness,Mystical Experience
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-07-04 07:00:39
abstract_source: OpenAlex
abstract_source_url: https://admin.research-repository.uwa.edu.au/en/publications/12436068-2f0c-4c50-8bb8-de189a427289
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"https://admin.research-repository.uwa.edu.au/en/publications/12436068-2f0c-4c50-8bb8-de189a427289","source_url":"https://admin.research-repository.uwa.edu.au/en/publications/12436068-2f0c-4c50-8bb8-de189a427289","doi":"","pmid":"","publication_date":"2019-10-31","importer_version":"2.1.3","text_redistributed":false}


title: Johns Hopkins Opens Research Center on Psychedelics
authors: Nick Zagorski
journal: Psychiatric News
publication_date: 2019-10-27
doi: 10.1176/appi.pn.2019.10a16
source_url: https://doi.org/10.1176/appi.pn.2019.10a16
source_record_id: DOI:10.1176/appi.pn.2019.10a16
substance_tags: psilocybin
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-07-04 07:00:39
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1176/appi.pn.2019.10a16
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Anxiety,PTSD,Addiction,Eating Disorders,Consciousness,Biomarkers,Clinical Trial,Healthcare Workers,Safety

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1176/appi.pn.2019.10a16","source_url":"https://doi.org/10.1176/appi.pn.2019.10a16","doi":"10.1176/appi.pn.2019.10a16","pmid":"","publication_date":"2019-10-27","importer_version":"2.1.3","text_redistributed":false}


title: Clinical and Mechanistic Effects of Psilocybin in Alcohol Addicted Patients
authors: Case Medical Research
journal: Case Medical Research
publication_date: 2019-10-28
doi: 10.31525/ct1-nct04141501
source_url: https://doi.org/10.31525/ct1-nct04141501
source_record_id: DOI:10.31525/ct1-nct04141501
substance_tags: psilocybin
topic_tags: Receptor Pharmacology
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:49
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.31525/ct1-nct04141501
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.31525/ct1-nct04141501","source_url":"https://doi.org/10.31525/ct1-nct04141501","doi":"10.31525/ct1-nct04141501","pmid":"","publication_date":"2019-10-28","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease
authors: Kernel Networks Inc.
journal: Case Medical Research
publication_date: 2019-10-10
doi: 10.31525/ct1-nct04123314
source_url: https://doi.org/10.31525/ct1-nct04123314
source_record_id: DOI:10.31525/ct1-nct04123314
substance_tags: psilocybin
topic_tags: Depression
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:49
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.31525/ct1-nct04123314","source_url":"https://doi.org/10.31525/ct1-nct04123314","doi":"10.31525/ct1-nct04123314","pmid":"","publication_date":"2019-10-10","importer_version":"2.1.3","text_redistributed":false}


title: Modified E. coli pump out psilocybin
authors: Megha Satyanarayana
journal: C&EN Global Enterprise
publication_date: 2019-10-06
doi: 10.1021/cen-09739-scicon9
source_url: https://doi.org/10.1021/cen-09739-scicon9
source_record_id: DOI:10.1021/cen-09739-scicon9
substance_tags: psilocybin,psilocin
topic_tags: Depression,Pharmacology,Mechanism of Action,Clinical Trial
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-07-04 07:00:39
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1021/cen-09739-scicon9
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1021/cen-09739-scicon9","source_url":"https://doi.org/10.1021/cen-09739-scicon9","doi":"10.1021/cen-09739-scicon9","pmid":"","publication_date":"2019-10-06","importer_version":"2.1.3","text_redistributed":false}


title: Motives for Classical and Novel Psychoactive Substances Use in Psychedelic Polydrug Users
authors: Hannes Kettner, Natasha L. Mason, Kim P. C. Kuypers
journal: Contemporary Drug Problems
publication_date: 2019-09-01
doi: 10.1177/0091450919863899
source_url: https://doi.org/10.1177/0091450919863899
source_record_id: DOI:10.1177/0091450919863899
substance_tags: psilocybin
topic_tags: Addiction,Receptor Pharmacology,Consciousness,Observational Study,Toxicity
study_type: Observational Study
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:49
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1177/0091450919863899
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1177/0091450919863899","source_url":"https://doi.org/10.1177/0091450919863899","doi":"10.1177/0091450919863899","pmid":"","publication_date":"2019-09-01","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin for depression: Considerations for clinical trial design
authors: Kelley C. O’Donnell, Sarah E. Mennenga, Michael P. Bogenschutz
journal: Journal of Psychedelic Studies
publication_date: 2019-09-01
doi: 10.1556/2054.2019.026
source_url: https://doi.org/10.1556/2054.2019.026
source_record_id: DOI:10.1556/2054.2019.026
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Receptor Pharmacology,Clinical Trial,Review Article,Safety
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:49
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1556/2054.2019.026
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1556/2054.2019.026","source_url":"https://doi.org/10.1556/2054.2019.026","doi":"10.1556/2054.2019.026","pmid":"","publication_date":"2019-09-01","importer_version":"2.1.3","text_redistributed":false}


title: Accounting for Microdosing Classic Psychedelics
authors: Blake Beaton, Heith Copes, Megan Webb, Andy Hochstetler, Peter S. Hendricks
journal: Journal of Drug Issues
publication_date: 2019-08-30
doi: 10.1177/0022042619871008
source_url: https://doi.org/10.1177/0022042619871008
source_record_id: DOI:10.1177/0022042619871008
substance_tags: psilocybin
topic_tags: Pharmacology,Microdosing,Toxicity
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:49
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1177/0022042619871008
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1177/0022042619871008","source_url":"https://doi.org/10.1177/0022042619871008","doi":"10.1177/0022042619871008","pmid":"","publication_date":"2019-08-30","importer_version":"2.1.3","text_redistributed":false}


title: Non-drug altered states as psychedelic experiences
journal: Greenwich Academic Literature Archive (University of Greenwich)
publication_date: 2019-08-15
source_url: https://www.breakingconvention.co.uk/speaker-DavidLuke.html
source_record_id: https://www.breakingconvention.co.uk/speaker-DavidLuke.html
substance_tags: psilocybin
topic_tags: Consciousness,Personality Change
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-07-04 07:00:39
abstract_source: OpenAlex
abstract_source_url: https://www.breakingconvention.co.uk/speaker-DavidLuke.html
text_rights_status: unverified_not_redistributed
authors:
David Luke, Christopher Timmermann, Mendel Kaelen, David Schwartman, Beth Bell-Langford, Aimee Tollan, Viktor Hadzhiyski, Gabriella Bergin-Cartwright

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"https://www.breakingconvention.co.uk/speaker-DavidLuke.html","source_url":"https://www.breakingconvention.co.uk/speaker-DavidLuke.html","doi":"","pmid":"","publication_date":"2019-08-15","importer_version":"2.1.3","text_redistributed":false}


title: Beyond Cannabis: Psychedelic Decriminalization and Social Justice
authors: Dustin Marlan
journal: eYLS (Yale Law School)
publication_date: 2019-08-15
source_url: https://lawcommons.lclark.edu/lclr/vol23/iss3/4
source_record_id: https://lawcommons.lclark.edu/lclr/vol23/iss3/4
substance_tags: psilocybin
topic_tags: Depression,Addiction,Consciousness,Wellbeing
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:49
abstract_source: OpenAlex
abstract_source_url: https://lawcommons.lclark.edu/lclr/vol23/iss3/4
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"https://lawcommons.lclark.edu/lclr/vol23/iss3/4","source_url":"https://lawcommons.lclark.edu/lclr/vol23/iss3/4","doi":"","pmid":"","publication_date":"2019-08-15","importer_version":"2.1.3","text_redistributed":false}


title: The Potential of Psilocybin Administration in Terminal Cancer Patients
authors: Richard Simoneaux
journal: Oncology Times
publication_date: 2019-06-28
doi: 10.1097/01.cot.0000574916.46844.cf
source_url: https://doi.org/10.1097/01.cot.0000574916.46844.cf
source_record_id: DOI:10.1097/01.cot.0000574916.46844.cf
substance_tags: psilocybin,psilocin
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:49
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1097/01.cot.0000574916.46844.cf
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Anxiety,Addiction,End-of-Life Distress,Chronic Pain,Pharmacology,Receptor Pharmacology,Consciousness,Clinical Trial,Cancer Patients,Treatment-Resistant Depression,Healthcare Workers,Safety,Adverse Events

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1097/01.cot.0000574916.46844.cf","source_url":"https://doi.org/10.1097/01.cot.0000574916.46844.cf","doi":"10.1097/01.cot.0000574916.46844.cf","pmid":"","publication_date":"2019-06-28","importer_version":"2.1.3","text_redistributed":false}


title: Disruptive Psychopharmacology.
authors: Heifets BD, Malenka RC.
journal: JAMA Psychiatry
publication_date: 2019-07-30
doi: 10.1001/jamapsychiatry.2019.1145
pubmed_id: 31241740
source_url: https://doi.org/10.1001/jamapsychiatry.2019.1145
source_record_id: PMID:31241740
substance_tags: psilocybin
topic_tags: Depression,Pharmacology
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:49
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1001/jamapsychiatry.2019.1145
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:31241740","source_url":"https://doi.org/10.1001/jamapsychiatry.2019.1145","doi":"10.1001/jamapsychiatry.2019.1145","pmid":"31241740","publication_date":"2019-07-30","importer_version":"2.1.3","text_redistributed":false}


authors: Doreen M. Lewis
journal: Addictive Disorders & Their Treatment
publication_date: 2019-06-09
doi: 10.1097/adt.0000000000000178
source_url: https://doi.org/10.1097/adt.0000000000000178
source_record_id: DOI:10.1097/adt.0000000000000178
substance_tags: psilocybin
topic_tags: Anxiety,Receptor Pharmacology,Emotional Processing,Observational Study,Toxicity
study_type: Observational Study
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-07-02 20:42:13
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1097/adt.0000000000000178
text_rights_status: unverified_not_redistributed
title:
Faces of HPPD: Hallucinogen Persisting Perception Disorder Patient Survey Results and a Descriptive Analysis of Patient Demographics, Medical Background, Drug Use History, Symptoms, and Treatments

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1097/adt.0000000000000178","source_url":"https://doi.org/10.1097/adt.0000000000000178","doi":"10.1097/adt.0000000000000178","pmid":"","publication_date":"2019-06-09","importer_version":"2.1.3","text_redistributed":false}


title: Introduction: Evidence for entheogen use in prehistory and world religions
authors: Michael Winkelman
journal: Journal of Psychedelic Studies
publication_date: 2019-06-01
doi: 10.1556/2054.2019.024
source_url: https://doi.org/10.1556/2054.2019.024
source_record_id: DOI:10.1556/2054.2019.024
substance_tags: psilocybin
topic_tags: Receptor Pharmacology,Consciousness,Spirituality,Review Article
study_type: Review Article
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:50
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1556/2054.2019.024
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1556/2054.2019.024","source_url":"https://doi.org/10.1556/2054.2019.024","doi":"10.1556/2054.2019.024","pmid":"","publication_date":"2019-06-01","importer_version":"2.1.3","text_redistributed":false}


title: Entheogens in Christian art: Wasson, Allegro, and the Psychedelic Gospels
authors: Jerry B. Brown, Julie M. Brown
journal: Journal of Psychedelic Studies
publication_date: 2019-06-01
doi: 10.1556/2054.2019.019
source_url: https://doi.org/10.1556/2054.2019.019
source_record_id: DOI:10.1556/2054.2019.019
substance_tags: psilocybin
topic_tags: Chronic Pain
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:50
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1556/2054.2019.019
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1556/2054.2019.019","source_url":"https://doi.org/10.1556/2054.2019.019","doi":"10.1556/2054.2019.019","pmid":"","publication_date":"2019-06-01","importer_version":"2.1.3","text_redistributed":false}


title: T137. Psilocybin-Assisted Group Therapy for Demoralization in Long-Term AIDS Survivors
journal: Biological Psychiatry
publication_date: 2019-04-30
doi: 10.1016/j.biopsych.2019.03.460
source_url: https://doi.org/10.1016/j.biopsych.2019.03.460
source_record_id: DOI:10.1016/j.biopsych.2019.03.460
substance_tags: psilocybin
topic_tags: Depression,Anxiety
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-07-04 07:00:39
text_rights_status: not_applicable_no_text
authors:
B. Anderson, Alicia Danforth, Robert B. Daroff, Christopher S. Stauffer, James Dilley, Jennifer Mitchell, Joshua Woolley

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.biopsych.2019.03.460","source_url":"https://doi.org/10.1016/j.biopsych.2019.03.460","doi":"10.1016/j.biopsych.2019.03.460","pmid":"","publication_date":"2019-04-30","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelic Medicine: Careful Studies, Regulations Are the Answer
authors: Paul Summergrad
journal: Psychiatric News
publication_date: 2019-04-30
doi: 10.1176/appi.pn.2019.5a25
source_url: https://doi.org/10.1176/appi.pn.2019.5a25
source_record_id: DOI:10.1176/appi.pn.2019.5a25
substance_tags: psilocybin
topic_tags: Brain Imaging,Pharmacology,Mechanism of Action,Aging,Safety
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:50
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1176/appi.pn.2019.5a25
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1176/appi.pn.2019.5a25","source_url":"https://doi.org/10.1176/appi.pn.2019.5a25","doi":"10.1176/appi.pn.2019.5a25","pmid":"","publication_date":"2019-04-30","importer_version":"2.1.3","text_redistributed":false}


journal: Current Addiction Reports
publication_date: 2019-04-22
doi: 10.1007/s40429-019-00249-z
source_url: https://doi.org/10.1007/s40429-019-00249-z
source_record_id: DOI:10.1007/s40429-019-00249-z
substance_tags: psilocybin
topic_tags: Receptor Pharmacology,Consciousness,Toxicity
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-07-02 20:42:13
text_rights_status: not_applicable_no_text
title:
New Psychoactive Substances (NPS), Psychedelic Experiences and Dissociation: Clinical and Clinical Pharmacological Issues

authors:
Fabrizio Schifano, Flavia Napoletano, Stefania Chiappini, Laura Orsolini, Amira Guirguis, John Corkery, Stefania Bonaccorso, A Ricciardi, Norbert Scherbaum, Alessandro Vento

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1007/s40429-019-00249-z","source_url":"https://doi.org/10.1007/s40429-019-00249-z","doi":"10.1007/s40429-019-00249-z","pmid":"","publication_date":"2019-04-22","importer_version":"2.1.3","text_redistributed":false}


title: Attitudes Toward Medical Psychedelics
authors: McKenna Silva
journal: Dominican Scholar (Dominican University of California)
publication_date: 2019-04-17
source_url: https://scholar.dominican.edu/scw/SCW2019/conference-presentations-exhibits-and-performances/83
source_record_id: https://scholar.dominican.edu/scw/SCW2019/conference-presentations-exhibits-and-performances/83
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Addiction,Receptor Pharmacology,Wellbeing,Spirituality,Observational Study
study_type: Observational Study
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-07-04 07:00:39
abstract_source: OpenAlex
abstract_source_url: https://scholar.dominican.edu/scw/SCW2019/conference-presentations-exhibits-and-performances/83
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"https://scholar.dominican.edu/scw/SCW2019/conference-presentations-exhibits-and-performances/83","source_url":"https://scholar.dominican.edu/scw/SCW2019/conference-presentations-exhibits-and-performances/83","doi":"","pmid":"","publication_date":"2019-04-17","importer_version":"2.1.3","text_redistributed":false}


title: Effects of SERT Inhibition on the Subjective Response to Psilocybin in Healthy Subjects
authors: Kernel Networks Inc.
journal: Case Medical Research
publication_date: 2019-04-12
doi: 10.31525/ct1-nct03912974
source_url: https://doi.org/10.31525/ct1-nct03912974
source_record_id: DOI:10.31525/ct1-nct03912974
substance_tags: psilocybin
topic_tags: Pharmacology
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:50
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.31525/ct1-nct03912974","source_url":"https://doi.org/10.31525/ct1-nct03912974","doi":"10.31525/ct1-nct03912974","pmid":"","publication_date":"2019-04-12","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelics Improve the Mental Health of Rats
authors: Meghan Hibicke, Alexus N. Landry, Zoe K. Talman, Charles D. Nichols
journal: The FASEB Journal
publication_date: 2019-04-01
doi: 10.1096/fasebj.2019.33.1_supplement.666.1
source_url: https://doi.org/10.1096/fasebj.2019.33.1_supplement.666.1
source_record_id: DOI:10.1096/fasebj.2019.33.1_supplement.666.1
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Pharmacology,Receptor Pharmacology,Clinical Trial,Animal Study
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:50
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1096/fasebj.2019.33.1_supplement.666.1
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1096/fasebj.2019.33.1_supplement.666.1","source_url":"https://doi.org/10.1096/fasebj.2019.33.1_supplement.666.1","doi":"10.1096/fasebj.2019.33.1_supplement.666.1","pmid":"","publication_date":"2019-04-01","importer_version":"2.1.3","text_redistributed":false}


title: Relationship Of Magic Mushroom Literation As A Drug With Abuse It's Use As A Hallucination
authors: Yuri Rahayu, Andi Riyanto, Agung Wibowo
journal: International Journal on Advanced Science Education and Religion
publication_date: 2019-03-28
doi: 10.33648/ijoaser.v2i1.25
source_url: https://doi.org/10.33648/ijoaser.v2i1.25
source_record_id: DOI:10.33648/ijoaser.v2i1.25
substance_tags: psilocybin,psilocin
topic_tags: General
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:50
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.33648/ijoaser.v2i1.25
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.33648/ijoaser.v2i1.25","source_url":"https://doi.org/10.33648/ijoaser.v2i1.25","doi":"10.33648/ijoaser.v2i1.25","pmid":"","publication_date":"2019-03-28","importer_version":"2.1.3","text_redistributed":false}


title: A Study of Psilocybin for Major Depressive Disorder (MDD)
authors: Kernel Networks Inc.
journal: Case Medical Research
publication_date: 2019-03-07
doi: 10.31525/ct1-nct03866174
source_url: https://doi.org/10.31525/ct1-nct03866174
source_record_id: DOI:10.31525/ct1-nct03866174
substance_tags: psilocybin
topic_tags: Depression
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:50
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.31525/ct1-nct03866174","source_url":"https://doi.org/10.31525/ct1-nct03866174","doi":"10.31525/ct1-nct03866174","pmid":"","publication_date":"2019-03-07","importer_version":"2.1.3","text_redistributed":false}


title: Is Psychedelic Medicine on the Horizon?
authors: Nick Zagorski
journal: Psychiatric News
publication_date: 2019-02-28
doi: 10.1176/appi.pn.2019.1b1
source_url: https://doi.org/10.1176/appi.pn.2019.1b1
source_record_id: DOI:10.1176/appi.pn.2019.1b1
substance_tags: psilocybin
study_type: Review Article
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:50
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1176/appi.pn.2019.1b1
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Consciousness,Review Article,Case Report,Observational Study,Cancer Patients,Treatment-Resistant Depression,Safety

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1176/appi.pn.2019.1b1","source_url":"https://doi.org/10.1176/appi.pn.2019.1b1","doi":"10.1176/appi.pn.2019.1b1","pmid":"","publication_date":"2019-02-28","importer_version":"2.1.3","text_redistributed":false}


authors: Ahmed Al-Imam, Faris Lami
journal: Modern Applied Science
publication_date: 2019-02-13
doi: 10.5539/mas.v13n3p13
source_url: https://doi.org/10.5539/mas.v13n3p13
source_record_id: DOI:10.5539/mas.v13n3p13
substance_tags: psilocybin
topic_tags: Receptor Pharmacology
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:50
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.5539/mas.v13n3p13
text_rights_status: unverified_not_redistributed
title:
One Ultimate Journey? AKA the Huxley’s Method: Perspectives of (Ab)Users of Hallucinogens and Entheogens on Having Planned Pre-Mortem Psychedelic Trip

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.5539/mas.v13n3p13","source_url":"https://doi.org/10.5539/mas.v13n3p13","doi":"10.5539/mas.v13n3p13","pmid":"","publication_date":"2019-02-13","importer_version":"2.1.3","text_redistributed":false}


title: The effects of psilocybin microdosing on perception: a double-blind controlled study
authors: Michiel van Elk, George Fejer, Josephine Marschall, Pascal Lempe
journal: OSF Preprints (OSF Preprints)
publication_date: 2019-01-30
source_url: https://osf.io/cn8z4
source_record_id: https://osf.io/cn8z4
substance_tags: psilocybin
topic_tags: Microdosing
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-07-04 07:00:39
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"https://osf.io/cn8z4","source_url":"https://osf.io/cn8z4","doi":"","pmid":"","publication_date":"2019-01-30","importer_version":"2.1.3","text_redistributed":false}


title: 2018: A watershed year for psychedelic science
authors: Jacob S. Aday, Christopher C. Davoli, Emily K. Bloesch
journal: Drug Science Policy and Law
publication_date: 2019-01-01
doi: 10.1177/2050324519872284
source_url: https://doi.org/10.1177/2050324519872284
source_record_id: DOI:10.1177/2050324519872284
substance_tags: psilocybin
topic_tags: Depression,Pharmacology,Treatment-Resistant Depression
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:50
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1177/2050324519872284
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1177/2050324519872284","source_url":"https://doi.org/10.1177/2050324519872284","doi":"10.1177/2050324519872284","pmid":"","publication_date":"2019-01-01","importer_version":"2.1.3","text_redistributed":false}


authors: Felix Scholkmann, Lisa Holper, Katrin H. Preller, Franz X. Vollenweider
journal: Matters
publication_date: 2019-01-01
doi: 10.5167/uzh-181782
source_url: https://doi.org/10.5167/uzh-181782
source_record_id: DOI:10.5167/uzh-181782
substance_tags: psilocybin
topic_tags: Brain Imaging,Aging
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:50
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.5167/uzh-181782
text_rights_status: unverified_not_redistributed
title:
Effects of psilocybin on functional connectivity measured with fNIRS: Insights from a single-subject pilot study

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.5167/uzh-181782","source_url":"https://doi.org/10.5167/uzh-181782","doi":"10.5167/uzh-181782","pmid":"","publication_date":"2019-01-01","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin induces aberrant prediction error processing for tactile mismatch responses
authors: P. Dürler
journal: European Neuropsychopharmacology
publication_date: 2019-01-01
doi: 10.1016/j.euroneuro.2018.11.477
source_url: https://doi.org/10.1016/j.euroneuro.2018.11.477
source_record_id: DOI:10.1016/j.euroneuro.2018.11.477
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Addiction,Receptor Pharmacology
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:50
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.euroneuro.2018.11.477","source_url":"https://doi.org/10.1016/j.euroneuro.2018.11.477","doi":"10.1016/j.euroneuro.2018.11.477","pmid":"","publication_date":"2019-01-01","importer_version":"2.1.3","text_redistributed":false}


title: Use of MDMA & Psilocybin in the Treatment of PTSD
authors: Camden Grant-Howard, Joel S. Steele
journal: PDXScholar (Portland State University)
publication_date: 2018-12-31
source_url: https://pdxscholar.library.pdx.edu/studentsymposium/2019/Posters/14
source_record_id: https://pdxscholar.library.pdx.edu/studentsymposium/2019/Posters/14
substance_tags: psilocybin
topic_tags: PTSD,Emotional Processing
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-07-04 07:00:39
abstract_source: OpenAlex
abstract_source_url: https://pdxscholar.library.pdx.edu/studentsymposium/2019/Posters/14
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"https://pdxscholar.library.pdx.edu/studentsymposium/2019/Posters/14","source_url":"https://pdxscholar.library.pdx.edu/studentsymposium/2019/Posters/14","doi":"","pmid":"","publication_date":"2018-12-31","importer_version":"2.1.3","text_redistributed":false}


title: These fungi drug cicadas with psilocybin or amphetamine to make them mate nonstop
authors: Tina Hesman Saey
journal: Access Science
publication_date: 2019-01-01
substance_tags: psilocybin
topic_tags: Pharmacology
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:50
text_rights_status: not_applicable_no_text
source_url:
https://www.accessscience.com/content/these-fungi-drug-cicadas-with-psilocybin-or-amphetamine-to-make-them-mate-nonstop/SN1907011

source_record_id:
https://www.accessscience.com/content/these-fungi-drug-cicadas-with-psilocybin-or-amphetamine-to-make-them-mate-nonstop/SN1907011

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"https://www.accessscience.com/content/these-fungi-drug-cicadas-with-psilocybin-or-amphetamine-to-make-them-mate-nonstop/SN1907011","source_url":"https://www.accessscience.com/content/these-fungi-drug-cicadas-with-psilocybin-or-amphetamine-to-make-them-mate-nonstop/SN1907011","doi":"","pmid":"","publication_date":"2019-01-01","importer_version":"2.1.3","text_redistributed":false}


authors: Emma Christersson
journal: KTH Publication Database DiVA (KTH Royal Institute of Technology)
publication_date: 2018-12-31
source_url: http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-17255
source_record_id: http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-17255
substance_tags: psilocybin
study_type: Review Article
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-07-04 07:00:39
abstract_source: OpenAlex
abstract_source_url: http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-17255
text_rights_status: unverified_not_redistributed
title:
The Psychedelic Altered State of Consciousness: An Assessment of the Current Status of Psychedelic Research

topic_tags:
Brain Imaging,Consciousness,Aging,Emotional Processing,Mystical Experience,Review Article,Healthy Volunteers

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-17255","source_url":"http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-17255","doi":"","pmid":"","publication_date":"2018-12-31","importer_version":"2.1.3","text_redistributed":false}


authors: William G. Crane
journal: Furman University Scholar Exchange (Furman University)
publication_date: 2019-01-01
source_url: https://scholarexchange.furman.edu/furmanengaged/2019/all/522
source_record_id: https://scholarexchange.furman.edu/furmanengaged/2019/all/522
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Addiction,Receptor Pharmacology
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:50
abstract_source: OpenAlex
abstract_source_url: https://scholarexchange.furman.edu/furmanengaged/2019/all/522
text_rights_status: unverified_not_redistributed
title:
Serotonergic Psychoactive Compounds as a Treatment for Addiction, Anxiety, and Depression: Their Efficacy and Legality

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"https://scholarexchange.furman.edu/furmanengaged/2019/all/522","source_url":"https://scholarexchange.furman.edu/furmanengaged/2019/all/522","doi":"","pmid":"","publication_date":"2019-01-01","importer_version":"2.1.3","text_redistributed":false}


title: THE POTENTIAL THERAPEUTIC VALUE OF PSILOCYBIN: In Relation to Depression
authors: Isabella Stendahl
journal: Diva portal (Dalarna University Library)
publication_date: 2018-12-31
source_url: http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-17749
source_record_id: http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-17749
substance_tags: psilocybin
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-07-04 07:00:39
abstract_source: OpenAlex
abstract_source_url: http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-17749
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Anxiety,OCD,Headache / Migraine,Brain Imaging,Mechanism of Action,Aging,Emotional Processing,Creativity

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-17749","source_url":"http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-17749","doi":"","pmid":"","publication_date":"2018-12-31","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin-Assisted Therapy: A Double-Blind Randomized Controlled Trial
authors: Katherine Gruppo
journal: Yale School of Medicine Physician Associate Program Thesis
publication_date: 2019-01-01
source_url: https://elischolar.library.yale.edu/cgi/viewcontent.cgi?article=1050&context=ysmpa_theses
source_record_id: https://elischolar.library.yale.edu/cgi/viewcontent.cgi?article=1050&context=ysmpa_theses
substance_tags: psilocybin
topic_tags: Randomized Controlled Trial
study_type: Randomized Controlled Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:57:51
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"https://elischolar.library.yale.edu/cgi/viewcontent.cgi?article=1050&context=ysmpa_theses","source_url":"https://elischolar.library.yale.edu/cgi/viewcontent.cgi?article=1050&context=ysmpa_theses","doi":"","pmid":"","publication_date":"2019-01-01","importer_version":"2.1.3","text_redistributed":false}


title: Effects of psilocin on the striatal monoamine contents in mice and rats
authors: Maho Hirasawa
journal: The Pharmaceutical Society of Japan
publication_date: 2020-02-01
source_url: https://confit.atlas.jp/guide/event/pharm140/subject/4P156-201-13/detail
source_record_id: https://confit.atlas.jp/guide/event/pharm140/subject/4P156-201-13/detail
substance_tags: psilocin
topic_tags: Receptor Pharmacology,Animal Study
study_type: Animal Study
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:59
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"https://confit.atlas.jp/guide/event/pharm140/subject/4P156-201-13/detail","source_url":"https://confit.atlas.jp/guide/event/pharm140/subject/4P156-201-13/detail","doi":"","pmid":"","publication_date":"2020-02-01","importer_version":"2.1.3","text_redistributed":false}


title: Qualitative analysis of synthetic opioids, synthetic hallucinogens and LSD in urine using LC-MS/MS
authors: Xue Qin Ng, Asimah Hamzah, Mei Ling Evelyn Goh, Hooi Yan Moy, Yi Ju Yao, Chi Pang Lui
journal: Australian Journal of Forensic Sciences
publication_date: 2019-02-11
doi: 10.1080/00450618.2019.1568565
source_url: https://doi.org/10.1080/00450618.2019.1568565
source_record_id: DOI:10.1080/00450618.2019.1568565
substance_tags: psilocin
topic_tags: Addiction,Pharmacology,Toxicity
study_type: Qualitative Study
source_name: OpenAlex
publication_status: published
date_added: 2026-07-02 20:42:13
last_checked: 2026-08-09 08:25:59
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1080/00450618.2019.1568565
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1080/00450618.2019.1568565","source_url":"https://doi.org/10.1080/00450618.2019.1568565","doi":"10.1080/00450618.2019.1568565","pmid":"","publication_date":"2019-02-11","importer_version":"2.1.3","text_redistributed":false}


authors: Seale M.
journal: Research Square
publication_date: 2026-07-02
doi: 10.21203/rs.3.rs-10208910/v1
source_url: https://doi.org/10.21203/rs.3.rs-10208910/v1
source_record_id: DOI:10.21203/rs.3.rs-10208910/v1
substance_tags: psilocybin
topic_tags: Depression,Observational Study,Drug Interactions
study_type: Observational Study
source_name: Europe PMC
publication_status: preprint
date_added: 2026-07-03 01:20:31
last_checked: 2026-08-09 08:14:51
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.21203/rs.3.rs-10208910/v1
text_rights_status: unverified_not_redistributed
title:
Sexual identity as a moderator of associations between lifetime MDMA/ecstasy or psilocybin use and mental health outcomes: An exploratory analysis of a nationally representative sample using NSDUH 2015-2019

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"DOI:10.21203/rs.3.rs-10208910/v1","source_url":"https://doi.org/10.21203/rs.3.rs-10208910/v1","doi":"10.21203/rs.3.rs-10208910/v1","pmid":"","publication_date":"2026-07-02","importer_version":"2.1.3","text_redistributed":false}


authors: Koning Elena, Richard Jérémie, Keshen Aaron
journal: International Journal of Eating Disorders
publication_date: 2026-07-02
doi: 10.1002/eat.70164
pubmed_id: 42393007
source_url: https://doi.org/10.1002/eat.70164
source_record_id: PMID:42393007
substance_tags: psilocybin
study_type: Clinical Trial
source_name: Crossref
publication_status: published
date_added: 2026-07-04 01:20:05
last_checked: 2026-08-09 08:28:46
abstract_source: Crossref
abstract_source_url: https://doi.org/10.1002/eat.70164
text_rights_status: unverified_not_redistributed
title:
Psilocybin as a Transdiagnostic Treatment for Eating Disorders and Comorbid Psychopathology: Implications for Clinical Nosology and Research Directions

topic_tags:
Eating Disorders,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Clinical Trial,Review Article,Safety

source_provenance_json:
{"source_name":"Crossref","source_record_id":"PMID:42393007","source_url":"https://doi.org/10.1002/eat.70164","doi":"10.1002/eat.70164","pmid":"42393007","publication_date":"2026-07-02","importer_version":"2.1.3","text_redistributed":false}


authors: Schuman HDM, Mina R, Barkova S, Nguyen T, Deleemans JM, Carlson LE
journal: Global advances in integrative medicine and health
publication_date: 2026-01-01
doi: 10.1177/27536130261459354
pubmed_id: 42396366
source_url: https://pubmed.ncbi.nlm.nih.gov/42396366/
source_record_id: PMID:42396366
substance_tags: psilocybin
topic_tags: End-of-Life Distress,Cancer Patients,Toxicity
study_type: Qualitative Study
source_name: PubMed
publication_status: published
date_added: 2026-07-04 01:20:05
last_checked: 2026-08-09 08:27:46
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/42396366/
text_rights_status: unverified_not_redistributed
title:
Healthcare Providers' Perspectives on Psychedelic-Assisted Therapies Across Clinical Contexts: "I Can Offer Medical Assistance in Dying, but I Can't Prescribe Psychedelics".

source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:42396366","source_url":"https://pubmed.ncbi.nlm.nih.gov/42396366/","doi":"10.1177/27536130261459354","pmid":"42396366","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}


authors: Whitfield Henry J., Schepers Jan, Mason Natasha L., Luca Maria, Kuypers Kim P. C.
journal: Journal of Psychedelic Studies
publication_date: 2026-07-03
doi: 10.1556/2054.2026.00530
source_url: https://doi.org/10.1556/2054.2026.00530
source_record_id: DOI:10.1556/2054.2026.00530
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Wellbeing,Psychological Flexibility,Observational Study,Drug Interactions
study_type: Clinical Trial
source_name: Crossref
publication_status: published
date_added: 2026-07-04 01:20:27
last_checked: 2026-08-09 08:28:46
abstract_source: Crossref
abstract_source_url: https://doi.org/10.1556/2054.2026.00530
text_rights_status: unverified_not_redistributed
title:
Trajectories of psychedelic-assisted change: An observational study of a psilocybin retreat program followed by psychotherapeutic interventions

source_provenance_json:
{"source_name":"Crossref","source_record_id":"DOI:10.1556/2054.2026.00530","source_url":"https://doi.org/10.1556/2054.2026.00530","doi":"10.1556/2054.2026.00530","pmid":"","publication_date":"2026-07-03","importer_version":"2.1.3","text_redistributed":false}


authors: Stefanie Enriquez Geppert, Lisa Bevers, Arvid Rosander, Peter Fodran, Vince Polito
publication_date: 2026-06-29
source_url: https://research.rug.nl/en/publications/370a82bd-d8db-4a02-b644-bf0c9131680b
source_record_id: https://research.rug.nl/en/publications/370a82bd-d8db-4a02-b644-bf0c9131680b
substance_tags: psilocybin
topic_tags: Clinical Trial,Safety,Toxicity
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 01:20:27
last_checked: 2026-08-09 08:25:04
text_rights_status: not_applicable_no_text
title:
Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical Development

journal:
University of Groningen research database (University of Groningen / Centre for Information Technology)

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"https://research.rug.nl/en/publications/370a82bd-d8db-4a02-b644-bf0c9131680b","source_url":"https://research.rug.nl/en/publications/370a82bd-d8db-4a02-b644-bf0c9131680b","doi":"","pmid":"","publication_date":"2026-06-29","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin helps woman with Alzheimer's
authors: Busby Mattha
journal: New Scientist
publication_date: 2026-07-01
doi: 10.1016/s0262-4079(26)01034-1
source_url: https://doi.org/10.1016/s0262-4079(26)01034-1
source_record_id: DOI:10.1016/s0262-4079(26)01034-1
substance_tags: psilocybin
topic_tags: General
study_type: Other
source_name: Crossref
publication_status: published
date_added: 2026-07-04 01:20:27
last_checked: 2026-08-09 08:28:46
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"Crossref","source_record_id":"DOI:10.1016/s0262-4079(26)01034-1","source_url":"https://doi.org/10.1016/s0262-4079(26)01034-1","doi":"10.1016/s0262-4079(26)01034-1","pmid":"","publication_date":"2026-07-01","importer_version":"2.1.3","text_redistributed":false}


title: Policy Considerations for Psychedelics in Research and Medicine - What’s Next on the Schedule?
authors: Matthew A. Boehm, Oriana Mayorga
journal: Journal of Science Policy & Governance
publication_date: 2026-07-02
doi: 10.38126/jspg280103
source_url: https://doi.org/10.38126/jspg280103
source_record_id: DOI:10.38126/jspg280103
substance_tags: psilocybin
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 01:20:30
last_checked: 2026-08-09 08:25:03
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.38126/jspg280103
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Anxiety,PTSD,Mechanism of Action,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Toxicity

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.38126/jspg280103","source_url":"https://doi.org/10.38126/jspg280103","doi":"10.38126/jspg280103","pmid":"","publication_date":"2026-07-02","importer_version":"2.1.3","text_redistributed":false}


authors: Sharchaton A, Parsha S, Azerrad SP, Dekel Y, Rabah N, Páleníček T, Kurzbaum E
journal: Journal of fungi (Basel, Switzerland)
publication_date: 2026-07-02
doi: 10.3390/jof12070486
pubmed_id: 42506248
source_url: https://pubmed.ncbi.nlm.nih.gov/42506248/
source_record_id: PMID:42506248
substance_tags: psilocybin,psilocin
topic_tags: General
study_type: Other
source_name: PubMed
publication_status: published
date_added: 2026-07-04 01:20:30
last_checked: 2026-08-09 08:27:46
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/42506248/
text_rights_status: unverified_not_redistributed
title:
Surprising Variability in Tryptamine Profiles of Fruiting Bodies: Inter- and Intra-Strain Differences Across 14 Strains Cultivated Under Controlled Conditions.

source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:42506248","source_url":"https://pubmed.ncbi.nlm.nih.gov/42506248/","doi":"10.3390/jof12070486","pmid":"42506248","publication_date":"2026-07-02","importer_version":"2.1.3","text_redistributed":false}


journal: Translational Psychiatry
publication_date: 2026-06-23
doi: 10.1038/s41398-026-04203-2
pubmed_id: 42342649
source_url: https://doi.org/10.1038/s41398-026-04203-2
source_record_id: PMID:42342649
substance_tags: psilocybin
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:34
last_checked: 2026-07-04 06:34:34
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1038/s41398-026-04203-2
text_rights_status: unverified_not_redistributed
title:
Mechanistic insights toward dissociating therapeutic from psychedelic effects: bridging the gap between psychedelic research and mental health care

authors:
Mauro Pettorruso, Giacomo d’Andrea, Antonio Inserra, Clara Cavallotto, Stefano Censi, Étienne Billard, Antonio Di Stefano, Luisa De Risio, Maria Giulia Tullo, Claudio D’Addario, Giorgio Di Lorenzo, Richard G. Wise, Stefano L. Sensi, Francesca Zoratto, Giovanni Martinotti

topic_tags:
Depression,Anxiety,Chronic Pain,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Personality Change,Mystical Experience,Clinical Trial,Animal Study,Toxicity

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"PMID:42342649","source_url":"https://doi.org/10.1038/s41398-026-04203-2","doi":"10.1038/s41398-026-04203-2","pmid":"42342649","publication_date":"2026-06-23","importer_version":"2.1.3","text_redistributed":false}


authors: Claudino Dos Santos JC, Bolan SJ, Lodetti G, Viana GL, Rico EP, Gonçalves CL
journal: Journal of psychiatric research
publication_date: 2026-06-23
doi: 10.1016/j.jpsychires.2026.06.035
pubmed_id: 42385294
source_url: https://pubmed.ncbi.nlm.nih.gov/42385294/
source_record_id: PMID:42385294
substance_tags: psilocybin
study_type: Clinical Trial
source_name: PubMed
publication_status: published
date_added: 2026-07-04 06:34:34
last_checked: 2026-08-09 08:27:47
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/42385294/
text_rights_status: unverified_not_redistributed
title:
Psychedelics and autism spectrum disorder: Mechanistic insights, translational evidence and ethical challenges.

topic_tags:
Anxiety,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Clinical Trial,Review Article,Animal Study,Safety,Drug Interactions

source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:42385294","source_url":"https://pubmed.ncbi.nlm.nih.gov/42385294/","doi":"10.1016/j.jpsychires.2026.06.035","pmid":"42385294","publication_date":"2026-06-23","importer_version":"2.1.3","text_redistributed":false}


authors: Racca Camille, Cordier Cécilie
journal: protocols.io
publication_date: 2026-06-21
doi: 10.17504/protocols.io.j8nlk7ey6g5r/v1
source_url: https://doi.org/10.17504/protocols.io.j8nlk7ey6g5r/v1
source_record_id: DOI:10.17504/protocols.io.j8nlk7ey6g5r/v1
substance_tags: psilocybin,psilocin
topic_tags: Headache / Migraine,Meta-Analysis,Systematic Review,Review Article,Safety
study_type: Meta-Analysis
source_name: Crossref
publication_status: protocol
date_added: 2026-07-04 06:34:34
last_checked: 2026-08-09 09:00:16
abstract_source: Crossref
abstract_source_url: https://doi.org/10.17504/protocols.io.j8nlk7ey6g5r/v1
text_rights_status: unverified_not_redistributed
title:
Psychedelics and related compounds in cluster headache and migraine: a systematic review and meta-analysis v1

source_provenance_json:
{"source_name":"Crossref","source_record_id":"DOI:10.17504/protocols.io.j8nlk7ey6g5r/v1","source_url":"https://doi.org/10.17504/protocols.io.j8nlk7ey6g5r/v1","doi":"10.17504/protocols.io.j8nlk7ey6g5r/v1","pmid":"","publication_date":"2026-06-21","importer_version":"2.1.3","text_redistributed":false}


authors: Eric P. Rubenstein
journal: Journal of Advances in Developmental Research
publication_date: 2026-06-17
doi: 10.71097/ijaidr.v17.i1.1997
source_url: https://doi.org/10.71097/ijaidr.v17.i1.1997
source_record_id: DOI:10.71097/ijaidr.v17.i1.1997
substance_tags: psilocybin
study_type: Review Article
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:35
last_checked: 2026-07-04 06:34:35
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.71097/ijaidr.v17.i1.1997
text_rights_status: unverified_not_redistributed
title:
Beyond Psychedelic Microdosing: Therapeutic Potential, Neuropharmacology, and Safety Considerations in Low-Dose Psychoactive Use

topic_tags:
Anxiety,Chronic Pain,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Microdosing,Emotional Processing,Creativity,Spirituality,Psychological Flexibility,Review Article,Safety,Toxicity,Drug Interactions

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.71097/ijaidr.v17.i1.1997","source_url":"https://doi.org/10.71097/ijaidr.v17.i1.1997","doi":"10.71097/ijaidr.v17.i1.1997","pmid":"","publication_date":"2026-06-17","importer_version":"2.1.3","text_redistributed":false}


title: “I even saw four deer grazing”: online-offline entanglements in the psilocybin pluriverse
authors: Wanke Michał, Matuszewski Paweł, Siuda Piotr
journal: OSF Preprints
publication_date: 2026-06-17
doi: 10.31235/osf.io/tk4bv_v1
source_url: https://doi.org/10.31235/osf.io/tk4bv_v1
source_record_id: DOI:10.31235/osf.io/tk4bv_v1
substance_tags: psilocybin
topic_tags: Aging,Safety
study_type: Qualitative Study
source_name: Crossref
publication_status: preprint
date_added: 2026-07-04 06:34:35
last_checked: 2026-08-09 09:00:16
abstract_source: Crossref
abstract_source_url: https://doi.org/10.31235/osf.io/tk4bv_v1
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Crossref","source_record_id":"DOI:10.31235/osf.io/tk4bv_v1","source_url":"https://doi.org/10.31235/osf.io/tk4bv_v1","doi":"10.31235/osf.io/tk4bv_v1","pmid":"","publication_date":"2026-06-17","importer_version":"2.1.3","text_redistributed":false}


title: Dextromethorphan Beyond the Cough: Exploring Its Psychedelic Potential: A Systematic Review
authors: Edward P. Hackett, Aditi Chaudhri -, Linda Hasman, Rajbala Thakur, Michael Scott, Robert H. Dworkin
journal: CNS Drugs
publication_date: 2026-06-14
doi: 10.1007/s40263-026-01305-9
pubmed_id: 42295696
source_url: https://doi.org/10.1007/s40263-026-01305-9
source_record_id: PMID:42295696
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:35
last_checked: 2026-07-04 06:34:35
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1007/s40263-026-01305-9
text_rights_status: unverified_not_redistributed
topic_tags:
Pharmacology,Mystical Experience,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Case Report,Observational Study,Safety

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"PMID:42295696","source_url":"https://doi.org/10.1007/s40263-026-01305-9","doi":"10.1007/s40263-026-01305-9","pmid":"42295696","publication_date":"2026-06-14","importer_version":"2.1.3","text_redistributed":false}


title: THE PSYCHEDELIC AND KETAMINE RENAISSANCE IN THE FACE OF THE CRISIS IN MODERN PSYCHIATRY
journal: International Journal of Innovative Technologies in Social Science
publication_date: 2026-06-14
doi: 10.31435/ijitss.2(50).2026.5605
source_url: https://doi.org/10.31435/ijitss.2(50).2026.5605
source_record_id: DOI:10.31435/ijitss.2(50).2026.5605
substance_tags: psilocybin
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:35
last_checked: 2026-07-04 06:34:35
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.31435/ijitss.2(50).2026.5605
text_rights_status: unverified_not_redistributed
authors:
Julia Osipowska, Marlena Kwolek, Alicja Judzińska, Bartosz Piech, Kamila Sobczyńska, Justyna Ignarska, Magda Terbosh, Sabina Kubicz `Mzabi, Emilia Trojanowska, Magdalena Dubaj

topic_tags:
Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Toxicity

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.31435/ijitss.2(50).2026.5605","source_url":"https://doi.org/10.31435/ijitss.2(50).2026.5605","doi":"10.31435/ijitss.2(50).2026.5605","pmid":"","publication_date":"2026-06-14","importer_version":"2.1.3","text_redistributed":false}


authors: Udoro AJ, Yukyi Y, Ansari AZ, Gandara HA, Ahmed F, Hunt D
journal: Cureus
publication_date: 2026-06-01
doi: 10.7759/cureus.110791
pubmed_id: 42445624
source_url: https://pubmed.ncbi.nlm.nih.gov/42445624/
source_record_id: PMID:42445624
substance_tags: psilocybin
topic_tags: Anxiety,Mechanism of Action,Receptor Pharmacology,Case Report,Healthcare Workers,Toxicity
study_type: Case Report
source_name: PubMed
publication_status: published
date_added: 2026-07-04 06:34:35
last_checked: 2026-08-09 08:27:47
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/42445624/
text_rights_status: unverified_not_redistributed
title:
Acute Hallucinogen Intoxication Following Ingestion of a Commercially Available Mushroom Extract Product: A Case Report.

source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:42445624","source_url":"https://pubmed.ncbi.nlm.nih.gov/42445624/","doi":"10.7759/cureus.110791","pmid":"42445624","publication_date":"2026-06-01","importer_version":"2.1.3","text_redistributed":false}


authors: Zuzana Postránecká, Matyáš Lucký, Viktor Mravčík, Tomáš Páleníček
journal: Journal of Psychedelic Studies
publication_date: 2026-06-12
doi: 10.1556/2054.2026.00514
source_url: https://doi.org/10.1556/2054.2026.00514
source_record_id: DOI:10.1556/2054.2026.00514
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:35
last_checked: 2026-08-09 08:25:06
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1556/2054.2026.00514
text_rights_status: unverified_not_redistributed
title:
Integrating psychedelic-assisted psychotherapy into addiction care in the Czech Republic: Clinical evidence, safety, and regulatory developments

topic_tags:
Addiction,Chronic Pain,Randomized Controlled Trial,Systematic Review,Review Article,Observational Study,Safety,Toxicity

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1556/2054.2026.00514","source_url":"https://doi.org/10.1556/2054.2026.00514","doi":"10.1556/2054.2026.00514","pmid":"","publication_date":"2026-06-12","importer_version":"2.1.3","text_redistributed":false}


authors: Gaurav Uppal, Naima Gul, Asha Dhandapani, Sathyan Soundararajan, Khushboo Kansal
journal: BJPsych Open
publication_date: 2026-06-01
doi: 10.1192/bjo.2026.11141
source_url: https://doi.org/10.1192/bjo.2026.11141
source_record_id: DOI:10.1192/bjo.2026.11141
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:35
last_checked: 2026-08-09 08:25:07
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1192/bjo.2026.11141
text_rights_status: unverified_not_redistributed
title:
From Altered States to Altered Trajectories and From Molecules to Meaning: A Network Meta Analysis Mapping Comparative Efficacy of Psychedelic Assisted Therapies in Modern Psychiatry

topic_tags:
Addiction,Aging,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Drug Interactions

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1192/bjo.2026.11141","source_url":"https://doi.org/10.1192/bjo.2026.11141","doi":"10.1192/bjo.2026.11141","pmid":"","publication_date":"2026-06-01","importer_version":"2.1.3","text_redistributed":false}


journal: Open Access CRIS of the University of Bern
publication_date: 2026-05-28
doi: 10.48620/98266
source_url: https://doi.org/10.48620/98266
source_record_id: DOI:10.48620/98266
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:35
last_checked: 2026-08-09 08:25:07
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.48620/98266
text_rights_status: unverified_not_redistributed
title:
Blinding integrity in psychedelic research: Evidence from a comparative randomized controlled trial of psilocybin, MDMA, and methylphenidate in healthy volunteers.

authors:
L Belinger, N M Rieser, E J E Engeli, L Becciolini, M Clamote, M Pribis, F Saissi, G.A. Florineth, N L Hehl, M Herdener, K H Preller

topic_tags:
Addiction,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Healthy Volunteers,Toxicity

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.48620/98266","source_url":"https://doi.org/10.48620/98266","doi":"10.48620/98266","pmid":"","publication_date":"2026-05-28","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin-Assisted Therapy in the Management of Anxiety and Depression Among Cancer Patients
authors: Caleb Lemus
journal: Digital Showcase Research, Scholarship, & Creative Works (University of Lynchburg)
publication_date: 2026-05-22
source_url: https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3713&context=dmscjournal
source_record_id: https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3713&context=dmscjournal
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:35
last_checked: 2026-08-09 08:25:07
abstract_source: OpenAlex
abstract_source_url: https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3713&context=dmscjournal
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Anxiety,End-of-Life Distress,Chronic Pain,Neuroplasticity,Aging,Wellbeing,Emotional Processing,Randomized Controlled Trial,Review Article,Cancer Patients,Safety

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3713&context=dmscjournal","source_url":"https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3713&context=dmscjournal","doi":"","pmid":"","publication_date":"2026-05-22","importer_version":"2.1.3","text_redistributed":false}


authors: Rachel N Clark
journal: Digital Showcase Research, Scholarship, & Creative Works (University of Lynchburg)
publication_date: 2026-05-22
source_url: https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3694&context=dmscjournal
source_record_id: https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3694&context=dmscjournal
substance_tags: psilocybin
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:35
last_checked: 2026-08-09 08:25:07
abstract_source: OpenAlex
abstract_source_url: https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3694&context=dmscjournal
text_rights_status: unverified_not_redistributed
title:
The Use of Psilocybin for Managing Refractory Behavioral Health Conditions: A New and Promising Approach

topic_tags:
Depression,Anxiety,Addiction,Pharmacology,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Safety,Toxicity

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3694&context=dmscjournal","source_url":"https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3694&context=dmscjournal","doi":"","pmid":"","publication_date":"2026-05-22","importer_version":"2.1.3","text_redistributed":false}


authors: Dallas T Mason
journal: Digital Showcase Research, Scholarship, & Creative Works (University of Lynchburg)
publication_date: 2026-05-22
source_url: https://digitalshowcase.lynchburg.edu/dmscjournal/vol8/iss1/6
source_record_id: https://digitalshowcase.lynchburg.edu/dmscjournal/vol8/iss1/6
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:35
last_checked: 2026-08-09 08:25:07
abstract_source: OpenAlex
abstract_source_url: https://digitalshowcase.lynchburg.edu/dmscjournal/vol8/iss1/6
text_rights_status: unverified_not_redistributed
title:
Psilocybin for Treatment-Resistant Depression: A Comprehensive Review of Mechanisms and Therapeutic Potential

topic_tags:
Depression,Chronic Pain,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Aging,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Toxicity

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"https://digitalshowcase.lynchburg.edu/dmscjournal/vol8/iss1/6","source_url":"https://digitalshowcase.lynchburg.edu/dmscjournal/vol8/iss1/6","doi":"","pmid":"","publication_date":"2026-05-22","importer_version":"2.1.3","text_redistributed":false}


title: Ancient Wisdom, Modern Questions: Western and Orthodox Christianity Engage Psychedelic Spirituality
authors: Geoffrey Ready, Ron Cole-Turner
journal: Religions
publication_date: 2026-05-18
doi: 10.3390/rel17050604
source_url: https://doi.org/10.3390/rel17050604
source_record_id: DOI:10.3390/rel17050604
substance_tags: psilocybin
topic_tags: Spirituality,Mystical Experience
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:35
last_checked: 2026-08-09 08:25:07
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.3390/rel17050604
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.3390/rel17050604","source_url":"https://doi.org/10.3390/rel17050604","doi":"10.3390/rel17050604","pmid":"","publication_date":"2026-05-18","importer_version":"2.1.3","text_redistributed":false}


authors: Sean M. Viña
journal: Psychoactives
publication_date: 2026-05-11
doi: 10.3390/psychoactives5020014
source_url: https://doi.org/10.3390/psychoactives5020014
source_record_id: DOI:10.3390/psychoactives5020014
substance_tags: psilocybin
topic_tags: Depression,Observational Study,Toxicity
study_type: Observational Study
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:35
last_checked: 2026-07-04 06:34:35
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.3390/psychoactives5020014
text_rights_status: unverified_not_redistributed
title:
Psychedelic Use and Missed Needed Mental Health Treatment: Gender Differences in Unmet Perceived Need for Care

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.3390/psychoactives5020014","source_url":"https://doi.org/10.3390/psychoactives5020014","doi":"10.3390/psychoactives5020014","pmid":"","publication_date":"2026-05-11","importer_version":"2.1.3","text_redistributed":false}


authors: Khadija Kamene
journal: Premier Journal of Neuroscience
publication_date: 2026-05-11
doi: 10.70389/pjn.100014
source_url: https://doi.org/10.70389/pjn.100014
source_record_id: DOI:10.70389/pjn.100014
substance_tags: psilocybin
study_type: Systematic Review
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:35
last_checked: 2026-08-09 08:25:08
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.70389/pjn.100014
text_rights_status: unverified_not_redistributed
title:
Treatment-Resistant Depression in the 21st Century: A Scoping Review of Psychedelics and Neuromodulation in Transforming Care

topic_tags:
Depression,Anxiety,Chronic Pain,Mechanism of Action,Systematic Review,Review Article,Treatment-Resistant Depression,Toxicity

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.70389/pjn.100014","source_url":"https://doi.org/10.70389/pjn.100014","doi":"10.70389/pjn.100014","pmid":"","publication_date":"2026-05-11","importer_version":"2.1.3","text_redistributed":false}


authors: Jessie Kim, Liam Lochhead, Cory R. Weissman
journal: Pharmacology Research & Perspectives
publication_date: 2026-05-10
doi: 10.1002/prp2.70262
pubmed_id: 42108552
source_url: https://doi.org/10.1002/prp2.70262
source_record_id: PMID:42108552
substance_tags: psilocybin
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:35
last_checked: 2026-08-09 08:25:08
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1002/prp2.70262
text_rights_status: unverified_not_redistributed
title:
From Trials to Clinics: Considerations for Implementing Psychedelic-Assisted Therapy Into Clinical Practice

topic_tags:
Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Mystical Experience,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety,Adverse Events,Toxicity

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"PMID:42108552","source_url":"https://doi.org/10.1002/prp2.70262","doi":"10.1002/prp2.70262","pmid":"42108552","publication_date":"2026-05-10","importer_version":"2.1.3","text_redistributed":false}


title: Announcement of special issue: ‘Behavioural pharmacology of ketamine and psychedelic drugs’
authors: Bart A. Ellenbroek, Gernot Riedel
journal: Behavioural Pharmacology
publication_date: 2026-05-06
doi: 10.1097/fbp.0000000000000878
pubmed_id: 42100839
source_url: https://doi.org/10.1097/fbp.0000000000000878
source_record_id: PMID:42100839
substance_tags: psilocybin
study_type: Review Article
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:35
last_checked: 2026-08-09 08:25:08
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1097/fbp.0000000000000878
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Addiction,Pharmacology,Receptor Pharmacology,Review Article,Treatment-Resistant Depression,Safety,Toxicity

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"PMID:42100839","source_url":"https://doi.org/10.1097/fbp.0000000000000878","doi":"10.1097/fbp.0000000000000878","pmid":"42100839","publication_date":"2026-05-06","importer_version":"2.1.3","text_redistributed":false}


title: Characterizing psilocybin’s effects on nociception and thermoregulation in preclinical pain models
authors: Tyler Girard, Boris Heifets, Robert Sapolsky, X Chen, Stanford University
journal: Stanford Digital Repository
publication_date: 2026-04-30
doi: 10.25740/yr748bv5776
source_url: https://doi.org/10.25740/yr748bv5776
source_record_id: DOI:10.25740/yr748bv5776
substance_tags: psilocybin
topic_tags: Chronic Pain,Pharmacology,Animal Study,Toxicity,Inflammation
study_type: Animal Study
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:35
last_checked: 2026-08-09 08:25:08
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.25740/yr748bv5776
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.25740/yr748bv5776","source_url":"https://doi.org/10.25740/yr748bv5776","doi":"10.25740/yr748bv5776","pmid":"","publication_date":"2026-04-30","importer_version":"2.1.3","text_redistributed":false}


journal: Repository for Publications and Research Data (ETH Zurich)
publication_date: 2026-04-30
doi: 10.3929/ethz-c-000799490
source_url: http://hdl.handle.net/20.500.11850/799490
source_record_id: DOI:10.3929/ethz-c-000799490
substance_tags: psilocybin
topic_tags: Chronic Pain,Mystical Experience,Healthy Volunteers,Toxicity
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:35
last_checked: 2026-08-09 08:25:08
abstract_source: OpenAlex
abstract_source_url: http://hdl.handle.net/20.500.11850/799490
text_rights_status: unverified_not_redistributed
title:
Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled Settings

authors:
Kurt Stocker, Matthias Hartmann, Frederick S. Barrett, William A. Richards, Nathan D. Sepeda, Laura Ley, Anna M. Becker, Friederike Holze, Matthias E. Liechti

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.3929/ethz-c-000799490","source_url":"http://hdl.handle.net/20.500.11850/799490","doi":"10.3929/ethz-c-000799490","pmid":"","publication_date":"2026-04-30","importer_version":"2.1.3","text_redistributed":false}


title: Evaluating the evidence for repressed memory recovery in psychedelic contexts
journal: Psychopharmacology
publication_date: 2026-04-28
doi: 10.1007/s00213-026-07076-x
pubmed_id: 42053657
source_url: https://doi.org/10.1007/s00213-026-07076-x
source_record_id: PMID:42053657
substance_tags: psilocybin
topic_tags: Mechanism of Action,Consciousness,Review Article,Toxicity
study_type: Review Article
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:35
last_checked: 2026-07-04 06:34:35
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1007/s00213-026-07076-x
text_rights_status: unverified_not_redistributed
authors:
Anne-Fiona Griesfeller, Lotte Kooman, Lilian Kloft-Heller, Samuli Kangaslampi, Johannes G Ramaekers, Henry Otgaar

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"PMID:42053657","source_url":"https://doi.org/10.1007/s00213-026-07076-x","doi":"10.1007/s00213-026-07076-x","pmid":"42053657","publication_date":"2026-04-28","importer_version":"2.1.3","text_redistributed":false}


title: 157. Opposing 5-HT Receptors Modulate Psilocybin's Action on Dendritic Calcium Dynamics
authors: Neil K. Savalia, Lingxiao Shao, Cory Knox, A. Gilbert, Quan Jiang, Alex Kwan
journal: Biological Psychiatry
publication_date: 2026-04-25
doi: 10.1016/j.biopsych.2026.03.391
source_url: https://doi.org/10.1016/j.biopsych.2026.03.391
source_record_id: DOI:10.1016/j.biopsych.2026.03.391
substance_tags: psilocybin
topic_tags: Mechanism of Action,Receptor Pharmacology,Toxicity
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:35
last_checked: 2026-08-09 08:25:09
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.biopsych.2026.03.391","source_url":"https://doi.org/10.1016/j.biopsych.2026.03.391","doi":"10.1016/j.biopsych.2026.03.391","pmid":"","publication_date":"2026-04-25","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin use among Basotho healers and non-healers in southern Africa
journal: OSF Preprints
publication_date: 2026-04-23
doi: 10.31235/osf.io/429dw_v1
source_url: https://doi.org/10.31235/osf.io/429dw_v1
source_record_id: DOI:10.31235/osf.io/429dw_v1
substance_tags: psilocybin
topic_tags: Spirituality
study_type: Other
source_name: Crossref
publication_status: preprint
date_added: 2026-07-04 06:34:35
last_checked: 2026-08-09 09:00:16
abstract_source: Crossref
abstract_source_url: https://doi.org/10.31235/osf.io/429dw_v1
text_rights_status: unverified_not_redistributed
authors:
Stark-Elster Eli, Sethathi Mamosebetsi, van der Merwe Breyten, Nayak Sandeep Manel, Yaden David Bryce, Singh Manvir

source_provenance_json:
{"source_name":"Crossref","source_record_id":"DOI:10.31235/osf.io/429dw_v1","source_url":"https://doi.org/10.31235/osf.io/429dw_v1","doi":"10.31235/osf.io/429dw_v1","pmid":"","publication_date":"2026-04-23","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelics: Historical Context, Emerging Science, and Future Clinical Frontiers
authors: Vipul Janardan, Amit Khanna, Om Prakash, Anadrika Debbarma, SK Mathur
journal: Journal of Mental Health Disorders
publication_date: 2026-04-18
doi: 10.33696/mentalhealth.6.068
source_url: https://doi.org/10.33696/mentalhealth.6.068
source_record_id: DOI:10.33696/mentalhealth.6.068
substance_tags: psilocybin
topic_tags: Depression,PTSD,Addiction,Consciousness,Treatment-Resistant Depression,Toxicity
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:35
last_checked: 2026-08-09 08:25:09
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.33696/mentalhealth.6.068
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.33696/mentalhealth.6.068","source_url":"https://doi.org/10.33696/mentalhealth.6.068","doi":"10.33696/mentalhealth.6.068","pmid":"","publication_date":"2026-04-18","importer_version":"2.1.3","text_redistributed":false}


authors: Juan Moisés de la Serna de la Serna
journal: Zenodo (CERN European Organization for Nuclear Research)
publication_date: 2026-04-17
doi: 10.5281/zenodo.19620938
source_url: https://doi.org/10.5281/zenodo.19620938
source_record_id: DOI:10.5281/zenodo.19620938
substance_tags: psilocybin
topic_tags: Chronic Pain
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:35
last_checked: 2026-08-09 08:25:09
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.5281/zenodo.19620938
text_rights_status: unverified_not_redistributed
title:
Neural Entropy and Cognitive Flexibility: A Research Agenda for Psilocybin-Assisted Therapy [FUTURE DIRECTIONS v1.0]

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.5281/zenodo.19620938","source_url":"https://doi.org/10.5281/zenodo.19620938","doi":"10.5281/zenodo.19620938","pmid":"","publication_date":"2026-04-17","importer_version":"2.1.3","text_redistributed":false}


title: Oregon's Psilocybin Services: A Summary and Public Health Commentary.
authors: LoParco CR, Bone C, Galvin AM, Rossheim ME, Berg CJ
journal: Health behavior research
publication_date: 2026-01-01
pubmed_id: 42428139
source_url: https://pubmed.ncbi.nlm.nih.gov/42428139/
source_record_id: PMID:42428139
substance_tags: psilocybin
topic_tags: Emotional Processing,Adolescents,Safety
study_type: Other
source_name: PubMed
publication_status: published
date_added: 2026-07-04 06:34:35
last_checked: 2026-08-09 08:34:30
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/42428139/
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:42428139","source_url":"https://pubmed.ncbi.nlm.nih.gov/42428139/","doi":"","pmid":"42428139","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}


title: Investigating Psychedelic Tryptamines: Extraction and Quantification from Psilocybe Mushrooms
authors: Beatriz P. Senra, Ricardo Jorge Dinis-Oliveira, Carlos J. A. Ribeiro
journal: Science Letters
publication_date: 2026-04-17
doi: 10.48797/sl.2026.498
source_url: https://doi.org/10.48797/sl.2026.498
source_record_id: DOI:10.48797/sl.2026.498
substance_tags: psilocybin,psilocin
topic_tags: Toxicity
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:35
last_checked: 2026-08-09 08:25:09
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.48797/sl.2026.498
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.48797/sl.2026.498","source_url":"https://doi.org/10.48797/sl.2026.498","doi":"10.48797/sl.2026.498","pmid":"","publication_date":"2026-04-17","importer_version":"2.1.3","text_redistributed":false}


journal: Science Letters
publication_date: 2026-04-17
doi: 10.48797/sl.2026.497
source_url: https://doi.org/10.48797/sl.2026.497
source_record_id: DOI:10.48797/sl.2026.497
substance_tags: psilocybin,psilocin
topic_tags: Pharmacology,Oxidative Stress,Animal Study,Toxicity
study_type: Animal Study
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:35
last_checked: 2026-08-09 08:25:09
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.48797/sl.2026.497
text_rights_status: unverified_not_redistributed
title:
Psilocybin and Psilocybe cubensis extract exhibit divergent behavioural and toxicological effects in rats

authors:
Diana Dias da Silva, Andreia Machado Brito-da-Costa, Francisco Sacadura, Mariana Carvalho, Helena Carmo, Ricardo Jorge Dinis-Oliveira, Áurea Madureira-Carvalho

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.48797/sl.2026.497","source_url":"https://doi.org/10.48797/sl.2026.497","doi":"10.48797/sl.2026.497","pmid":"","publication_date":"2026-04-17","importer_version":"2.1.3","text_redistributed":false}


title: Impact of psilocybin and Psilocybe cubensis extract on gut microbiota in Wistar Han rats
journal: Science Letters
publication_date: 2026-04-17
doi: 10.48797/sl.2026.492
source_url: https://doi.org/10.48797/sl.2026.492
source_record_id: DOI:10.48797/sl.2026.492
substance_tags: psilocybin,psilocin
topic_tags: Pharmacology,Animal Study,Microbiome
study_type: Animal Study
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:35
last_checked: 2026-08-09 08:25:09
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.48797/sl.2026.492
text_rights_status: unverified_not_redistributed
authors:
Francisco Sacadura, Cláudia Marques, Andreia Machado Brito-da-Costa, Mariana Carvalho, Helena Carmo, Ricardo Jorge Dinis-Oliveira, Áurea Madureira-Carvalho, Diana Dias da Silva

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.48797/sl.2026.492","source_url":"https://doi.org/10.48797/sl.2026.492","doi":"10.48797/sl.2026.492","pmid":"","publication_date":"2026-04-17","importer_version":"2.1.3","text_redistributed":false}


authors: Nikita Sanati Morel, Dea Siggaard Stenbaek, Johan Lundberg, Maria Beckman
journal: Figshare
publication_date: 2026-04-09
doi: 10.6084/m9.figshare.32048850
source_url: https://doi.org/10.6084/m9.figshare.32048850
source_record_id: DOI:10.6084/m9.figshare.32048850
substance_tags: psilocybin
topic_tags: Depression,Chronic Pain,Randomized Controlled Trial
study_type: Randomized Controlled Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:35
last_checked: 2026-08-09 08:25:09
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.6084/m9.figshare.32048850
text_rights_status: unverified_not_redistributed
title:
Additional file 1 of Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depression

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.6084/m9.figshare.32048850","source_url":"https://doi.org/10.6084/m9.figshare.32048850","doi":"10.6084/m9.figshare.32048850","pmid":"","publication_date":"2026-04-09","importer_version":"2.1.3","text_redistributed":false}


journal: 2026 IEEE 23rd International Symposium on Biomedical Imaging (ISBI)
publication_date: 2026-04-08
doi: 10.1109/isbi61048.2026.11515300
source_url: https://doi.org/10.1109/isbi61048.2026.11515300
source_record_id: DOI:10.1109/isbi61048.2026.11515300
substance_tags: psilocybin
topic_tags: Brain Imaging
study_type: Other
source_name: Crossref
publication_status: published
date_added: 2026-07-04 06:34:35
last_checked: 2026-08-09 08:34:58
abstract_source: Crossref
abstract_source_url: https://doi.org/10.1109/isbi61048.2026.11515300
text_rights_status: unverified_not_redistributed
title:
Brain-MGF: Multimodal Graph Fusion Network for EEG-FMRI Brain Connectivity Analysis Under Psilocybin

authors:
Yap Sin-Yee, Noman Fuad, Loo Junn Yong, Stoliker Devon, Khajehnejad Moein, Phan Raphaël C.-W., Dowe David L., Razi Adeel, Ting Chee-Ming

source_provenance_json:
{"source_name":"Crossref","source_record_id":"DOI:10.1109/isbi61048.2026.11515300","source_url":"https://doi.org/10.1109/isbi61048.2026.11515300","doi":"10.1109/isbi61048.2026.11515300","pmid":"","publication_date":"2026-04-08","importer_version":"2.1.3","text_redistributed":false}


title: Classic psychedelics in obsessive-compulsive disorder: a circuit-based framework
authors: Saif S. Ali, Robin L. Carhart-Harris, Karl G. Sieg
journal: Nature Mental Health
publication_date: 2026-03-31
doi: 10.1038/s44220-026-00626-4
source_url: https://doi.org/10.1038/s44220-026-00626-4
source_record_id: DOI:10.1038/s44220-026-00626-4
substance_tags: psilocybin
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:35
last_checked: 2026-07-04 06:34:35
text_rights_status: not_applicable_no_text
topic_tags:
Addiction,OCD,Chronic Pain,Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Aging

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1038/s44220-026-00626-4","source_url":"https://doi.org/10.1038/s44220-026-00626-4","doi":"10.1038/s44220-026-00626-4","pmid":"","publication_date":"2026-03-31","importer_version":"2.1.3","text_redistributed":false}


journal: Religion Brain & Behavior
publication_date: 2026-03-31
doi: 10.1080/2153599x.2026.2635353
source_url: https://doi.org/10.1080/2153599x.2026.2635353
source_record_id: DOI:10.1080/2153599x.2026.2635353
substance_tags: psilocybin
topic_tags: Personality Change,Mystical Experience,Healthy Volunteers
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:36
last_checked: 2026-08-09 08:25:09
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1080/2153599x.2026.2635353
text_rights_status: unverified_not_redistributed
title:
Mystical dynamics: renewal, luminous light, and ego disintegration as key features associated with mystical oneness-a psychometric analysis using the PES100 in controlled psychedelic studies

authors:
Kurt Stocker, Matthias Hartmann, Frederick S. Barrett, Willam Richards, Nathan D. Sepeda, Isabelle Straumann, Aaron Klaiber, Severin B. Vogt, Livio Erne, Laura Ley, A. Becker, Patrick Vizeli, Friederike Holze, Matthias E. Liechti

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1080/2153599x.2026.2635353","source_url":"https://doi.org/10.1080/2153599x.2026.2635353","doi":"10.1080/2153599x.2026.2635353","pmid":"","publication_date":"2026-03-31","importer_version":"2.1.3","text_redistributed":false}


authors: Kenji Hashimoto, Feyza Arıcıoğlu, Mesut Çetin
journal: Psychiatry and Clinical Psychopharmacology
publication_date: 2026-03-30
doi: 10.65801/pcp.3512
source_url: https://doi.org/10.65801/pcp.3512
source_record_id: DOI:10.65801/pcp.3512
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:36
last_checked: 2026-08-09 08:25:10
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.65801/pcp.3512
text_rights_status: unverified_not_redistributed
title:
Therapeutic Potential of Classical Psychedelics and NonHallucinogenic Psychoplastogens in Psychiatric Disorders

topic_tags:
Depression,Addiction,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Review Article,Animal Study,Safety,Toxicity,Drug Interactions

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.65801/pcp.3512","source_url":"https://doi.org/10.65801/pcp.3512","doi":"10.65801/pcp.3512","pmid":"","publication_date":"2026-03-30","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelic Experiences and Finitude in Serious Illness: A Qualitative Synthesis
authors: Ana Cláudia Mesquita Garcia, Geovanna Maria Isidoro, Cremilson de Paula Silva
journal: Journal of Pain and Symptom Management
publication_date: 2026-03-26
doi: 10.1016/j.jpainsymman.2026.03.012
pubmed_id: 41903620
source_url: https://doi.org/10.1016/j.jpainsymman.2026.03.012
source_record_id: PMID:41903620
substance_tags: psilocybin
study_type: Systematic Review
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:36
last_checked: 2026-07-04 06:34:36
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1016/j.jpainsymman.2026.03.012
text_rights_status: unverified_not_redistributed
topic_tags:
Anxiety,End-of-Life Distress,Chronic Pain,Consciousness,Emotional Processing,Spirituality,Systematic Review,Review Article

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"PMID:41903620","source_url":"https://doi.org/10.1016/j.jpainsymman.2026.03.012","doi":"10.1016/j.jpainsymman.2026.03.012","pmid":"41903620","publication_date":"2026-03-26","importer_version":"2.1.3","text_redistributed":false}


title: Classic psychedelic medicines for adolescent refractory mental health disease
authors: Aly Shah Aziz
journal: Journal of Psychedelic Studies
publication_date: 2026-03-26
doi: 10.1556/2054.2026.00452
source_url: https://doi.org/10.1556/2054.2026.00452
source_record_id: DOI:10.1556/2054.2026.00452
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Clinical Trial,Observational Study,Adolescents,Safety,Toxicity
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:36
last_checked: 2026-08-09 08:25:10
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1556/2054.2026.00452
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1556/2054.2026.00452","source_url":"https://doi.org/10.1556/2054.2026.00452","doi":"10.1556/2054.2026.00452","pmid":"","publication_date":"2026-03-26","importer_version":"2.1.3","text_redistributed":false}


authors: Stanley Everett Sambey
journal: Zenodo (CERN European Organization for Nuclear Research)
publication_date: 2026-03-25
doi: 10.5281/zenodo.19221582
source_url: https://doi.org/10.5281/zenodo.19221582
source_record_id: DOI:10.5281/zenodo.19221582
substance_tags: psilocybin
topic_tags: Neuroplasticity,Brain Imaging,Default Mode Network,Aging
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:36
last_checked: 2026-08-09 08:25:10
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.5281/zenodo.19221582
text_rights_status: unverified_not_redistributed
title:
Psychedelic-Induced Constraint Destabilization and Reconstruction as a Mechanism for Cognitive Reset

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.5281/zenodo.19221582","source_url":"https://doi.org/10.5281/zenodo.19221582","doi":"10.5281/zenodo.19221582","pmid":"","publication_date":"2026-03-25","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelic-Assisted Psychotherapy: Attitudes of Law Enforcement and Military Personnel
authors: Alexandra Hopkins, Cassandra A. Bailey, Emily Rybak, Mia M. Ricardo
journal: Journal of Police and Criminal Psychology
publication_date: 2026-03-22
doi: 10.1007/s11896-026-09807-4
source_url: https://doi.org/10.1007/s11896-026-09807-4
source_record_id: DOI:10.1007/s11896-026-09807-4
substance_tags: psilocybin
topic_tags: Chronic Pain,Safety,Toxicity
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:36
last_checked: 2026-07-04 06:34:36
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1007/s11896-026-09807-4","source_url":"https://doi.org/10.1007/s11896-026-09807-4","doi":"10.1007/s11896-026-09807-4","pmid":"","publication_date":"2026-03-22","importer_version":"2.1.3","text_redistributed":false}


journal: Drugs Education Prevention and Policy
publication_date: 2026-03-22
doi: 10.1080/09687637.2026.2645025
source_url: https://doi.org/10.1080/09687637.2026.2645025
source_record_id: DOI:10.1080/09687637.2026.2645025
substance_tags: psilocybin
topic_tags: Chronic Pain,Safety
study_type: Qualitative Study
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:36
last_checked: 2026-08-09 08:25:10
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1080/09687637.2026.2645025
text_rights_status: unverified_not_redistributed
title:
“You can only take your clients as far as you’ve been yourself”: examining the intersections between psychedelic-assisted therapy, lived-living experience, and clinical practice

authors:
Jordan J. Negrine, Stephen Bright, Monica J. Barratt, Matthew Pennell, Anthony Barnett, James Bennett-Levy, Timothy Piatkowski

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1080/09687637.2026.2645025","source_url":"https://doi.org/10.1080/09687637.2026.2645025","doi":"10.1080/09687637.2026.2645025","pmid":"","publication_date":"2026-03-22","importer_version":"2.1.3","text_redistributed":false}


title: When I use a word... The psychedelic mind’s eye
authors: J K Aronson
journal: BMJ
publication_date: 2026-03-20
doi: 10.1136/bmj.s548
pubmed_id: 41862175
source_url: https://doi.org/10.1136/bmj.s548
source_record_id: PMID:41862175
substance_tags: psilocybin
topic_tags: Receptor Pharmacology,Consciousness
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:36
last_checked: 2026-08-09 08:25:10
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1136/bmj.s548
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"PMID:41862175","source_url":"https://doi.org/10.1136/bmj.s548","doi":"10.1136/bmj.s548","pmid":"41862175","publication_date":"2026-03-20","importer_version":"2.1.3","text_redistributed":false}


title: Editorial: Psychedelic substances and neurological diseases: from basics to clinical application
authors: Alessandra Linardi, Ariadiny Lima Caetano, Rodrigo Portes Ureshino
journal: Frontiers in Pharmacology
publication_date: 2026-03-15
doi: 10.3389/fphar.2026.1816812
pubmed_id: 41919223
source_url: https://doi.org/10.3389/fphar.2026.1816812
source_record_id: PMID:41919223
substance_tags: psilocybin
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:36
last_checked: 2026-07-04 06:34:36
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.3389/fphar.2026.1816812
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Anxiety,PTSD,Addiction,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Mitochondrial Function,Oxidative Stress,Wellbeing,Spirituality,Clinical Trial,Review Article,Animal Study,Toxicity,Proteomics,Inflammation

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"PMID:41919223","source_url":"https://doi.org/10.3389/fphar.2026.1816812","doi":"10.3389/fphar.2026.1816812","pmid":"41919223","publication_date":"2026-03-15","importer_version":"2.1.3","text_redistributed":false}


title: Hallucinogens for Mood and Anxiety Disorders: A Critical Review of Psychedelic-Assisted Therapies
authors: Georgia Chlebek
journal: ThinkIR: The University of Louisville's Institutional Repository (University of Louisville)
publication_date: 2026-03-16
source_url: https://ir.library.louisville.edu/tce/vol3/iss1/11
source_record_id: https://ir.library.louisville.edu/tce/vol3/iss1/11
substance_tags: psilocybin
study_type: Review Article
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:36
last_checked: 2026-08-09 08:25:10
abstract_source: OpenAlex
abstract_source_url: https://ir.library.louisville.edu/tce/vol3/iss1/11
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Anxiety,PTSD,Addiction,Review Article,Adolescents,Treatment-Resistant Depression,Adverse Events,Toxicity

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"https://ir.library.louisville.edu/tce/vol3/iss1/11","source_url":"https://ir.library.louisville.edu/tce/vol3/iss1/11","doi":"","pmid":"","publication_date":"2026-03-16","importer_version":"2.1.3","text_redistributed":false}


title: A fungus among us: investigating queensland’s largest magic mushroom growing operation
authors: Kate Brough, Corinna Lange
journal: Australian Journal of Forensic Sciences
publication_date: 2026-03-16
doi: 10.1080/00450618.2026.2617320
source_url: https://doi.org/10.1080/00450618.2026.2617320
source_record_id: DOI:10.1080/00450618.2026.2617320
substance_tags: psilocybin,psilocin
topic_tags: Drug Interactions
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:36
last_checked: 2026-08-09 08:25:10
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1080/00450618.2026.2617320
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1080/00450618.2026.2617320","source_url":"https://doi.org/10.1080/00450618.2026.2617320","doi":"10.1080/00450618.2026.2617320","pmid":"","publication_date":"2026-03-16","importer_version":"2.1.3","text_redistributed":false}


title: Public attitudes diverge sharply on legal use of psychedelics
authors: Valerie A. Canady
journal: Mental Health Weekly
publication_date: 2026-03-02
doi: 10.1002/mhw.34775
source_url: https://doi.org/10.1002/mhw.34775
source_record_id: DOI:10.1002/mhw.34775
substance_tags: psilocybin
topic_tags: Addiction,Consciousness,Toxicity
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:36
last_checked: 2026-08-09 08:25:10
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1002/mhw.34775
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1002/mhw.34775","source_url":"https://doi.org/10.1002/mhw.34775","doi":"10.1002/mhw.34775","pmid":"","publication_date":"2026-03-02","importer_version":"2.1.3","text_redistributed":false}


journal: Zenodo (CERN European Organization for Nuclear Research)
publication_date: 2026-03-01
doi: 10.5281/zenodo.18796594
source_url: https://doi.org/10.5281/zenodo.18796594
source_record_id: DOI:10.5281/zenodo.18796594
substance_tags: psilocybin
topic_tags: Depression,Pharmacology,Animal Study,Microbiome,Inflammation,Immune Function
study_type: Animal Study
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:36
last_checked: 2026-08-09 08:25:10
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.5281/zenodo.18796594
text_rights_status: unverified_not_redistributed
title:
THE EFFECT OF PSILOCYBIN AND EUGENOL ON LIPOPOLYSACCHARIDE INDUCED INFLAMMATION IN SMALL AND LARGE INTESTINE OF MICE

authors:
Zeinab Asghari, Gregory Robinson, Marta Gerasymchuk, Esmaeel Ghasemi Gojani, Timur Zanikov, Yasaman Rastamian, Olga Kovalchuk, Igor Kovalchuk*

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.5281/zenodo.18796594","source_url":"https://doi.org/10.5281/zenodo.18796594","doi":"10.5281/zenodo.18796594","pmid":"","publication_date":"2026-03-01","importer_version":"2.1.3","text_redistributed":false}


authors: Ana Deutsch, Luis E. Contreras, Sarah Kratina, Leah M. Mayo
journal: Therapeutic Advances in Psychopharmacology
publication_date: 2026-02-28
doi: 10.1177/20451253261433836
pubmed_id: 41918771
source_url: https://doi.org/10.1177/20451253261433836
source_record_id: PMID:41918771
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:36
last_checked: 2026-07-04 06:34:36
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1177/20451253261433836
text_rights_status: unverified_not_redistributed
title:
A scoping review of mystical-type experiences and mood symptom outcomes in psychedelic therapy clinical trials: comparing life-threatening disease and depressive populations

topic_tags:
Depression,Anxiety,End-of-Life Distress,Chronic Pain,Mechanism of Action,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Review Article,Toxicity

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"PMID:41918771","source_url":"https://doi.org/10.1177/20451253261433836","doi":"10.1177/20451253261433836","pmid":"41918771","publication_date":"2026-02-28","importer_version":"2.1.3","text_redistributed":false}


authors: C Faria, Diana Dias da Silva, João José Sousa
journal: Instituto Politécnico do Porto
publication_date: 2026-02-27
doi: 10.26537/prpaeh.v4i3.7173
source_url: https://doi.org/10.26537/prpaeh.v4i3.7173
source_record_id: DOI:10.26537/prpaeh.v4i3.7173
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:36
last_checked: 2026-08-09 08:25:10
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.26537/prpaeh.v4i3.7173
text_rights_status: unverified_not_redistributed
title:
Psilocybin-assisted therapy for major depressive disorder: implications for clinical effectiveness, health economics, and regulatory decision-making

topic_tags:
Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.26537/prpaeh.v4i3.7173","source_url":"https://doi.org/10.26537/prpaeh.v4i3.7173","doi":"10.26537/prpaeh.v4i3.7173","pmid":"","publication_date":"2026-02-27","importer_version":"2.1.3","text_redistributed":false}


title: Psilocin as a Broad Inhibitor of CYP450 Enzymes: Integrated In Vitro and In Silico Evidence
journal: Instituto Politécnico do Porto
publication_date: 2026-02-25
doi: 10.26537/prpaeh.v4i3.7159
source_url: https://doi.org/10.26537/prpaeh.v4i3.7159
source_record_id: DOI:10.26537/prpaeh.v4i3.7159
substance_tags: psilocybin,psilocin
topic_tags: Neuroplasticity,Pharmacology,In Vitro Study,Safety,Toxicity,Drug Interactions
study_type: In Vitro Study
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:36
last_checked: 2026-08-09 08:25:11
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.26537/prpaeh.v4i3.7159
text_rights_status: unverified_not_redistributed
authors:
Diana Silva, Andreia Machado Brito-da-Costa, Mariana Carvalho, Ricardo Jorge Dinis-Oliveira, Áurea Madureira-Carvalho, Sérgio F. Sousa

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.26537/prpaeh.v4i3.7159","source_url":"https://doi.org/10.26537/prpaeh.v4i3.7159","doi":"10.26537/prpaeh.v4i3.7159","pmid":"","publication_date":"2026-02-25","importer_version":"2.1.3","text_redistributed":false}


title: Cogumelos do gênero Psilocybe nas Américas e no Brasil
authors: Anita Lino
journal: Anthropology of Consciousness
publication_date: 2026-02-22
doi: 10.1111/anoc.70031
source_url: https://doi.org/10.1111/anoc.70031
source_record_id: DOI:10.1111/anoc.70031
substance_tags: psilocybin
topic_tags: Spirituality
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:36
last_checked: 2026-08-09 08:25:11
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1111/anoc.70031
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1111/anoc.70031","source_url":"https://doi.org/10.1111/anoc.70031","doi":"10.1111/anoc.70031","pmid":"","publication_date":"2026-02-22","importer_version":"2.1.3","text_redistributed":false}


authors: Rafael Lancelotta, Paul Nagib, Stacey B. Armstrong, Adam W. Levin, A. B. Davis
journal: Journal of Psychedelic Studies
publication_date: 2026-02-12
doi: 10.1556/2054.2026.00462
source_url: https://doi.org/10.1556/2054.2026.00462
source_record_id: DOI:10.1556/2054.2026.00462
substance_tags: psilocybin
topic_tags: Chronic Pain,Emotional Processing,Clinical Trial,Drug Interactions
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:36
last_checked: 2026-08-09 08:25:11
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1556/2054.2026.00462
text_rights_status: unverified_not_redistributed
title:
Development and assessment of a psychedelic-assisted therapy music playlist for clinical trials: Theory, intentionality, and metrics

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1556/2054.2026.00462","source_url":"https://doi.org/10.1556/2054.2026.00462","doi":"10.1556/2054.2026.00462","pmid":"","publication_date":"2026-02-12","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin and Animal Testing: Charting an End to the Use of Animals in Drug Development Research
authors: Amanda L. Elyse
publication_date: 2026-02-12
substance_tags: psilocybin
topic_tags: Pharmacology,Clinical Trial,Toxicity
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:36
last_checked: 2026-08-09 08:25:11
abstract_source: OpenAlex
text_rights_status: unverified_not_redistributed
journal:
Digital Commons at University of Maryland Carey Law (University of Maryland Francis King Carey School of Law)

source_url:
https://digitalcommons.law.umaryland.edu/cgi/viewcontent.cgi?article=1002&context=jhclp_online_issue

source_record_id:
https://digitalcommons.law.umaryland.edu/cgi/viewcontent.cgi?article=1002&context=jhclp_online_issue

abstract_source_url:
https://digitalcommons.law.umaryland.edu/cgi/viewcontent.cgi?article=1002&context=jhclp_online_issue

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"https://digitalcommons.law.umaryland.edu/cgi/viewcontent.cgi?article=1002&context=jhclp_online_issue","source_url":"https://digitalcommons.law.umaryland.edu/cgi/viewcontent.cgi?article=1002&context=jhclp_online_issue","doi":"","pmid":"","publication_date":"2026-02-12","importer_version":"2.1.3","text_redistributed":false}


title: Exploring a Decade of Microdosing Research: A Qualitative Meta-synthesis of Microdosing Literature
authors: Blake Beaton
journal: Deviant Behavior
publication_date: 2026-02-09
doi: 10.1080/01639625.2026.2624690
source_url: https://doi.org/10.1080/01639625.2026.2624690
source_record_id: DOI:10.1080/01639625.2026.2624690
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Addiction,Microdosing
study_type: Qualitative Study
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:36
last_checked: 2026-08-09 08:25:11
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1080/01639625.2026.2624690
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1080/01639625.2026.2624690","source_url":"https://doi.org/10.1080/01639625.2026.2624690","doi":"10.1080/01639625.2026.2624690","pmid":"","publication_date":"2026-02-09","importer_version":"2.1.3","text_redistributed":false}


authors: Alexa Camarena-Michel, John Michael Rague
journal: Current Opinion in Toxicology
publication_date: 2026-02-06
doi: 10.1016/j.cotox.2026.100574
source_url: https://doi.org/10.1016/j.cotox.2026.100574
source_record_id: DOI:10.1016/j.cotox.2026.100574
substance_tags: psilocybin
topic_tags: Review Article,Toxicity
study_type: Review Article
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:36
last_checked: 2026-07-04 06:34:36
text_rights_status: not_applicable_no_text
title:
Effects of cannabis and psychedelic use on cognitive, psychomotor, and driving performance: A review of recent literature

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.cotox.2026.100574","source_url":"https://doi.org/10.1016/j.cotox.2026.100574","doi":"10.1016/j.cotox.2026.100574","pmid":"","publication_date":"2026-02-06","importer_version":"2.1.3","text_redistributed":false}


title: Activity-Dependent Neural Rewiring by Psilocybin: A Monosynaptic Rabies Virus Tracing Study
authors: Zen Revista
journal: Zenodo (CERN European Organization for Nuclear Research)
publication_date: 2026-02-06
doi: 10.5281/zenodo.18501514
source_url: https://doi.org/10.5281/zenodo.18501514
source_record_id: DOI:10.5281/zenodo.18501514
substance_tags: psilocybin
study_type: Review Article
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:36
last_checked: 2026-08-09 08:25:11
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.5281/zenodo.18501514
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Chronic Pain,Neuroplasticity,Brain Imaging,Mechanism of Action,Aging,Review Article,Toxicity

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.5281/zenodo.18501514","source_url":"https://doi.org/10.5281/zenodo.18501514","doi":"10.5281/zenodo.18501514","pmid":"","publication_date":"2026-02-06","importer_version":"2.1.3","text_redistributed":false}


authors: Zen Revista
journal: Zenodo (CERN European Organization for Nuclear Research)
publication_date: 2026-02-06
doi: 10.5281/zenodo.18501568
source_url: https://doi.org/10.5281/zenodo.18501568
source_record_id: DOI:10.5281/zenodo.18501568
substance_tags: psilocybin
study_type: Review Article
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:36
last_checked: 2026-08-09 08:25:11
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.5281/zenodo.18501568
text_rights_status: unverified_not_redistributed
title:
Activity-Dependent Neural Rewiring: Mechanisms of Psilocybin-Induced Cortical Network Reorganization

topic_tags:
Chronic Pain,Neuroplasticity,Brain Imaging,Mechanism of Action,Aging,Review Article,Animal Study,Toxicity

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.5281/zenodo.18501568","source_url":"https://doi.org/10.5281/zenodo.18501568","doi":"10.5281/zenodo.18501568","pmid":"","publication_date":"2026-02-06","importer_version":"2.1.3","text_redistributed":false}


title: Protecting patient autonomy in psychedelic-assisted psychotherapy: a nursing ethics perspective
authors: Aditi Kanwar, Nitin Jeengar, Pramod Kumar Ashaiya
journal: Zenodo (CERN European Organization for Nuclear Research)
publication_date: 2026-01-30
doi: 10.5281/zenodo.18425838
source_url: https://doi.org/10.5281/zenodo.18425838
source_record_id: DOI:10.5281/zenodo.18425838
substance_tags: psilocybin
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:36
last_checked: 2026-08-09 08:25:11
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.5281/zenodo.18425838
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Chronic Pain,Consciousness,Emotional Processing,Treatment-Resistant Depression,Safety,Toxicity

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.5281/zenodo.18425838","source_url":"https://doi.org/10.5281/zenodo.18425838","doi":"10.5281/zenodo.18425838","pmid":"","publication_date":"2026-01-30","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelic research and sexuality: opportunities and pitfalls
authors: H. Knegtering, Thalia Herder, Nynke Boonstra, S. K. Spoelstra
journal: The Journal of Sexual Medicine
publication_date: 2026-01-28
doi: 10.1093/jsxmed/qdag025
pubmed_id: 41722098
source_url: https://doi.org/10.1093/jsxmed/qdag025
source_record_id: PMID:41722098
substance_tags: psilocybin
topic_tags: Depression,PTSD,Addiction,Emotional Processing,Review Article,Toxicity,Drug Interactions
study_type: Review Article
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:36
last_checked: 2026-08-09 08:25:11
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1093/jsxmed/qdag025
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"PMID:41722098","source_url":"https://doi.org/10.1093/jsxmed/qdag025","doi":"10.1093/jsxmed/qdag025","pmid":"41722098","publication_date":"2026-01-28","importer_version":"2.1.3","text_redistributed":false}


journal: Zenodo (CERN European Organization for Nuclear Research)
publication_date: 2026-01-26
doi: 10.5281/zenodo.18375715
source_url: https://doi.org/10.5281/zenodo.18375715
source_record_id: DOI:10.5281/zenodo.18375715
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:36
last_checked: 2026-08-09 08:25:12
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.5281/zenodo.18375715
text_rights_status: unverified_not_redistributed
title:
The therapeutic efficacy of psilocybin in major depressive disorder: A review of recent clinical and mechanistic evidence

authors:
Fernando Mora López, Johynny Solís Solís, Ekaterina Daniela Hernández Baker, Olger Herrera Barboza, David Diaz Polo, Daniela Consumi Cordero

topic_tags:
Depression,Chronic Pain,Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Biomarkers,Aging,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Review Article,Treatment-Resistant Depression,Safety,Adverse Events,Toxicity

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.5281/zenodo.18375715","source_url":"https://doi.org/10.5281/zenodo.18375715","doi":"10.5281/zenodo.18375715","pmid":"","publication_date":"2026-01-26","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelics in psychiatric treatment: a literature review
journal: Quality in Sport
publication_date: 2026-01-26
doi: 10.12775/qs.2026.50.68013
source_url: https://doi.org/10.12775/qs.2026.50.68013
source_record_id: DOI:10.12775/qs.2026.50.68013
substance_tags: psilocybin
study_type: Systematic Review
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:36
last_checked: 2026-08-09 08:25:12
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.12775/qs.2026.50.68013
text_rights_status: unverified_not_redistributed
authors:
Adam Wolski, Ewa Szplit, Mikołaj Franciszek Patalong, Roman Cemaga, Mateusz Kubicki, Przemysław Kołodziej, Natalia Bruska, Bartłomiej Błaszkowski, Andrii Bilyk, Katarzyna Więckowska

topic_tags:
Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Clinical Trial,Systematic Review,Review Article,Safety,Toxicity

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.12775/qs.2026.50.68013","source_url":"https://doi.org/10.12775/qs.2026.50.68013","doi":"10.12775/qs.2026.50.68013","pmid":"","publication_date":"2026-01-26","importer_version":"2.1.3","text_redistributed":false}


title: RAND: Microdosing surges as millions turned to psychedelics in 2025
authors: Valerie A. Canady
journal: Mental Health Weekly
publication_date: 2026-01-23
doi: 10.1002/mhw.34732
source_url: https://doi.org/10.1002/mhw.34732
source_record_id: DOI:10.1002/mhw.34732
substance_tags: psilocybin
topic_tags: Microdosing,Observational Study
study_type: Observational Study
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:36
last_checked: 2026-08-09 08:25:12
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1002/mhw.34732
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1002/mhw.34732","source_url":"https://doi.org/10.1002/mhw.34732","doi":"10.1002/mhw.34732","pmid":"","publication_date":"2026-01-23","importer_version":"2.1.3","text_redistributed":false}


title: Does psilocybin help with mental health conditions?
authors: Tripdatabase
journal: Zenodo (CERN European Organization for Nuclear Research)
publication_date: 2026-01-22
doi: 10.5281/zenodo.18339283
source_url: https://doi.org/10.5281/zenodo.18339283
source_record_id: DOI:10.5281/zenodo.18339283
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Addiction,Chronic Pain,Safety,Toxicity
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:36
last_checked: 2026-08-09 08:25:12
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.5281/zenodo.18339283
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.5281/zenodo.18339283","source_url":"https://doi.org/10.5281/zenodo.18339283","doi":"10.5281/zenodo.18339283","pmid":"","publication_date":"2026-01-22","importer_version":"2.1.3","text_redistributed":false}


title: Is psilocybin only effective as part of psychotherapy?
authors: Tripdatabase
journal: Zenodo (CERN European Organization for Nuclear Research)
publication_date: 2026-01-22
doi: 10.5281/zenodo.18339347
source_url: https://doi.org/10.5281/zenodo.18339347
source_record_id: DOI:10.5281/zenodo.18339347
substance_tags: psilocybin
topic_tags: Anxiety,Chronic Pain,Pharmacology,Clinical Trial
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:36
last_checked: 2026-08-09 08:25:12
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.5281/zenodo.18339347
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.5281/zenodo.18339347","source_url":"https://doi.org/10.5281/zenodo.18339347","doi":"10.5281/zenodo.18339347","pmid":"","publication_date":"2026-01-22","importer_version":"2.1.3","text_redistributed":false}


journal: Open Access CRIS of the University of Bern
publication_date: 2026-01-21
doi: 10.48620/94398
source_url: https://doi.org/10.48620/94398
source_record_id: DOI:10.48620/94398
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:36
last_checked: 2026-08-09 08:25:12
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.48620/94398
text_rights_status: unverified_not_redistributed
title:
Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy: A Systematic Review and Meta-Analysis.

authors:
Florineth, Gianluca Andri, Klima, Isabell, Boeker, Anna Laura, Catzeflis, Polina, Wopfner, Alexander, Denier, Niklaus, Bracht, Tobias, Adorjan, Kristina, Pfammatter, Mario, Müller, Felix, Soravia, Leila Maria

topic_tags:
Depression,Microdosing,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Case Report,Safety,Toxicity,Drug Interactions

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.48620/94398","source_url":"https://doi.org/10.48620/94398","doi":"10.48620/94398","pmid":"","publication_date":"2026-01-21","importer_version":"2.1.3","text_redistributed":false}


journal: Repository for Publications and Research Data (ETH Zurich)
publication_date: 2026-01-20
doi: 10.3929/ethz-c-000793359
source_url: http://hdl.handle.net/20.500.11850/793359
source_record_id: DOI:10.3929/ethz-c-000793359
substance_tags: psilocybin
topic_tags: Pharmacology,Mechanism of Action,Receptor Pharmacology,Toxicity
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:36
last_checked: 2026-08-09 08:25:12
text_rights_status: not_applicable_no_text
title:
Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanisms

authors:
Martina Colognesi, Daniela Gabbia, Anna Signor, Miles Sarill, Lucia Centofanti, Andrea Rinaldi, Luciano Cascione, Sara Nunziata, Marco Banzato, Andrea Mattarei, Giovanna Finzi, Sonia Sonda, Diana Pendin, Ilaria Zanotto, Stefano Comai, Gianfranco Pasut, Abdullah Alajati, Miriam Saponaro, Loredana Bucciarelli, Maria Elena Lunati, Andrea Alimonti, et al.

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.3929/ethz-c-000793359","source_url":"http://hdl.handle.net/20.500.11850/793359","doi":"10.3929/ethz-c-000793359","pmid":"","publication_date":"2026-01-20","importer_version":"2.1.3","text_redistributed":false}


journal: Psychedelic Medicine
publication_date: 2026-01-12
doi: 10.1177/28314425251413425
source_url: https://doi.org/10.1177/28314425251413425
source_record_id: DOI:10.1177/28314425251413425
substance_tags: psilocybin
topic_tags: Anxiety,Addiction,Chronic Pain,Spirituality,Mystical Experience,Toxicity
study_type: Qualitative Study
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:37
last_checked: 2026-08-09 08:25:12
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1177/28314425251413425
text_rights_status: unverified_not_redistributed
title:
Intentions, Spirituality, Set, and Setting Are Associated with Mystical Experiences in Psilocybin-Assisted Therapy

authors:
Kelsey T. Laird, Prabha Siddarth, Ashley Ramos, Rhianna Rich, Brittany Youssef, Grace M. Schwartz, Karina Sergi, Micah Linton, L. Schwartzberg, Daniel F. Kelly, Keith G. Heinzerling

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1177/28314425251413425","source_url":"https://doi.org/10.1177/28314425251413425","doi":"10.1177/28314425251413425","pmid":"","publication_date":"2026-01-12","importer_version":"2.1.3","text_redistributed":false}


title: The impact of drug control on wider research: Psychedelic mushroom exploration
authors: Sam Lasham, Rhys Ponton
journal: Drug Science Policy and Law
publication_date: 2026-01-01
doi: 10.1177/20503245251412697
source_url: https://doi.org/10.1177/20503245251412697
source_record_id: DOI:10.1177/20503245251412697
substance_tags: psilocybin
topic_tags: Pharmacology,Toxicity
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:37
last_checked: 2026-08-09 08:25:13
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1177/20503245251412697
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1177/20503245251412697","source_url":"https://doi.org/10.1177/20503245251412697","doi":"10.1177/20503245251412697","pmid":"","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin Treatment for Refractory Depression: A Clinical Review
authors: Jensen, Hailey A
journal: Digital Commons - Gardner-Webb University (Gardner-Webb University)
publication_date: 2026-01-01
source_url: https://digitalcommons.gardner-webb.edu/pa-department-journal-of-medical-science/63
source_record_id: https://digitalcommons.gardner-webb.edu/pa-department-journal-of-medical-science/63
substance_tags: psilocybin
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:37
last_checked: 2026-08-09 08:25:13
abstract_source: OpenAlex
abstract_source_url: https://digitalcommons.gardner-webb.edu/pa-department-journal-of-medical-science/63
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Chronic Pain,Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"https://digitalcommons.gardner-webb.edu/pa-department-journal-of-medical-science/63","source_url":"https://digitalcommons.gardner-webb.edu/pa-department-journal-of-medical-science/63","doi":"","pmid":"","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}


authors: L. Puhl, L. Kunz, M. Berger, G. Gründer, L. Mertens, M. Spangemacher
journal: Neuroscience Applied
publication_date: 2026-01-01
doi: 10.1016/j.nsa.2025.106390
source_url: https://doi.org/10.1016/j.nsa.2025.106390
source_record_id: DOI:10.1016/j.nsa.2025.106390
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Chronic Pain,Treatment-Resistant Depression,Toxicity
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:37
last_checked: 2026-08-09 08:25:13
text_rights_status: not_applicable_no_text
title:
Relationship between cardiovascular effects and psychedelic experiences under psilocybin in patients with treatment-resistant depression

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2025.106390","source_url":"https://doi.org/10.1016/j.nsa.2025.106390","doi":"10.1016/j.nsa.2025.106390","pmid":"","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}


title: The role of 5-HT2A receptors in sleep architecture and memory consolidation in the animal model
authors: K. Aleksič
journal: Neuroscience Applied
publication_date: 2026-01-01
doi: 10.1016/j.nsa.2025.106729
source_url: https://doi.org/10.1016/j.nsa.2025.106729
source_record_id: DOI:10.1016/j.nsa.2025.106729
substance_tags: psilocybin
topic_tags: Receptor Pharmacology,Animal Study
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:37
last_checked: 2026-08-09 08:25:13
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1016/j.nsa.2025.106729
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2025.106729","source_url":"https://doi.org/10.1016/j.nsa.2025.106729","doi":"10.1016/j.nsa.2025.106729","pmid":"","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}


authors: N. Mcgowan, J. Rucker, R. Yehuda, M. Agrawal, H. Simmons, S. Das, G. Goodwin
journal: Neuroscience Applied
publication_date: 2026-01-01
doi: 10.1016/j.nsa.2025.106821
source_url: https://doi.org/10.1016/j.nsa.2025.106821
source_record_id: DOI:10.1016/j.nsa.2025.106821
substance_tags: psilocybin
topic_tags: Depression,PTSD,Chronic Pain,Pharmacology,Clinical Trial,Safety
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:37
last_checked: 2026-08-09 08:25:13
text_rights_status: not_applicable_no_text
title:
An open-label study of single-dose COMP360 psilocybin for post-traumatic stress disorder: safety, tolerability, and secondary efficacy outcomes

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2025.106821","source_url":"https://doi.org/10.1016/j.nsa.2025.106821","doi":"10.1016/j.nsa.2025.106821","pmid":"","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}


journal: Neuroscience Applied
publication_date: 2026-01-01
doi: 10.1016/j.nsa.2025.106393
source_url: https://doi.org/10.1016/j.nsa.2025.106393
source_record_id: DOI:10.1016/j.nsa.2025.106393
substance_tags: psilocybin
topic_tags: Addiction,Pharmacology,Receptor Pharmacology,Animal Study,Toxicity
study_type: Animal Study
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:37
last_checked: 2026-08-09 08:25:13
text_rights_status: not_applicable_no_text
title:
Psilocybin and ibogaine as therapeutic candidates for cocaine addiction: Insights from a rat self-administration model

authors:
I.R.A. Koutrouli, K. Šíchová, W. Kacper, V. Brejtr, K. Aleksič, N. Miniariková, E. Lhotková, M. Nikolič, T. Páleníček

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2025.106393","source_url":"https://doi.org/10.1016/j.nsa.2025.106393","doi":"10.1016/j.nsa.2025.106393","pmid":"","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}


authors: L. Marwood, M. Young, J. Chai-Rees, S. Mistry, S. Maxwell, G.M. Goodwin
journal: Neuroscience Applied
publication_date: 2026-01-01
doi: 10.1016/j.nsa.2025.106572
source_url: https://doi.org/10.1016/j.nsa.2025.106572
source_record_id: DOI:10.1016/j.nsa.2025.106572
substance_tags: psilocybin
topic_tags: Pharmacology,Clinical Trial,Randomized Controlled Trial,Toxicity
study_type: Randomized Controlled Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:37
last_checked: 2026-08-09 08:25:13
text_rights_status: not_applicable_no_text
title:
The impact of COMP360 psilocybin on anhedonia: post-hoc analyses from a phase IIb randomised controlled trial

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2025.106572","source_url":"https://doi.org/10.1016/j.nsa.2025.106572","doi":"10.1016/j.nsa.2025.106572","pmid":"","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}


journal: Neuroscience Applied
publication_date: 2026-01-01
doi: 10.1016/j.nsa.2025.105779
source_url: https://doi.org/10.1016/j.nsa.2025.105779
source_record_id: DOI:10.1016/j.nsa.2025.105779
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:37
last_checked: 2026-08-09 08:25:13
text_rights_status: not_applicable_no_text
title:
Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE): Results of a randomized active placebo-controlled trial

authors:
L.J. Mertens, M. Koslowski, F. Betzler, M. Brand, R. Evens, L. Krätner, A. Jungaberle, H. Jungaberle, T. Majić, C.N. Schmitz, A. Ströhle, D. Scharf, M. Spangemacher, M. Wolff, Z. Assadi, B. Scharif, L. Becher, L.V. Färber, N. Kirchen, E. Kulakova, L. Kunz, A. Meijer, B. Rohrmoser, S. Wellek, M. Berger, G. Gründer

topic_tags:
Depression,Anxiety,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Safety

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2025.105779","source_url":"https://doi.org/10.1016/j.nsa.2025.105779","doi":"10.1016/j.nsa.2025.105779","pmid":"","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}


journal: Neuroscience Applied
publication_date: 2026-01-01
doi: 10.1016/j.nsa.2025.105782
source_url: https://doi.org/10.1016/j.nsa.2025.105782
source_record_id: DOI:10.1016/j.nsa.2025.105782
substance_tags: psilocybin
topic_tags: Toxicity
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:37
last_checked: 2026-08-09 08:25:13
text_rights_status: not_applicable_no_text
title:
Low dose psilocybin differentially alters resting-state network connectivity in autistic and non-autistic people

authors:
T. Whelan, M. Dimitrov, C.L. Ellis, F. Moruzzi, J. Kangas, N. Khalil, G. Ivin, E. Daly, NA Puts, D.G.M. Murphy, G.M. McAlonan

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2025.105782","source_url":"https://doi.org/10.1016/j.nsa.2025.105782","doi":"10.1016/j.nsa.2025.105782","pmid":"","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}


title: Electrical brain changes following psilocybin administration in sprague-dawley rats
authors: B. Richardson, V. Bruno, J. O'Byrne, G. Gobbi
journal: Neuroscience Applied
publication_date: 2026-01-01
doi: 10.1016/j.nsa.2025.106819
source_url: https://doi.org/10.1016/j.nsa.2025.106819
source_record_id: DOI:10.1016/j.nsa.2025.106819
substance_tags: psilocybin
topic_tags: Pharmacology,Toxicity
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:37
last_checked: 2026-08-09 08:25:13
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2025.106819","source_url":"https://doi.org/10.1016/j.nsa.2025.106819","doi":"10.1016/j.nsa.2025.106819","pmid":"","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}


title: ‘Shroom’ for concern: a case of psychedelic mushroom-induced acute kidney injury
authors: Maurice Lam, C. Khor, S. Hultin, J. J. Cheung, N. A. Shah
journal: Internal Medicine Journal
publication_date: 2026-01-01
doi: 10.1111/imj.70313
pubmed_id: 41518153
source_url: https://doi.org/10.1111/imj.70313
source_record_id: PMID:41518153
substance_tags: psilocybin
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:37
last_checked: 2026-08-09 08:25:13
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1111/imj.70313
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Anxiety,Addiction,OCD,Chronic Pain,Mechanism of Action,Receptor Pharmacology,Safety,Toxicity

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"PMID:41518153","source_url":"https://doi.org/10.1111/imj.70313","doi":"10.1111/imj.70313","pmid":"41518153","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}


title: Effects of Serotonergic Psychedelics on Synaptic Function and Neuroplasticity
authors: Aneta Petrušková
journal: OPUS FAU - Online publication system of Friedrich-Alexander-Universität Erlangen-Nürnberg
publication_date: 2025-12-31
doi: 10.25593/open-fau-2619
source_url: https://open.fau.de/handle/openfau/38445
source_record_id: DOI:10.25593/open-fau-2619
substance_tags: psilocin
study_type: Animal Study
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:37
last_checked: 2026-07-04 07:00:32
abstract_source: OpenAlex
abstract_source_url: https://open.fau.de/handle/openfau/38445
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Anxiety,Addiction,End-of-Life Distress,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Animal Study,Toxicity

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.25593/open-fau-2619","source_url":"https://open.fau.de/handle/openfau/38445","doi":"10.25593/open-fau-2619","pmid":"","publication_date":"2025-12-31","importer_version":"2.1.3","text_redistributed":false}


authors: Hannah Whitmore, Maria Mangini, Heather Leutwyler, Brian Anderson
journal: Palliative Medicine Reports
publication_date: 2026-01-01
doi: 10.1177/26892820251401798
source_url: https://doi.org/10.1177/26892820251401798
source_record_id: DOI:10.1177/26892820251401798
substance_tags: psilocybin
topic_tags: Anxiety,Emotional Processing,Clinical Trial,Toxicity
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:37
last_checked: 2026-08-09 08:25:13
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1177/26892820251401798
text_rights_status: unverified_not_redistributed
title:
Facing Mortality Together: A Constructivist Grounded Theory Analysis of Group Psilocybin Therapy Among Older Long-Term AIDS Survivor Gay Men

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1177/26892820251401798","source_url":"https://doi.org/10.1177/26892820251401798","doi":"10.1177/26892820251401798","pmid":"","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}


journal: Figshare
publication_date: 2026-01-01
doi: 10.6084/m9.figshare.31199189.v1
source_url: https://doi.org/10.6084/m9.figshare.31199189.v1
source_record_id: DOI:10.6084/m9.figshare.31199189.v1
substance_tags: psilocybin
topic_tags: Eating Disorders
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:37
last_checked: 2026-08-09 08:25:13
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.6084/m9.figshare.31199189.v1
text_rights_status: unverified_not_redistributed
title:
Additional file 2 of An open-label pilot study of psilocybin-assisted therapy for binge eating disorder

authors:
Jesse Dallery, Jennifer L. Miller, Jeff Boissoneault, Lauren Harvey, Lindsey Ives, Alexandra Knerr, Shelby Blaes, Morgan N. Ransom, Melissa S. Munson, James P. Gilligan, Michael H. Silverman, Peter R. Guzzo, Beverlee Loeser

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.6084/m9.figshare.31199189.v1","source_url":"https://doi.org/10.6084/m9.figshare.31199189.v1","doi":"10.6084/m9.figshare.31199189.v1","pmid":"","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}


journal: Figshare
publication_date: 2026-01-01
doi: 10.6084/m9.figshare.31199186.v1
source_url: https://doi.org/10.6084/m9.figshare.31199186.v1
source_record_id: DOI:10.6084/m9.figshare.31199186.v1
substance_tags: psilocybin
topic_tags: Eating Disorders
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:37
last_checked: 2026-08-09 08:25:13
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.6084/m9.figshare.31199186.v1
text_rights_status: unverified_not_redistributed
title:
Additional file 1 of An open-label pilot study of psilocybin-assisted therapy for binge eating disorder

authors:
Jesse Dallery, Jennifer L. Miller, Jeff Boissoneault, Lauren Harvey, Lindsey Ives, Alexandra Knerr, Shelby Blaes, Morgan N. Ransom, Melissa S. Munson, James P. Gilligan, Michael H. Silverman, Peter R. Guzzo, Beverlee Loeser

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.6084/m9.figshare.31199186.v1","source_url":"https://doi.org/10.6084/m9.figshare.31199186.v1","doi":"10.6084/m9.figshare.31199186.v1","pmid":"","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}


authors: Belle Buzzi
journal: VCU Scholars Compass (Virginia Commonwealth University)
publication_date: 2026-01-01
source_url: https://scholarscompass.vcu.edu/etd/8246
source_record_id: https://scholarscompass.vcu.edu/etd/8246
substance_tags: psilocybin
study_type: Animal Study
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:37
last_checked: 2026-08-09 08:25:13
abstract_source: OpenAlex
abstract_source_url: https://scholarscompass.vcu.edu/etd/8246
text_rights_status: unverified_not_redistributed
title:
Exploring Psychedelics as Novel Therapeutics for Smoking Cessation: Mechanistic Insights from Animal Studies

topic_tags:
Depression,Addiction,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Animal Study

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"https://scholarscompass.vcu.edu/etd/8246","source_url":"https://scholarscompass.vcu.edu/etd/8246","doi":"","pmid":"","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelic-assisted psychotherapy: Clarifying the role of the "psychotherapy"
authors: Stefan Jerotić, Olga Čolović, Nađa Marić
journal: Medicinska istrazivanja
publication_date: 2026-01-01
doi: 10.5937/medi0-62051
source_url: https://doi.org/10.5937/medi0-62051
source_record_id: DOI:10.5937/medi0-62051
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:37
last_checked: 2026-08-09 08:25:13
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.5937/medi0-62051
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,PTSD,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Review Article,Toxicity

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.5937/medi0-62051","source_url":"https://doi.org/10.5937/medi0-62051","doi":"10.5937/medi0-62051","pmid":"","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}


journal: Journal of the Brazilian Chemical Society
publication_date: 2026-01-01
doi: 10.21577/0103-5053.20260049
source_url: https://doi.org/10.21577/0103-5053.20260049
source_record_id: DOI:10.21577/0103-5053.20260049
substance_tags: psilocybin,psilocin
topic_tags: Depression,Anxiety,PTSD
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:37
last_checked: 2026-08-09 08:25:13
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.21577/0103-5053.20260049
text_rights_status: unverified_not_redistributed
title:
Optimization of Psilocybin Extraction from Psilocybe cubensis Mushrooms and Characterization of the Fungal Extract

authors:
Mateus Araújo da Luz, Taynah Pereira Galdino, Lucas Matheus da S. Oliveira, H. Guedes, Anauara Silva, Victor I. Afonso, Suédina M. L. Silva, Antônio G. B. Lima, Marcus V. L. Fook, Maria C. M. Torres

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.21577/0103-5053.20260049","source_url":"https://doi.org/10.21577/0103-5053.20260049","doi":"10.21577/0103-5053.20260049","pmid":"","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}


authors: Yosr Ziadi, Taehwan Park
journal: Open MIND
publication_date: 2026-01-01
doi: 10.17605/osf.io/nrt59
source_url: https://osf.io/nrt59
source_record_id: DOI:10.17605/osf.io/nrt59
substance_tags: psilocybin
topic_tags: Depression,Chronic Pain,Clinical Trial,Treatment-Resistant Depression
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:37
last_checked: 2026-08-09 08:25:13
abstract_source: OpenAlex
abstract_source_url: https://osf.io/nrt59
text_rights_status: unverified_not_redistributed
title:
Cost-Effectiveness of Psilocybin-Assisted Therapy (PAT) for Patients with Treatment-Resistant Depression

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.17605/osf.io/nrt59","source_url":"https://osf.io/nrt59","doi":"10.17605/osf.io/nrt59","pmid":"","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}


journal: Neuroscience Applied
publication_date: 2026-01-01
doi: 10.1016/j.nsa.2026.106906
source_url: https://doi.org/10.1016/j.nsa.2026.106906
source_record_id: DOI:10.1016/j.nsa.2026.106906
substance_tags: psilocybin
topic_tags: General
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:37
last_checked: 2026-08-09 08:25:13
text_rights_status: not_applicable_no_text
title:
Dynamic response of intrinsic connectivity networks to low-dose psilocybin during face matching in autistic adults

authors:
Y. Ge, T.P. Whelan, M. Dimitrov, C.L. Ellis, F. Moruzzi, J. Kangas, F.M. Ponteduro, N. Khalil, S. Fenn-Moltu, NA Puts, E. Daly, D.G.M. Murphy, G.M. McAlonan, D. Batalle

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2026.106906","source_url":"https://doi.org/10.1016/j.nsa.2026.106906","doi":"10.1016/j.nsa.2026.106906","pmid":"","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}


authors: I. Totomanova, E.C.H.M. Haijen, P.P.M. Hurks, NL Mason, JG Ramaekers, K.P.C. Kuypers
journal: Neuroscience Applied
publication_date: 2026-01-01
doi: 10.1016/j.nsa.2026.106942
source_url: https://doi.org/10.1016/j.nsa.2026.106942
source_record_id: DOI:10.1016/j.nsa.2026.106942
substance_tags: psilocybin
topic_tags: Chronic Pain,Microdosing
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:37
last_checked: 2026-08-09 08:25:13
text_rights_status: not_applicable_no_text
title:
Self-reported benefits and harms of microdosing with natural psilocybin: preliminary results from a naturalistic study

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2026.106942","source_url":"https://doi.org/10.1016/j.nsa.2026.106942","doi":"10.1016/j.nsa.2026.106942","pmid":"","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}


authors: E. Lopez, J O Lundberg, F. Hieronymus, M. Beckman, H. Yngwe, C.J. Ekman, M. Tiger, N. Edvall
journal: Neuroscience Applied
publication_date: 2026-01-01
doi: 10.1016/j.nsa.2026.106904
source_url: https://doi.org/10.1016/j.nsa.2026.106904
source_record_id: DOI:10.1016/j.nsa.2026.106904
substance_tags: psilocybin
topic_tags: Chronic Pain,Pharmacology,Clinical Trial,Toxicity
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:37
last_checked: 2026-08-09 08:25:13
text_rights_status: not_applicable_no_text
title:
Symptom-level antidepressant response to psilocybin: exploratory outcomes comparing psilocybin treatment to niacin

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2026.106904","source_url":"https://doi.org/10.1016/j.nsa.2026.106904","doi":"10.1016/j.nsa.2026.106904","pmid":"","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelics and Mental Health: Psilocybin and Depression. A Sistematic Review
authors: Marta Gómez Álvarez, Javier Calleja-Conde, Víctor Echeverry-Alzate
journal: Open Science Framework
publication_date: 2026-01-01
doi: 10.17605/osf.io/yu3n9
source_url: https://doi.org/10.17605/osf.io/yu3n9
source_record_id: DOI:10.17605/osf.io/yu3n9
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:37
last_checked: 2026-08-09 08:25:13
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.17605/osf.io/yu3n9
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Addiction,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Toxicity

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.17605/osf.io/yu3n9","source_url":"https://doi.org/10.17605/osf.io/yu3n9","doi":"10.17605/osf.io/yu3n9","pmid":"","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}


authors: Mahvash Khan, Muhammad Omar Malik, Sara Sajjad, Muhammad Uzair, Inayat Shah, Muhammad Ismail Bhatti
journal: Genetics and Molecular Research
publication_date: 2026-01-01
doi: 10.4238/e91xh631
source_url: https://doi.org/10.4238/e91xh631
source_record_id: DOI:10.4238/e91xh631
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:37
last_checked: 2026-08-09 08:25:13
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.4238/e91xh631
text_rights_status: unverified_not_redistributed
title:
COMBINATION OF PSILOCYBIN AND COGNITIVE BEHAVIORAL THERAPY IMPROVES OXYTOCIN LEVELS AND DEPRESSIVE SYMPTOMS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER

topic_tags:
Depression,Anxiety,OCD,Pharmacology,Receptor Pharmacology,Emotional Processing,Randomized Controlled Trial,Drug Interactions

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.4238/e91xh631","source_url":"https://doi.org/10.4238/e91xh631","doi":"10.4238/e91xh631","pmid":"","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}


title: Motivation-based subtypes of psilocybin microdosers
authors: Ethan Klukas
journal: Open Collections
publication_date: 2026-01-01
doi: 10.14288/1.0452623
source_url: https://doi.org/10.14288/1.0452623
source_record_id: DOI:10.14288/1.0452623
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Microdosing,Wellbeing,Creativity,Randomized Controlled Trial,Toxicity
study_type: Randomized Controlled Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:37
last_checked: 2026-08-09 08:25:13
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.14288/1.0452623
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.14288/1.0452623","source_url":"https://doi.org/10.14288/1.0452623","doi":"10.14288/1.0452623","pmid":"","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelics and neuroanesthesia: A narrative review of converging mechanisms
authors: Kunal Kumar Sharma
journal: Journal of Scientific Innovations in Anesthesiology
publication_date: 2025-12-31
doi: 10.65929/jsia.2026.1.2.002
source_url: https://doi.org/10.65929/jsia.2026.1.2.002
source_record_id: DOI:10.65929/jsia.2026.1.2.002
substance_tags: psilocybin
study_type: Review Article
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:37
last_checked: 2026-07-04 07:00:32
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.65929/jsia.2026.1.2.002
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Review Article,Treatment-Resistant Depression,Toxicity,Drug Interactions

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.65929/jsia.2026.1.2.002","source_url":"https://doi.org/10.65929/jsia.2026.1.2.002","doi":"10.65929/jsia.2026.1.2.002","pmid":"","publication_date":"2025-12-31","importer_version":"2.1.3","text_redistributed":false}


authors: Manasicha Wongpaiboon, Jackson L. Shelton, Eric Delgado Rendon, Maddison Vail
journal: Current Treatment Options in Psychiatry
publication_date: 2025-12-25
doi: 10.1007/s40501-025-00373-w
source_url: https://doi.org/10.1007/s40501-025-00373-w
source_record_id: DOI:10.1007/s40501-025-00373-w
substance_tags: psilocybin
topic_tags: PTSD,Pharmacology,Clinical Trial,Meta-Analysis,Systematic Review,Review Article,Safety,Toxicity
study_type: Meta-Analysis
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:37
last_checked: 2026-07-04 06:34:37
text_rights_status: not_applicable_no_text
title:
A Systematic Review of the efficacy, safety, and Tolerability of Psychedelics in the Treatment of post-traumatic Stress Disorder

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1007/s40501-025-00373-w","source_url":"https://doi.org/10.1007/s40501-025-00373-w","doi":"10.1007/s40501-025-00373-w","pmid":"","publication_date":"2025-12-25","importer_version":"2.1.3","text_redistributed":false}


journal: Psychedelic medicine (New Rochelle, N.Y.)
publication_date: 2026-09-01
doi: 10.1177/28314425251387655
pubmed_id: 42539824
source_url: https://pubmed.ncbi.nlm.nih.gov/42539824/
source_record_id: PMID:42539824
substance_tags: psilocybin
topic_tags: Addiction,Mechanism of Action,Wellbeing
study_type: Clinical Trial
source_name: PubMed
publication_status: published
date_added: 2026-07-04 06:34:37
last_checked: 2026-08-09 08:27:44
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/42539824/
text_rights_status: unverified_not_redistributed
title:
A Nature-Themed Video Intervention Increases Nature Relatedness in Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder.

authors:
Rich R, Laird K, Siddarth P, Youssef B, Schwartz GM, Ramos A, Sergi K, Linton M, Schwartzberg L, Kelly DF, Heinzerling KG

source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:42539824","source_url":"https://pubmed.ncbi.nlm.nih.gov/42539824/","doi":"10.1177/28314425251387655","pmid":"42539824","publication_date":"2026-09-01","importer_version":"2.1.3","text_redistributed":false}


authors: Fei Liu, Jiaxin Li, Wen-Qiang Yang, Mao-Qiang He, Bin Cao, Qi Wu, R. Cheewangkoon, Rui-Lin Zhao
journal: Mycosphere
publication_date: 2025-12-25
doi: 10.5943/mycosphere/16/1/28
source_url: https://doi.org/10.5943/mycosphere/16/1/28
source_record_id: DOI:10.5943/mycosphere/16/1/28
substance_tags: psilocybin
topic_tags: Genomics,Transcriptomics
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:37
last_checked: 2026-08-09 08:25:14
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.5943/mycosphere/16/1/28
text_rights_status: unverified_not_redistributed
title:
Evolution and horizontal transfer of the psilocybin biosynthetic gene cluster drive the diversification of magic mushrooms

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.5943/mycosphere/16/1/28","source_url":"https://doi.org/10.5943/mycosphere/16/1/28","doi":"10.5943/mycosphere/16/1/28","pmid":"","publication_date":"2025-12-25","importer_version":"2.1.3","text_redistributed":false}


title: The genus Psilocybe in Italy
authors: Giuseppe Venturella, Manuela Rollini, Giulia Mirabile, Nicola Favia, Maria Letizia Gargano
journal: Italian Botanist
publication_date: 2025-12-22
doi: 10.3897/italianbotanist.20.181001
source_url: https://doi.org/10.3897/italianbotanist.20.181001
source_record_id: DOI:10.3897/italianbotanist.20.181001
substance_tags: psilocybin,psilocin
topic_tags: General
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:37
last_checked: 2026-08-09 08:25:14
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.3897/italianbotanist.20.181001
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.3897/italianbotanist.20.181001","source_url":"https://doi.org/10.3897/italianbotanist.20.181001","doi":"10.3897/italianbotanist.20.181001","pmid":"","publication_date":"2025-12-22","importer_version":"2.1.3","text_redistributed":false}


authors: Dana W. Sawyer
journal: Religions
publication_date: 2025-12-22
doi: 10.3390/rel17010009
source_url: https://doi.org/10.3390/rel17010009
source_record_id: DOI:10.3390/rel17010009
substance_tags: psilocybin
topic_tags: Consciousness,Spirituality,Mystical Experience
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:37
last_checked: 2026-08-09 08:25:14
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.3390/rel17010009
text_rights_status: unverified_not_redistributed
title:
Allowing Similarities: Using Aldous Huxley’s Views on Mystical Experience to Assess the Import of Profound Unitive Experiences Occasioned by Psychedelic Substances

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.3390/rel17010009","source_url":"https://doi.org/10.3390/rel17010009","doi":"10.3390/rel17010009","pmid":"","publication_date":"2025-12-22","importer_version":"2.1.3","text_redistributed":false}


journal: Psychology International
publication_date: 2025-12-19
doi: 10.3390/psycholint8010001
source_url: https://doi.org/10.3390/psycholint8010001
source_record_id: DOI:10.3390/psycholint8010001
substance_tags: psilocybin
study_type: Observational Study
source_name: OpenAlex
publication_status: published
date_added: 2026-07-04 06:34:37
last_checked: 2026-08-09 08:25:14
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.3390/psycholint8010001
text_rights_status: unverified_not_redistributed
title:
Effects of LSD and Psilocybin on Heart Rate in Patients Receiving Psychedelic Treatment for Depressive and Anxiety Disorders: A Retrospective Observational Study

authors:
Mylène Cheng, Tatiana Aboulafia Brakha, Albert Buchard, Raya Anastasova, Léa Girani, Anna Breitenmoser, Sylvie Alaux, Cédric Mabilais, Caroline Amberger, Federico Seragnoli, Leonice Furtado, Gabriel Thorens, Daniele Zullino, Louise Penzenstadler

topic_tags:
Depression,Anxiety,Chronic Pain,Observational Study,Treatment-Resistant Depression,Adverse Events,Toxicity,Drug Interactions

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.3390/psycholint8010001","source_url":"https://doi.org/10.3390/psycholint8010001","doi":"10.3390/psycholint8010001","pmid":"","publication_date":"2025-12-19","importer_version":"2.1.3","text_redistributed":false}


